Hopanoids Producing Bacteria and Related Biofertilizers, Compositions, Methods and Systems by Kulkarni, Gargi et al.
1111111111111111111i11111n11111uu1111111111u~
(12) United States Patent
Newman et al.
(54) HOPANOIDS PRODUCING BACTERIA AND
RELATED BIOFERTILIZERS,
COMPOSITIONS, METHODS AND SYSTEMS
(71) Applicant: CALIFORNIA INSTITUTE OF
TECHNOLOGY, Pasadena, CA (US)
(72) Inventors: Dianne K. Newman, Pasadena, CA
(US); Gargi Kulkarni, Pasadena, CA
(US); Brittany Jo Belin, Pasadena, CA
(US); Eric Geraud, Marseilles (FR);
Antonio Molinaro, Napoli (IT); Alba
Silipo, Napoli (IT)
(73) Assignee: CALIFORNIA INSTITUTE OF
TECHNOLOGY, Pasadena, CA (US)
(*) Notice: Subject to any disclaimer, the term of this
patent is extended or adjusted under 35
U.S.C. 154(b) by 0 days.
(21) Appl. No.: 15/298,172
(22) Filed: Oct. 19, 2016
(65) Prior Publication Data
US 2017/0107160 Al Apr. 20, 2017
Related U.S. Application Data
(60) Provisional application No. 62/243,418, filed on Oct.
19, 2015.
(51) Int. Cl.
AOIN 43/40 (2006.01)
C12N 1/00 (2006.01)
C12N 15/52 (2006.01)
C12N 15/82 (2006.01)
C05F 11/08 (2006.01)
C12N 1/20 (2006.01)
C12N 1114 (2006.01)
AOIN 63100 (2006.01)
(52) U.S. Cl.
CPC ................ C05F 11/08 (2013.01); C12N 1/20
(2013.01); AOIN 63100 (2013.01); C12N 1114
(2013.01); C12N 15152 (2013.01); C12N 15182
(2013.01); C12Y 402/01084 (2013.01)
(58) Field of Classification Search
CPC . C12N 1/20; C05F 11/00; C05F 11/08; GO1N
33/92
USPC ............ 435/252.2, 320.1, 157, 243; 504/101
See application file for complete search history.
(56) References Cited
U.S. PATENT DOCUMENTS
9,187,381 B1 * 11/2015 Lanz ...................... AOIN 63/02
OTHER PUBLICATIONS
Devos et al., (Proteins: Structure, Function and Genetics, 2000, vol.
41: 98-107).*
Whisstock et al., (Quarterly Reviews of Biophysics 2003, vol. 36
(3): 307-340.*
(io) Patent No.: US 10,131,585 B2
(45) Date of Patent: Nov. 20, 2018
Witkowski et al., (Biochemistry 38:11643-11650, 1999.*
Kisselev L., (Structure, 2002, vol. 10: 8-9.*
Komanieck et al. JBC 2014, 289, pp. 35644-35655.*
Poonia et al. Intl. j. of Eng and Man res 2011 pp. 36-38.*
Battacharjee et al. ( App Microbiol Biotech 2008, pp. 199-209.*
Bravo et al.: Fur J. Biochem 2001,268, 1323-1331.*
Casadaban, M.J. et al., "Analysis of Gene-Control Signals by
DNA-Fusion and Cloning in Escherichia-coli", Journal of Molecu-
lar Biology, 138(2), pp. 179-207, (1980).
Ehrhardt, D.W. et al., "Depolarization of Alfalfa Root Hair Mem-
brane Potential by Rhizobium meliloti Nod Factors", 256(5059), pp.
998-1000, (1992).
Kannenberg, E.L. et al., "The Occurrence of Hopanoid Lipids in
Bradyrhizobium Bacteria", FEMS Microbiology Letters, 127(3),
pp. 255-261, (1995).
Leontein, K. et al., "Assignment of Absolute-Configuration of
Sugars by g.l.c of Their Acetylated Glycosides Formed from Chiral
Alcohols", Carbohydrate Research, 62(2), pp. 359-362, (1978), 5
pages.
Markowitz, V.M. et al., "Comparative Genome Analysis in the
Integrated Microbial Genomes (IMG) System", Methods Mol.
Biol., 395, pp. 35-56, (2007), 23 pages.
Oldroyd, G.E. et al., "The Rules of Engagement in the Legume-
Rhizobial Symbiosis", Annu Rev Genet, 45, pp. 119-144, (2011), 28
pages.
Pearson, W.R. "Searching Protein Sequence Libraries: Comparison
of the Sensitivity and Selectivity of the Smith-Waterman and
FASTA Algorithms", Genomics, 11(3), pp. 635-650. 16 pages,
(1991).
Regensburger, B. et al., "RNA-Polymerase from Rhizobium japonieum",
Archives of Microbiology, 135(2), pp. 103-109, (1983), 9 pages.
Schafer, A. et al., "Small Mobilizable Multi-Purpose Cloning Vec-
tors Derived from the Escherichia coli Plasmids pK18 and pK19:
Selection of Defined Deletions in the Chromosome of Corynebacterium
glutamicum", Gene, 145(1), pp. 69-73, (1994).
Simon, R. et al., "A Broad Host Range Mobilization System for in
vivo Genetic-Engineering: Transposon Mutagenesis in Gram-
Negative Bacteria", Bio-Technology, 1(9), pp. 784-791, (1983), 10
pages.
Talbot, H.M. et al., "Structural Characterisation of Unsaturated
Bacterial Hopanoids by Atmospheric Pressure Chemical Ionisation
Liquid Chromatography/Ion Trap Mass Spectrometry", Rapid Com-
munications in Mass Spectrometry, 21, pp. 1613-1622. 10 pages,
(2007).
Talbot, H.M. et al., "Characteristic Fragmentation of
Bacteriohopanepolyols During Atmospheric Pressure Chemical Ionisa-
tion Liquid Chromatography/Ion Trap Mass Spectrometry", Rapid
Communications in Mass Spectrometry, 17, pp. 2788-2796. 9
pages, (2003).
Westphal, O. et al., ` Bacterial Lipopolysaccharide-Extraction with
Phenol-Water and Further Applications of the Procedure', Methods
Carbohydr Chem, 43, pp. 83-91, (1965).
* cited by examiner
Primary Examiner Robert B Mondesi
Assistant Examiner Mohammad Y Meah
(74) Attorney, Agent, or Firm Steinfl + Bruno LLP
(57) ABSTRACT
Hopanoids, hopanoids -producing nitrogen-fixing bacteria,
and related formulations, systems and methods are described
herein. In particular, hopanoids alone or in combination with
hopanoid-producing nitrogen-fixing bacteria can be used as
biofertilizer to stimulate plant growth and yield with
enhanced tolerance to diverse stresses found in plant-mi-
crobe symbiotic microenvironments.
26 Claims, 14 Drawing Sheets
Specification includes a Sequence Listing.
https://ntrs.nasa.gov/search.jsp?R=20190000749 2019-08-30T09:57:29+00:00Z
U.S. Patent Nov. 20, 2018 Sheet 1 of 14 US 10,131,585 B2
A} off
R R R I R 
ON H
VO, 
Hop-97(21)-ene (II) Hop42(29)-ene Hopan-21-ene (V) Hopan-22-o1 Tetrahymanol (VII)
(IV, Diploptene) (VI, Diplopterol)
H
ON N ON ON r i„
1
R...... a;.. Hz R '. 6N OHL Fl,
O H
BHP-608 (Vill) Aminobacteriohopanetriol (a) Bacteriohopanetetrol (b) Adenosylhopane (d)
R, = H., CH,
B} Na~a:: €3Etttl~i
FIG. 1
U.S. Patent Nov. 20, 2018 Sheet 2 of 14 US 10,131,585 B2
A)
_ of OH
1 
~•._~~r 
OH~352
Hopanoid
OH
20
Totrahymanol
Rs H. or CH,: R, = OH or NH,
B)
~S)4~~r`r$~GXXhQ,~ r4~~ re~a
, ~> > =<I 4llJDlL'lDi> < 1 L—><'-",
Shc 
I I
' t Hpnp ~llEE
HprtH
T-methyldiplopcene
Rffi,
-~adenosyl hopane E
OH OH
100.: 
-IV WT
VEI
50 I /V V)
J
Vili 
X100 • ` o 'I I AhpnP;
d q +
R
gs100, tori_; p --,
c~ Ah nH I
50
16 18 20 22 24 26 T28 30 32 34 36 38 40
Time (min)
FIG. 2
U.S. Patent Nov. 20, 2018 Sheet 3 of 14 US 10,131,585 B2
Root Nodule Nodule cross-section Plant Cells Symbiosome
3~
i.
-------
Nodule Cortical Cells Infected Zone Plant Nucleus Bacteroids Plant Cell Walt Bacteroid
Plant Cell Wall Peribacteroid Plant Membrane
FIG. 3
U.S. Patent Nov. 20, 2018 Sheet 4 of 14 US 10,131,585 B2
Penta-acylated Hexa-acylated Lipid A
1001 Lipid A 2622.8412128-36 WT
Hepta-acylated Lipid A
3135.22
so
+ Hopanoid + Hopanoid
A-------------- y Traces of
2'°' hopanoid
10-.~_. .w , 36:36.67
100 
Hem- acylated Lipid A
2607.56
AhpnA
w
.y
4)50-Hepta-acylated Lipid A
Penta-acylated 3121.09
Lipid A + Hopanoid + Hopanoid
o — Traces of
2128.96 
I 
I 
211 hopanoid
10
 1
... ~.ILI.,...i_... ,....aJ II 3636.11
2000 2360 2720
Hexa-acylated Lipid A
100-1 12609.53
Penta-acylated
Lipid A trace
t212 80
10 LiIr~YY.l..,i
AhpnH
2000 2360 2720 30
Mass (mlz)
FIG. 4
U.S. Patent Nov. 20, 2018 Sheet 5 of 14 US 10,131,585 B2
OA
0.38
0.38
0.34
0.32
0,3
~nrUe1 r. yn<».
WT AhpnP AhpnH
FIG. 5
U.S. Patent Nov. 20, 2018 Sheet 6 of 14 US 10,131,585 B2
FIG. 6
U.S. Patent Nov. 20, 2018 Sheet 7 of 14 US 10,131,585 B2
Q) Aerobic -30-C B) Aerobic - 37°C
1.5 1.5L X: C`:•
1
Cl
0.5 0.5
0 S0 100 ISO 200 p ...$0 1DO 150 200
F) G)
= 5 1 E+ly
N 4 i
0 3< **> L1E+4+11 2' * QlE+2is! --- 
SDS H2O, HC1 H2O NCR336
• WT C_ AhpnP `; xAhpnH
FIG. 7
U.S. Patent Nov. 20, 2018 Sheet 8 of 14 US 10,131,585 B2
AhpnH
AhpnP
B
r G
FIG. 8
U.S. Patent Nov. 20, 2018 Sheet 9 of 14 US 10,131,585 B2
B
Q ~
FIG. 9
U.S. Patent Nov. 20, 2018 Sheet 10 of 14 US 10,131,585 B2
m 1
1
n
c B
m
a 0.8
.c
0 0.6
4 0.4
U
Q 0.2
a
9 d.p.i. 14 d.p.i. 21 d.p.i.
9 d.pJ. 14 d.pJ. 21 d.p.i.
WT ' OhpnH q .AhpnP
FIG. l.0
U.S. Patent
1
~Y
M
Nov. 20, 2018
hpnP she hpnN
Sheet 11 of 14
FIG. 11
US 10,131,585 B2
U.S. Patent Nov. 20, 2018 Sheet 12 of 14 US 10,131,585 B2
FIG. 12
U.R. Patent &nv 20 2018 Sheet 13 of 14 US 10,131,383 G2
a. z ..... : .. .. ... > w
: + ~ \
©~'~.yy#<
+ : : ; w ''. .«_ma l.y .
.
.. , 2 :
4,4~
13
FIG. 13
U.S. Patent
Fl
~3.
Nov. 20, 2018 Sheet 14 of 14 US 10,131,585 B2
r,„
..... . ......... ............
C.
LO
m
Q
vMSX 6111%
4 8 8 10 13 16 19 22 25 28 31 34 37 40
dpi
~
{1 A
{
,C G C.A
...... 
fiiiii;•iiii.
..:...
WT -hmm wl -"~i WT -hpnm
FIG. 14
US 10,131,585 B2
HOPANOIDS PRODUCING BACTERIA AND
RELATED BIOFERTILIZERS,
COMPOSITIONS, METHODS AND SYSTEMS
CROSS REFERENCE TO RELATED 5
APPLICATIONS
The present application claims priority to U.S. Provisional
Application No. 62/243,418, entitled "Using Hopanoids to
Improve Stress Resistance in Biological Nitrogen Fixation" 10
filed on Oct. 19, 2015, which is incorporated herein by
reference in its entirety.
STATEMENT OF GOVERNMENT GRANT
15
This invention was made with government support under
Grant No. NNX12AD93G awarded by NASA, under Grant
No. CHE1224158 awarded by the National Science Foun-
dation, and under Grant No. 06434 awarded by the Howard
Hughes Medical Institute (HHMI). The government has 20
certain rights in the invention.
FIELD
The present disclosure relates to hopanoids, hopanoids 25
producing bacteria and related biofertilizers, microorgan-
isms, compositions, methods and systems comprising
hopanoid-producing microorganisms and related formula-
tions, and uses as biofertilizer in agriculture industry.
30
BACKGROUND
The exploitation of beneficial microbes as a biofertilizer
has become of paramount importance in agriculture sector
for their potential role in food safety and sustainable crop 35
production.
There remains however a challenge for developing eco-
friendly and economically feasible alternatives to chemical
fertilizers, which can improve soil fertility, health of the
environment, and agricultural productivity particularly 40
under different soil conditions.
SUMMARY
Provided herein are hopanoid-producing bacteria, and 45
related biofertilizers, microorganisms, formulations, and
methods which can comprise one or more particular types of
hopanoids and/or one or more hopanoid-producing nitrogen-
fixing bacteria. In several embodiments, the microorgan-
isms, and related biofertilizers, compositions methods and 50
systems described herein can improve stress-resistance dur-
ing the progression of plant-microbe symbiosis and in
particular of a legume-microbe symbiosis.
According to a first aspect, a biofertilizer for a leguminous
plant is described. The biofertilizer essentially consists of 55
one or more nitrogen-fixing rhizobia capable of producing
C35 hopanoids. In the biofertilizer, the one or more nitrogen-
fixing rhizobia capable of producing C35 hopanoids are in a
form suitable for administration to one or more leguminous
plant or seed, and/or for administration to a soil surrounding 60
the one or more leguminous plant or seed. In some embodi-
ments, the biofertilizer is in combination with carrier allow-
ing increased stability, viability and/or effectiveness of the
nitrogen-fixing bacteria gas exchance of the one or more
nitrogen-fixing rhizobia. 65
According to a second aspect, a method to provide a
biofertilizer for a leguminous plant, is described. The
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method comprises providing one or more candidate nitrogen
fixing rhizobia strains. The method further comprises detect-
ing among the one or more candidate nitrogen fixing rhizo-
bia strains, at least one rhizobia strain capable of producing
C35 hopanoids. The method further comprises providing the
at least one rhizobia strain capable of producing C35
hopanoids in a form suitable for administration to a legu-
minous plant or seed or soil surrounding a leguminous plant
or seed, thus providing a biofertilizer for the leguminous
plant. In some embodiments, the method further comprises
providing the at least one rhizobia strain capable of produc-
ing C35 hopanoids in combination with carrier allowing
increased stability, viability and/or effectiveness of the nitro-
gen-fixing bacteria gas exchance of the one or more nitro-
gen-fixing rhizobia.
According to a third aspect, a method to provide a
biofertilizer for a leguminous plant, is described. The
method comprises genetically engineering a nitrogen fixing
rhizobia strain incapable of producing C35 hopanoids to
introduce C35 synthesis genes thus providing a genetically
engineered nitrogen fixing rhizobia strains capable of pro-
ducing C35 hopanoids. The method further comprises pro-
viding the genetically engineered nitrogen fixing rhizobia
strains in a form suitable for administration to a leguminous
plant or seed, and/or a soil surrounding leguminous plant or
seed thus providing the biofertilizer for the leguminous
plant.
According to a fourth aspect, a biofertilizer composition
for a leguminous plant is described. The biofertilizer com-
position comprises one or more biofertilizers essentially
consisting of one or more nitrogen-fixing rhizobia capable of
producing C35 hopanoids and an acceptable vehicle. In some
embodiments, the biofertilizer composition can further com-
prise one or more C35 hopanoids. In the biofertilizer com-
position the one or more biofertilizers and the vehicle are
formulated for administration to a leguminous plant and/or
for administration to a leguminous seed. In some embodi-
ments the vehicle comprises at least one carrier allowing
increased stability, viability and/or effectiveness of the nitro-
gen-fixing bacteria gas exchance of the one or more nitro-
gen-fixing rhizobia.
According to a fifth aspect, a biofertilizer composition is
described. The biofertilizer composition comprises one or
more nitrogen-fixing rhizobia capable of producing C35
hopanoids and one or more C35 hopanoids. In some embodi-
ments the composition can be formulated for administration
to a leguminous plant, a leguminous seed and/or soil sur-
rounding the leguminous plant or leguminous seed. In some
embodiments, the biofertilizer composition further com-
prises one or more carriers allowing increased stability,
viability and/or effectiveness of the nitrogen-fixing bacteria
gas exchance of the one or more nitrogen-fixing rhizobia.
According to a sixth aspect, a genetically modified nitro-
gen-fixing rhizobium is described. The genetically modified
nitrogen-fixing rhizobium is a rhizobium naturally incapable
of producing C35 hopanoids and genetically engineered to
produce C35 hopanoids.
According to a seventh aspect, described herein is a
leguminous seed coated and/or inoculated with a biofertil-
izer, and/or biofertilizer composition herein described,
optionally in combination with one or more C35 hopanoids.
In the leguminous coated and/or inoculated seed, the nitro-
gen-fixing rhizobia in the biofertilizer and/or biofertilizer
composition can be rhizobia naturally capable of producing
C35 hopanoids and/or rhizobia naturally incapable of pro-
ducing C35 hopanoids and genetically modified to produce
C35 hopanoids.
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According to an eighth aspect, a method of fertilizing
leguminous plants is described. The method comprises
applying one or more biofertilizer and/or biofertilizer com-
positions herein described to a leguminous plant or soil
surrounding a leguminous plant for a time and under con-
ditions to allow symbiosis of the nitrogen-fixing rhizobia
with the leguminous plant. In some embodiments the biofer-
tilizer and/or biofertilizer compositions can be applied in
combination with one or more C35 hopanoids. In those
embodiments, applying the biofertilizer and/or biofertilizer
compositions and applying one or more C35 hopanoids are
performed for a time and under conditions allowing inter-
action of the one or more C35 hopanoids with the nitrogen-
fixing rhizobia in the administered biofertilizer and/or
biofertilizer compositions.
According to a ninth aspect, a method of fertilizing
leguminous plants is described. The method comprises coat-
ing and/or inoculating one or more seeds of the leguminous
plant with one or more biofertilizer and/or biofertilizer
compositions herein described. In some embodiments the
method further comprises coating and/or inoculating the one
or more seeds of the leguminous plant with one or more C35
hopanoids before the coating and/or inoculating the one or
more seeds of the leguminous plant with one or more
biofertilizer and/or biofertilizer composition.
According to a tenth aspect, a system to fertilize legumi-
nous plants is described. The system comprises one or more
biofertilizer and/or biofertilizer compositions herein
described and one or more C35 hopanoids for simultaneous
sequential or combined use in fertilizing a leguminous plant
herein described.
According to an eleventh aspect, a system to fertilize a
leguminous plant is described. The system comprises one or
more leguminous seed coated with one or more biofertilizer
and/or biofertilizer composition herein described and one or
more C35 hopanoids for simultaneous sequential or com-
bined use in fertilizing a leguminous plant herein described.
According to a twelfth aspect, a method of storing a
biofertilizer is described herein. The method comprises
providing a biofertilizer herein describe, the biofertilizer
comprising nitrogen-fixing bacteria that are naturally pro-
ducing C35 hopanoids and/or have been genetically modified
to produce C35 hopanoids, and storing the biofertilizer
formulation at a temperature between 22° C. and 37° C.
According to a thirteenth aspect, a biofertilizer for a soil
is described. The biofertilizer essentially consist of one or
more nitrogen-fixing rhizobia capable of producing C35
hopanoids and capable to fixing nitrogen outside a plant in
a form suitable for administration to the soil. Such biofer-
tilizer can be applied to oxygen-poor soils to enrich the soil
nitrogen content.
The biofertilizer, biofertilizer compositions, nitrogen-fix-
ing rhizobia, seeds and related methods and systems herein
described allow in several embodiments the nitrogen-fixing
rhizobia with enhanced tolerance to numerous stresses,
including acidic pH, high temperature, high osmolarity,
oxidative stress, detergents and antibiotics.
The biofertilizer, biofertilizer compositions, nitrogen-fix-
ing rhizobia, seeds and related methods and systems herein
described allow in several embodiments improved viability
of the rhizobia used in fertilization of leguminous plants,
and/or improvement of the related survive under soil con-
ditions, such as high temperature and low pH, to effectively
enhance plant growth and soil life and to improve soil
nitrogen content when leguminous plants are used for crop
rotation.
4
The biofertilizer, biofertilizer compositions, nitrogen-fix-
ing rhizobia, seeds and related methods and systems herein
described can be used in connection with agronomy, ecology
and other applications wherein increased stress-tolerance of
5 rhizobia is desired. Additional exemplary applications
would be identifiable by a skilled person upon reading of the
present disclosure.
The details of one or more embodiments of the disclosure
are set forth in the accompanying drawings and the descrip-
10 tion below. Other features, objects, and advantages will be
apparent from the description and drawings, and from the
claims.
BRIEF DESCRIPTION OF DRAWINGS
15
The accompanying drawings, which are incorporated into
and constitute a part of this specification, illustrate one or
more embodiments of the present disclosure and, together
20 with the detailed description and the examples, serve to
explain the principles and implementations of the disclosure.
FIG. 1 shows, in panel A, exemplary chemical structures
of hopanoids and related molecules and in panel B, the cell
envelope of a Gram-negative bacterium consisting of an
25 inner (IM) and an outer membrane (OM). Hopanoids are
found within both membranes. They are either "free" or, in
the case of C35 hopanoids, covalently bound to lipid A
(HoLA), which is present in the outer leaflet of the OM. As
seen in the expanded view of the OM, B. diazoefficiens
30 makes short (C3o) hopanoids like diploptene and extended
(C35) hopanoids like bacteriohopanetetrol (BHT) and ami-
notriol. Penta- and hexa-acylated Lipid A contain 5 and 6
fatty acyl chains, respectively. Hepta-acylated Lipid A con-
tains the C35 hopanoid, 34-carboxyl-bacteriohopane-32,33-
35 diol, covalently attached to hexa-acylated Lipid A. B. diazo-
efJiciens makes another triterpenoid with a gammacerane
skeleton called tetrahymanol. With the exception of HoLA,
hopanoid positioning in the inner vs outer leaflet has not
been established and example structures are placed ran-
4o domly. Dark gray and light gray colors represent hydrophilic
and hydrophobic regions, respectively.
FIG. 2 shows, in panel A, exemplary structures of a C35
hopanoid and tetrahymanol. B. diazoe{/iciens makes C31
hopanoids like diploptene (C-22—C-30) and diplopterol (OH
45 at C-22); C35 hopanoids like bacteriohopanetetrol (BHT,
R2 _01T) and amino-bacteriohopanetriol (aminotriol,
RZ NH2); and tetrahymanol. All these compounds can be
methylated at C-2 (2Me, Rl CH3). Panel B shows the
hopanoid biosynthetic gene cluster of B. diazoefficiens. In
50 this study, we focused on the genes colored in gray: she
(squalene hopene cyclase) catalyzes squalene cyclization to
hopene, the first reaction in the hopanoid biosynthetic path-
way; hpnH catalyzes addition of adenosine to hopene, the
first reaction in the synthesis of C35 hopanoids; and hpnP
55 catalyzes C-2 methylation. Panel C shows GC-MS and
LC-MS (inset) total ion chromatograms of total lipid
extracts from aerobically grown B. diazoefficiens strains.
GC-MS: Main hopanoid peaks are numbered and the meth-
ylated counterparts elute 0.2-0.5 min earlier: I, pregnane
60 acetate (standard); II, (2Me) hop-17(21)-ene; III, (2Me)
hop-x-ene; IV, (2Me) hop-22(29)-ene (diploptene); V, (2Me)
hop-21-ene, VI, (2Me) hopan-22-o1 (diplopterol); VII, (2Me
and 20Me) tetrahymanol; and VIII, BHP-508. LC-MS: a,
aminotriol; b, BHT; c, 2Me-aminotriol; d, adenosylhopane;
65 and e, 2Me-BHT. Lipid analysis for each strain was per-
formed in triplicates. For chemical structures of hopanoids,
refer to FIG. 1, panel A.
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FIG. 3 shows in some embodiments the endosymbiotic
context of B. diazoeffaciens within root nodules of A. afrasp-
era. B. diazoeffaciens exists as a bacteroid, a terminally
differentiated enlarged, elongated and polyploid state, within
infected plant cortical cells. In addition to its own mem-
brane, each bacteroid is surrounded by a peribacteroid
plant-derived membrane. The double-layered bacteroid is
called a symbiosome. The infected plant cell niche is char-
acterized by low 02, low pH, hyperosmosis and oxidative
stress [1, 2].
FIG. 4 shows in some embodiments the MALDI-MS
analysis of lipid A from B. diazoefficiens strains. Lipid A
from WT and AhpnP is composed of a mixture of penta-
acylated and hexa-acylated species, whereas AhpnH lipid A
is mainly hexa-acylated. A C35 hopanediolic acid is ester-
linked to hexa-acylated and hepta-acylated lipid A in WT
and AhpnP. AhpnH does not contain any lipid A-bound
hopanoids.
FIG. 5 plots whole cell membrane fluidity measurements
by fluorescence polarization, which show that rigidity
decreases for all strains as temperature increases and that the
AhpnH membrane is less rigid than that of WT or AhpnP
(**p<0.01 by Student's 2-Tailed t-test). Error bars represent
the standard deviation from three biological replicates (-22
technical replicates).
FIG. 6 shows in some embodiments the CRYO-transmis-
sion electron microscopy (TEM) micrographs which show
intact outer and inner membranes in all B. diazoeffaciens
strains. Scale-200 mu.
FIG. 7 shows in some embodiments the growth of B.
diazoeffaciens strains under various stress conditions.
Growth of WT (circle), AhpnP (square) and AhpnH (tri-
angle) was monitored at OD... in Panel A) PSY at 30° C.,
Panel B) PSY at 37° C., Panel C) microaerobic PSY with
0.5% 02 at 30° C., Panel D) PSY at pH-6 and 30° C. Each
curve represents the average of at least three biological
replicates, except the microaerobic growth curves for which
a representative data set out of four trials is shown. Growth
of B. diazoefficiens strains under stress as measured in Panel
E) stressor gradient plates with 50 mM NaCl, 500 mM
inositol, 0.4% bile salts or 1 mM EDTA or by Panel F) disc
diffusion assays with 10% SDS, 5.5 M H2O2 and 2 M HCl.
Error bars represent standard error (n=9). *p<0.05 and
**p<0.01 by Tukey's HSD test. Panel G) NCR335 sensi-
tivity of B. diazoeffaciens strains.
FIG. 8 shows in some embodiments that B. diazoefficiens
AhpnH mutant is impaired in symbiosis with soybean at 21
d.p.i. Panel A: Comparison of growth of plants, non-inocu-
lated (NI) or inoculated with WT, AhpnH and AhpnP. Panel
B: Quantification of acetylene reduction activity (ARA) in
plants inoculated with WT, AhpnH and AhpnP. Panel C:
Nodulation efficiency of WT, AhpnH and AhpnP on plants.
Error bars in B, C represent standard error (n=10). Based on
Tukey's HSD test differences between strains were found to
be insignificant, p>0.05. Panels D-L: Aspects of nodules
elicited by WT (Panels D, G, J), AhpnH (Panels E, H, K) and
AhpnP (Panels F, I, L). (D, E, F) Whole roots, scale-4 mm,
(Panels G, H, I) Cross-section of live nodules, scale=l mm.
(Panels 7, K, L) Nodule thin sections viewed by brightfield
microscopy, scale=l mm. Panels M-R: Observation of nod-
ules elicited by WT (Panels M, P), AhpnH (Panels N, Q) and
AhpnP (Panels O, R) strains by confocal microscopy using
Syto9 (green, healthy bacteroids), calcofluor (blue, plant cell
wall) and propidium iodide (red, infected plant nuclei and
bacteroids with compromised membranes). Scale-300 µm
(M, N, O) 50 µm (Panels P, Q, R). Panels S-X: Transmission
electron micrographs of nodules elicited by WT (Panels S,
6
V), AhpnH (Panels T, W) and AhpnP (Panels U, X). Scale=l
µm (Panels S, T, U), 0.2 µm (Panels V, W, X).
FIG. 9 illustrates in some embodiments that a B. diazo-
effaciens AhpnH mutant is impaired in symbiosis with A.
5 afraspera at 21 d.p.i. Panel A) Comparison of growth of
plants, non-inoculated (NI) or inoculated with WT, AhpnH
and AhpnP. Panel B) Quantification of acetylene reduction
activity (ARA) in plants inoculated with WT, AhpnH and
AhpnP. Error bars represent standard error (n=10). **p<0.01
io by Tukey's HSD test. Panel C) Number of nodules per plant
elicited by WT, AhpnH and AhpnP. Panels D-M) Aspect of
the nodules elicited by WT (Panels D, G, 7), AhpnP (Panels
E, H, K) and AhpnH (Panels F, I, L, M). (D, E, F) Whole
roots, scalel mm, (Panels G, H, I) Cross-section of live
15 nodules, scale-500 µm. (Panels 7, K, L) Nodule thin sections
viewed by brightfield microscopy, scale-500 µm. Panel M)
The black arrow shows plant defense reactions (necrotic
plant cells), scale-500 µm. Panel N) Aspect of the nodules
elicited by AhpnH as observed by confocal microscopy
20 using the live-dead kit, scale-200 µm. White arrows show
plant defense reactions. Panel 0) Aspect of the nodules
elicited by AhpnH stained with lugol. Scale-500 µm. White
arrows show starch granules in dark. Panels P-U) Confocal
microscopy observations of nodules elicited by WT (Panels
25 P, Q) AhpnH (Panels R, S) and AhpnP (Panels T, U) strains
and stained using Syto9 (green, healthy bacteroids), calco-
fluor (blue, plant cell wall) and propidium iodide (red,
infected plant nuclei and bacteroids with compromised
membranes). Scale-200 µm (P, R, T), 20 µm (Q, S, U).
30 Panels V-Z') TEM of nodules elicited by WT (Panels V, W,
X) and AhpnH (Panels Y, Z, Z'). Panels V, Y) Black arrows
show symbiososmes. Panel Z) Cell envelope of some
AhpnH bacteroids is not well delineated (bold black arrow)
and some deposits of cellular material can be observed in the
35 peribacteroid space (black arrow). Panel Z') The bold black
arrow shows bacteroid wall breakdown. The black arrow
shows cellular material of unknown origin. Scale-2 µm (V,
Y), 0.5 µm (W, Z), 0.2 µM (X, Z').
FIG. 10 shows in some embodiments kinetics of nodula-
40 tion and nitrogen fixation of A. afraspera plants inoculated
with B. diazoeffaciens. Panel A: Number of nodules elicited
by WT, AhpnH and AhpnP on plants at 9, 14 and 21 days
post inoculation (d.p.i.). Panel B: The acetylene-reducing
activity (ARA) in plants inoculated with WT, AhpnH and
45 AhpnP at 9, 14 and 21 d.p.i. Error bars represent standard
error (n=10). Asterisk above the error bars indicate signifi-
cant differences at *p<0.05 and **p<0.01 (Tukey's HSD
test).
FIG. 11 show, in panel (a), an exemplary structure of the
50 C35 hopanoid 2Me-bacteriohopanetetrol (BHT). The gene
she generates the pentacyclic core from squalene; the addi-
tion of a methyl group at the C2 position is performed by
hpnP; and the addition of a ribose-derived hydrocarbon
chain at the C30 position to form a C35 hopanoid is per-
55 formed by hpnH. Panel (b) plots acetylene reduction rates
for A. afraspera plants at 24 days post-inoculation (dpi) with
wild-type (WT), AhpnP or AhpnH B. diazoefficiens. Panel
(c) shows manual cross-sections of root nodules harvested at
24 dpi for wild type and AhpnH mutants stained with
60 Calcofluor white, propidium iodide (PI) or SYTO9. Panel
(d) shows normalization of acetylene reduction rates by
nodule dry weight for wild type and AhpnH mutants. All
values shown are average values from 10 plants per condi-
tion. Error bars represent standard deviation.
65 FIG. 12 shows in some embodiments acetylene reduction
rates per plant taken every four days after inoculation for
WT- and AhpnH-inoculated plants (panel a), number of
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nodules per plant, nodule dry weight per plant and plant
shoot heights for WT- and AhpnH-inoculated plants (panel
b) and images of 10 WT- and AhpnH-inoculated plants at 20
dpi and 40 dpi (panel c). All values shown are average values
per condition and are pooled from two replicates of four
plants each. Error bars represent standard deviation.
FIG. 13 shows in some embodiments sample tracking of
multiple nodules on a single WT plant (with nodule radii)
using digital microscopy (panel a); sample nodule growth
time series for WT and AhpnH plants (panel b), and same
nodule growth plot for a WT nodule (panels c-f). In par-
ticular, panel c shows the raw data; panel d shows the raw
data fit to quadratic, exponential or sigmoidal curves; panel
e shows additional parameter fits for the sigmoidal fit; and
panel f shows a schematic overview of nodule growth
parameters.
FIG. 14 illustrates a schematic overview of determinate
root nodule development in panel a. Parameters describing
this process include: to, the time of bacterial internalization,
and Vo, the volume of the first infected cell; tm,,,, the time at
which a nodule is visible by eye, and Vm,,,, the smallest
nodule volume visible by eye; tm,,, the time at which nodule
growth has leveled off, and Vm„, the volume of the nodule
when nodule growth stops; dV/dt, the rate of increase in
nodule volume between tm, and tm_. Panel b shows sample
wild-type nodule growth time course. Nodule radii are
measured directly and the nodule volume is determined by
approximation of nodules as spheres. Panel c plots the
distribution of newly-emerged nodules over time (in dpi) for
wild-type and AhpnH nodules from 40 plants each. Panels d,
e, and f plot the distributions of dV/dt, predicted to, and Vm_
for wild-type (N-75) and AhpnH nodules (N-50).
DETAILED DESCRIPTION
Provided herein are hopanoids, hopanoid-producing bac-
teria and related biofertilizers, compositions, methods and
systems that in several embodiment stimulate plant growth
with enhanced tolerance to stresses encountered during the
progression of plant-microbe symbioses.
The term "hopanoids” as used herein indicate bacterio-
hopanepolyols (BHPs), which is a class of pentacyclic
triterpenoids that are found in a variety of bacteria including
Gram-positive and Gram-negative bacteria as cell mem-
brane components.
Hopanoids in the sense of the disclosure include in
particular amphiphilic BHP comprising a C30 pentacyclic
triterpene hydrocarbon skeleton, derived from squalene via
the enzyme squalene-hopene cyclase, that can be linked via
a C—C bond to a C5 sugar moiety derived from ribose. In
some hopanoids, the polar moieties of BHP can attach
sugars, amino acids or other functionalized units, which can
be used for their preservation in the geological record. The
apolar ring system of hopanoids in the sense of the disclo-
sure can comprise an extra methyl group at either position 2
(2Me-hopanoids) or position 3 (3Me-hopanoids) located in
the A-ring, or by unsaturation and/or attachment to a ribose-
derived side chain (C35-hopanoids) (see Examples 3 and 4)
[3]. Distribution of hopanoids with different chemical struc-
ture among bacteria does not appear to follow a systematic
pattern. For example, BHPs methylated at C-2 are known to
be produced in abundance by cyanobacteria, but not by other
bacteria.
Hopanoids producing bacteria, in the sense of the disclo-
sure are bacteria having a gene set allowing production of
one or more hopanoids in the sense of the disclosure and in
particular a set of genes encoding molecules that catalyze
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the production of hopanoids using squalene as the beginning
molecular substrate, including but not limited to the follow-
ing genes: hpnP, hpnF (also known as shc), hpnG, hpnH, and
hpnO."
5 Hopanoid-producing bacteria comprise both free-living
bacteria and symbiotic bacteria. Examples of free-living
bacteria producing hopanoids include Rhodopseudomonas
palustris, Bacillus spp., Synechococcus spp., and Azoto-
bacter spp. Examples of symbiotic bacteria producing
to hopanoids include Bradyrhizobia spp., Frankia spp., Ana-
baena spp., and Nostoc spp. For example, hopanoids com-
prise BHPs localized in the cytoplasmic and outer mem-
branes of various bacteria such as Alicyclobacillus
acidocaldarius, Zymomonas mobilis, Frankia sp., and Strep-
15 tomyces coelicolor. In particular, hopanoids have been
found in nitrogen-fixing bacteria that form root or stem
nodules in symbiosis with various types of plants, where the
capacity for hopanoid biosynthesis is statistically enriched in
the (meta)genomes of bacteria associated with plants [4].
20 For example, hopanoids have been found in membranes of
plant symbionts of nitrogen-fixing Bradyrhizobia (40% of
total lipid extract (TLE)) and Frankia (87%) genera [5, 6].
Studies have shown that elimination of hopanoid biosynthe-
sis in photosynthetic Bradyrhizobium BTAil impairs its
25 symbiosis with the legume Aeschynomene evenia [7].
Hopanoids have not been found in other plant-associated
bacteria, including —50% of the symbiotic Rhizobiales fam-
ily. Exemplary hopanoids producing bacteria that are natu-
rally capable of producing hopanoids include strains from
30 Acetobacter, Acidiphilium, Azotobacter vinelandii, Bacillus
amyloliquefaciens, Bacillus anthracis, Bacillus cereus, Bur-
kholderia cenocepacia, Bradyrhizobium, Burkholderia,
Frankia, Geobacter, Methylobacterium, Pelobacter,
Nitrosococcus, Rhodopseudomonas, Rhodospirillum, Syn-
35 echocystis, Streptomyces, Zymomonas mobilis and others
identifiable by a person of ordinary skill in the art of
microbiology.
In hopanoids producing bacteria in the sense of the
disclosure, hopanoids can promote membrane rigidity [8]
4o and confer protection against numerous stresses, including
acidic or alkaline pH, high temperature, high osmolarity,
oxidative stress, detergents and antibiotics [7, 9-11]. The
structural variation of hopanoids, including modification by
methylation or the addition of diverse polar head groups,
45 suggests there may be specificity in their structures with
regard to localization and/or function. Evidence also sug-
gests that diverse hopanoid types have non-overlapping
roles. For example, in Rhodopseudomonas palustris [12]
and Burkholderia cenocepacia [10], C35 hopanoids are criti-
50 cal for OM stability, and resistance to low pH, detergent
(sodium dodecyl sulfate, SDS) and polymyxin B, respec-
tively. In R. palustris, the biosynthesis of 2Me-hopanoids is
transcriptionally induced under stress [9], suggesting that
2Me-hopanoids may contribute to stress resistance under
55 certain conditions and organisms. In Methylococcus capsu-
latus, 3Me-hopanoids contribute to late stationary phase
survival [13]. In vitro, 2Me-hopanoids rigidify membranes
of varied compositions [8]. However, no study has explored
whether different hopanoids impact fitness in a natural
60 ecological context. It is unclear whether there are functional
distinctions under specific environmental conditions for
diverse hopanoid types.
In embodiments herein described, biofertilizer to be used
to fertilize plants or soil are hopanoids producing bacteria
65 capable of producing C35 hopanoids. The term 
"C35
hopanoids" in the sense of the disclosure include in particu-
lar amphiphilic BHP comprising a C30 pentacyclic triterpene
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hydrocarbon skeleton, derived from squalene via the
enzyme squalene-hopene cyclase, and are linked via a C—C
bond to a Cs sugar moiety derived from ribose
In particular, in embodiments herein described, C35
hopanoids are compounds of Formula (I):
R
R13
24
N
C22, C31, C33 and C34 have independently R or S chirality;
R, R11, R12 and R13 are independently selected from H, D,
methyl, or ethyl groups;
R1, R3, R4, and R5 are selected from H, D, methyl,
hydroxymethyl, aminomethyl, hydroxyl, or amino groups,
wherein at least three of the R1, R3, R4, and R5 groups each
contains hydroxymethyl, aminomethyl, hydroxyl, or amino
groups;
R2 is selected from OH, NHz, hydroxymethyl, aminomethyl,
formula (II)
Formula (II)
R21
O Rzz
(O 
m2
R23
R25
R24
wherein a wavy line on the ring carbon indicates a R or S
chirality of the ring carbon,
m, and m2 are independently 0 or 1;
R21, R22, R23, R24 and R25 are selected from OH, NHz,
hydroxymethyl, or aminomethyl groups wherein R211 R22,
R23, R24 and R25 contain at least one NHz or aminomethyl
groups and one of R24 and R25 is hydroxymethyl, or amin-
omethyl groups.
In some embodiments, Formula (II) can be Formula (IIa)
or Formula (IIb):
Formula (IIa)
NH2
o ox
7-1-11111
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continued
Formula (IIb)
NH2
o
5 OH
HO
1oH
HO
10
In some embodiments, R3, R4 and Rs are OH. In some
embodiments, R2 is NH2. In some particular embodiments,
the C35 hopanoids are bacteriohopanetetrol (BHT) and
15 aminobacteriohopanetrial shown in FIG. 1A.
In some embodiments, the C35 hopanoids comprise
aminobacteriohopanetriol, bacteriohopanetriol, 2-methyl
bacteriohopanetriol, aminobacteriohopanetriol, bacterio-
hopanetetrol, 2Me-aminobacteriohopanetriol, adenosyl-
20 hopane, 2Me-bacteriohopanetetrol.
C35 hopanoids are produced in bacteria by a set of genes
comprising at least shc, hpnH and hpnG. The set can also
comprise hpnG, hpnP, and also hpnC, hpnD and hpnE,
depending on the specific C35 produced as will be under-
25 stood by a skilled person. For example, hnpH is required to
generate adenosyl hopane, which is a C35 hopanoid, how-
ever, hpnG and hpnG are needed to make aminobacterio-
hopanetetrol and bacteriohopanetetrol (Welander 2012
[12]). shc, hpnH and hpnG, hpnG, hpnP, hpnC, hpnD and
30 hpnE are conserved among various C35 producing bacteria
and encodes enzymes forming a hopanoid biosynethtic
pathway such as squalene-hopene cyclase (sch), B12 bind-
ing radical SAM (hpnH), nucleosidase (hpnG), ornithine-
oxo-acid-transaminase (hpnG), B12 binding radical SAM
35 (hpnP), squalene synthase (hpnC), squalene synthase
(hpnD), and squalene dependent FAD-dependent desaturase
(hpnE) as will be understood by a skilled person. In par-
ticular among different C35 producing bacteria strains, each
40 of the proteins encoded by shc, hpnH and hpnG, hpnG, hpnP,
hpnC, hpnD or hpnE genes shows a same enzymatic activity
in the different strains even if the sequences can differ from
strain to strain at a polynucleotide and/or at a protein level.
In particular, proteins encoded by each of shc, hpnH and
45 hpnG, hpnG, hpnP, and also hpnC, hpnD and hpnE can have
an amino acid sequence identity >55% at a protein level
while maintaining the respective enzymatic activity indi-
cated above (see e.g. hpnP as indicated by Ricci et al. [14])
The term "gene" as used herein indicates a polynucleotide
50 encoding for a protein that in some instances can take the
form of a unit of genomic DNA within a bacteria, plant or
other organisms.
The term "polynucleotide" as used herein indicates an
organic polymer composed of two or more monomers
55 including nucleotides, nucleosides or analogs thereof. The
term "nucleotide" refers to any of several compounds that
consist of a ribose or deoxyribose sugar joined to a purine or
pyrimidine base and to a phosphate group and that are the
60 basic structural units of nucleic acids. The term "nucleoside"
refers to a compound (as guanosine or adenosine) that
consists of a purine or pyrimidine base combined with
deoxyribose or ribose and is found especially in nucleic
acids. The term "nucleotide analog" or "nucleoside analog"
65 refers respectively to a nucleotide or nucleoside in which
one or more individual atoms have been replaced with a
different atom or a with a different functional group. Accord-
US 10,131,585 B2
11
ingly, the term polynucleotide includes nucleic acids of any
length, and in particular DNA RNA analogs and fragments
thereof.
The term "protein" as used herein indicates a polypeptide
with a particular secondary and tertiary structure that can
interact with another molecule and in particular, with other
biomolecules including other proteins, DNA, RNA, lipids,
metabolites, hormones, chemokines, and/or small mol-
ecules. The term "polypeptide" as used herein indicates an
organic linear, circular, or branched polymer composed of
two or more amino acid monomers and/or analogs thereof.
The term "polypeptide" includes amino acid polymers of
any length including full-length proteins and peptides, as
well as analogs and fragments thereof. A polypeptide of
three or more amino acids is also called a protein oligomer,
peptide, or oligopeptide. In particular, the terms "peptide"
and "oligopeptide" usually indicate a polypeptide with less
than 100 amino acid monomers. A protein "sequence"
indicates the order of the amino acids that form the primary
structure
As used herein the term "amino acid", "amino acid
monomer", or "amino acid residue" refers to organic com-
pounds composed of amine and carboxylic acid functional
groups, along with a side-chain specific to each amino acid.
In particular, alpha- or a-amino acid refers to organic
compounds composed of amine ( NH2) and carboxylic
acid (POOH), and a side-chain specific to each amino
acid connected to an alpha carbon. Different amino acids
have different side chains and have distinctive characteris-
tics, such as charge, polarity, aromaticity, reduction poten-
tial, hydrophobicity, and pKa. Amino acids can be cova-
lently linked to form a polymer through peptide bonds by
reactions between the amine group of a first amino acid and
the carboxylic acid group of a second amino acid. Amino
acid in the sense of the disclosure refers to any of the twenty
naturally occurring amino acids, non-natural amino acids,
and includes both D an L optical isomers.
The term "percent identity refers to a quantitative mea-
surement of the similarity between sequences of a polypep-
tide or a polynucleotide and in particular indicates the
amount of characters which match exactly between two
different sequences. Widely used similarity searching pro-
grams, like BLAST, PSI-BLAST [15], SSEARCH [16] [17],
FASTA [18] and the HMMER3 [19] programs produce
accurate statistical estimates, ensuring protein sequences
that share significant similarity also have similar structures.
In embodiments herein described, hopanoids producing
bacteria capable of producing C35 hopanoids, and particu-
larly C35 hopanoids of Formula (I), are nitrogen-fixing
bacteria and, in particular, symbiotic nitrogen fixing bacte-
ria, which can be used to fertilize a plant and/or a soil, as will
be understood by a skilled person upon reading of the
present disclosure.
The term "nitrogen-fixing bacteria" refers to microorgan-
isms capable of transforming atmospheric nitrogen to fixed
nitrogen in inorganic compounds usable by plants. Nitrogen-
fixing bacteria are also called diazotrophs; some diazotrophs
are capable of performing nitrogen fixation naturally in a
free-living state, while others can only fix nitrogen within
plant hosts. Examples of diazotrophs include non-symbiotic
bacteria, such as the plant-associated soil bacterium Azoto-
bacter, as well as symbiotic bacteria including rhizobia (in
particular Bradyrhizobia spp., Rhizobiacaea, Phyllobacte-
ria, Sinorhizobia (Ensifer), Mesorhizobia and Azorhizobia),
cyanobacteria (Anabaena spp., Nostoc spp.), Frankia spp.,
and others identifiable by a person of ordinary skill in the art.
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The wording "symbiotic bacteria" as used herein indicates
bacteria that provide fixed nitrogen to plants via direct
plant-microbe association in exchange for nutrients (gener-
ally carbon sources) and include the model bacteria
5 Sinorhizobium meliloti, Rhizobium leguminosarum, and
Bradyrhizobium diazoeffaciens. During symbiotic nitrogen
fixation, nitrogen-fixing bacteria establish a symbiotic rela-
tionship with plants in which the plant provides the nitrogen-
fixing bacteria with carbohydrates as an energy source and
10 the nitrogen-fixing bacteria provides the plant with nitrogen
in the form of ammonium. Examples of plant-microbe
symbioses include rhizobia associated with leguminous
plants and trees of the Acacia and Parasponia families,
15 Frankia associated with certain dicotyledonous species (ac-
tinorhizal plants), certain Azospirillum species, associated
with cereal grasses, Nostoc or Anabaena associated with
ferns, palms, lichens and homwort, and many other plant-
microbe symbiotic systems identifiable by a person of
20 ordinary skill in the art.
In particular, in embodiments herein described hopanoids
producing nitrogen-fixing bacteria capable of producing C35
hopanoids are rhizobia that can be used alone or in combi-
nation with C35 hopanoids to stimulate growth of legumi-
25 nous plants and/or fertilize a soil.
1 The term "leguminous plants" or "legumes" indicates
plants in the family of Fabaceae (or Leguminosae) with taxa
such as kudzu, clovers, soybeans, alfalfa, lupines, peanuts
and rooibos. Examples of leguminous plants include includ-
30 ing Vcia faba, Arachis hypogaea, Cicer arientum, Dolichos
lablab, Lupinus albus, Pisum arvense, Glycine max, Caja-
nus cajan, Lens esculenta, Figna radiate, Cyamopsis
tetragonoloba, Figna aconitifolius, Ficia hirsute, Trigonella
35 foenum-graecum, Onobrychis sativa, Coronilla cretica,
Ornithopus sativus, Desmodium intortum, Indigofera hir-
sute, Medicago sativa, Trifolium incarnatum, Lotus pedun-
culatus, Trifolium agrarium and Lotonois bainesii and oth-
ers identifiable to a person of ordinary skill in the relevant
40 art. Plants in the legume family can form symbioses with
nitrogen-fixing soil bacteria to provide a sustainable nitro-
gen source to improve fertility in agricultural settings. Most
legumes interact optimally with nitrogen-fixing bacteria of a
single genus, although the specificities of legumes for bac-
45 terial partners are largely uncharacterized. The nitrogen-
fixing rhizobia that form symbioses with a given legume are
referred to as legume symbionts. Examples of legume sym-
bionts include Bradyrhizobia, Rhizobiacaea, Phyllobacte-
ria, Sinorhizobia (Ensifer), Mesorhizobia and Azorhizobia.
50 The term "rhizobia" as used herein indicates a family of
Gram-negative soil bacteria that fix nitrogen in association
with plants. Rhizobia form an endosymbiotic nitrogen fixing
association with roots of legumes and some trees including
Acacia and Parasponia. In particular, rhizobia colonize
55 plant cells within root nodules where they convert atmo-
spheric nitrogen into ammonia and then provide organic
nitrogenous compounds such as glutamine or ureides to the
plant. The plant in turn provides the bacteria with organic
compounds made by photosynthesis. Most of the rhizobia
60 species are in the Rhizobiacae family in the alpha-proteo-
bacteria and are in Rhizobium, Mesorhizobium, Ensifer, or
Bradyrhizobium genera. There are also some other rhizobial
species, presumably arisen through lateral gene transfer of
symbiotic genes. In general, rhizobia consists of about 98
65 species in 13 genera, including Rhizobium, Mesorhizobium,
Ensifer, Bradyrhizobium, Burkholderia, Phyllobacterium,
Microvirga, Ochrobactrum, Methylobacterium, Cupriavi-
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dus, Devosia, and Shinella. Detailed taxonomic information
about rhizobia are identifiable by a person of ordinary skill
in the Azorhizobium, art.
In particular, in embodiments here described rhizobia
used in biofertilizers, and related seeds compositions, meth-
ods and systems are naturally capable of producing C35
hopanoids. Exemplary legume symbionts naturally capable
of producing C35 hopanoids include Bradyrhizobium BTAi1,
Bradyrhizobium japonicum, Bradyrhizobium diazoefficiens,
Bradyrhizobium ORS278 and Methylobacterium nodulans.
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Exemplary legume symbionts naturally incapable of pro-
ducing C35 hopanoids but capable of being engineered to
produce C35 hopanoids include Rhizobium edi, Rhizobium
leguminosarum, Mesorhizobium loti, Sinorhizobium meli-
loti, Azorhizobium caulinodans, and Ochrobactrum
anthropi. The symbiotic relationship between these and
other exemplary legume symbionts and their host plants, is
shown in Table 1. Table 1 also includes an indication
whether the rhizobia strain contains the hpnH gene that is
required for the C35 biosynthesis.
TABLE 1
Symbiotic relationship between exemplary legume symbionts and their host plants and
whether the hpnH Rene is present in the rhizobia strain
Rhizobia Native host(s)
hpnH
present
(Para)Burkholderia Mimosa spp. YES
caribensis
(Para)Burkholderia Mimosa spp. YES
mimosarum
(Para)Burkholderia nodosa Mimosa spp. NO
(Para)Burkholderia Aspalathus carnosa YES
phymatum
Azorhizobium caulinodans Sesbonia pp., e.g. Sesbania rostrata NO
Azorhizobium doebereinerae Sesbania virgata NO
Bradyrhizobium BTAil Aeschynomene indica, Aeschynomene evenia YES
Bradyrhizobium canariense Lupinus spp. UNKNOWN
Bradyrhizobium cytisi Cytisus villosus UNKNOWN
Bradyrhizobium Aeschynomene indica UNKNOWN
denitrificans
Bradyrhizobium elkanii Glycine soja YES
Bradyrhizobium iriomotense Entada koshunensis YES
Bradyrhizobium japonicum Glycine Max YES
Bradyrhizobium jicamae Pachyrhizus erosus YES
Bradyrhizobium Glycine spp. YES
liaoningense
Bradyrhizobium manausense Pgna unguiculata UNKNOWN
Bradyrhizobium Centrolobium paraense UNKNOWN
neotropicale
Bradyrhizobium sp. ORS278 Aeschynomene evenia, Aeschynomene indica YES
Bradyrhizobium sp. ORS285 Aeschynomene afraspera YES
Bradyrhizobium pachyrhizi Pachyrhizus erosus YES
Bradyrhizobium paxllaeri Phaseolus lunatus L. UNKNOWN
Bradyrhizobium retamae Retama spp. UNKNOWN
Bradyrhizobium Arachis hypogea L. UNKNOWN
subterraneum
Bradyrhizobium Lespedeza spp. YES
yuanmingense
Bradyrhizovbium Glycine max YES
diazoefficiens
Burkholderia cepacia Mimosa spp. YES
Burkholderia sabiae Mimosa spp. UNKNOWN
Burkholderia tuberum Aspalathus carnosa UNKNOWN
Cupriavidus taiwanensis Mimosa spp. YES
Devosia neptuniae Neptunia natans UNKNOWN
Mesorhizobium abyssinicae Acacia abyssinica UNKNOWN
Mesorhizobium albiziae 41bizia kalkora UNKNOWN
Mesorhizobium alhagi Alhagi sparsifolia NO
Mesorhizobium amorphae Amorpha fruticosa NO
Mesorhizobium australicum Biserrula pelecinus L. NO
Mesorhizobium camelthorni Alhagi sparsifolia UNKNOWN
Mesorhizobium caraganae Caragana spp. UNKNOWN
Mesorhizobium chacoense Prosopis alba UNKNOWN
Mesorhizobium ciceri Cicer arietinum L. NO
Mesorhizobium erdmanii Lotus spp. NO
Mesorhizobium gobiense Glycyrrhiza uralensis, Lotus corniculatus, Oxytropis glabra UNKNOWN
and Robinia pseudoacacia
Mesorhizobium hawassense Acacia spp. UNKNOWN
Mesorhizobium huakuii Aermopsis lupinoides NO
Mesorhizobium jarvisii Lotus spp. UNKNOWN
Mesorhizobium loti Lotus spp., e.g Lotus japonicus NO
Mesorhizobium Cicer arietinum L. UNKNOWN
mediterraneum
Mesorhizobium Anthyllis vulneraria NO
metallidurans
Mesorhizobium muleiense Cicer arietinum L. UNKNOWN
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TABLE 1-continued
Symbiotic relationship between exemplary legume symbionts and their host plants and
whether the hpnH gene is present in the rhizobia strain
hpnH
Rhizobia Native host(s) present
Mesorhizobium Biserrula pelecinus L. NO
opportunistum
Mesorhizobium plurifarium Acacia spp. NO
Mesorhizobium gingshengii Astragalus sinicus UNKNOWN
Mesorhizobium robiniae Robinia pseudoacacia UNKNOWN
Mesorhizobium sangaii Astragalus spp. UNKNOWN
Mesorhizobium Astragalus adsurgens UNKNOWN
septentrionale
Mesorhizobium shangrilense Caragana spp. UNKNOWN
Mesorhizobium shonense Acacia spp. UNKNOWN
Mesorhizobium Caragana spp. UNKNOWN
silamurunense
Mesorhizobium Anagyris latifolia and Lotus berthelotii UNKNOWN
tamadayense
Mesorhizobium tarimense Glycyrrhiza uralensis, Lotus corniculatus, Oxytropis glabra UNKNOWN
and Robinia pseudoacacia
Mesorhizobium temperatum Astragalus adsurgens UNKNOWN
Mesorhizobium Vcia spp., Rifolium spp. UNKNOWN
tianshanense
Methylobacterium nodulans Crotalaria spp. YES
Microvirga lotononidis Listia angolensis NO
Microvirga lupini Lupinus texensis NO
Microvirga zambiensis Listia angolensis UNKNOWN
Ochrobactmm anthropi Cicer arietinum
Ochrobactrum ciceri Cicer arietinum UNKNOWN
Ochrobactrum cytisi Cytisus scoparius UNKNOWN
Ochrobactrum lupini Lupinus albus UNKNOWN
Phyllobacterium ifrigiyense Astragalus algerianus, Lathyrus numidicus UNKNOWN
Phyllobacterium leguminum Argyrolobium uniflorum, Astragalus algerianus UNKNOWN
Phyllobacterium trifolii Rifolium spp. and Lupinus spp. UNKNOWN
Rhizobium alamii Medicago ruthenica NO
Rhizobium alkalisoli Caragana intermedia UNKNOWN
Rhizobium azibense Phaseolus vulgaris UNKNOWN
Rhizobium calliandrae Calliandra grandiflora UNKNOWN
Rhizobium cauense Kummerowia stipulacea UNKNOWN
Rhizobium cellulosilyticum Medicago sativa UNKNOWN
Rhizobium daejeonense Medicago sativa UNKNOWN
Rhizobium endophyticum Phaseolus vulgaris UNKNOWN
Rhizobium eth Phaseolus vulgaris L. NO
Rhizobium fabae Vcia faba UNKNOWN
Rhizobium freirei Phaseolus vulgaris NO
Rhizobium galegae Galega orientalis UNKNOWN
Rhizobium gallicum Phaseolus vulgaris NO
Rhizobium giardinii Phaseolus vulgaris NO
Rhizobium grahamii Dalea leporina, Leucaena leucocephala and Clitoria NO
ternatea
Rhizobium hainanense Hainan province legumes UNKNOWN
Rhizobium halophytocola Rosa rugosa UNKNOWN
Rhizobium herbae Various wild legumes in China UNKNOWN
Rhizobium huautlense Sesbania herbacea UNKNOWN
Rhizobium indigoferae Indigofera spp. UNKNOWN
Rhizobium jaguaris Calliandra grandiflora UNKNOWN
Rhizobium laguerreae Vcia faba UNKNOWN
Rhizobium leguminosarum Phaseolus vulgaris, Rifolium spp. Pisum sativum NO
Rhizobium leucaenae Leucaena leucocephala, Leucaena esculenta, common beans NO
(Phaseolus vulgaris) and Gliricidia sepium
Rhizobium loessense Astragalus and Lespedeza UNKNOWN
Rhizobium lusitanum Phaseolus vulgaris NO
Rhizobium mayense Calliandra grandiflora UNKNOWN
Rhizobium mesoamericanum Phaseolus vulgaris, siratro, cowpea and Mimosa pudica NO
Rhizobium mesosinicum 41bizia, Kummerowia and Dalbergia UNKNOWN
Rhizobium miluonense Lespedeza NO
Rhizobium mongolense Medicago ruthenica NO
Rhizobium multihospitium Robinia pseudoacacia NO
Rhizobium oryzae Phaseolus vulgaris and Glycine max UNKNOWN
Rhizobium paranaense Phaseolus vulgaris L. UNKNOWN
Rhizobium petrolearium Medicago sativa UNKNOWN
Rhizobium phaseoli Phaseolus vulgaris NO
Rhizobium pisi Pisum sativum UNKNOWN
Rhizobium sophorae Sophora flavescens UNKNOWN
Rhizobium sophoriradicis Sophora flavescens UNKNOWN
Rhizobium sphaerophysae Sphaerophysa salsula UNKNOWN
Rhizobium sullae Hedysarum coronarium L. NO
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TABLE 1-continued
Symbiotic relationship between exemplary legume symbionts and their host plants and
whether the hpnH gene is present in the rhizobia strain
hpnH
Rhizobia Native host(s) present
Rhizobium taibaishanense Kummerowia striata UNKNOWN
Rhizobium tibeticum Trigonella archiducis-nicolai, Medicago lupulina, Medicago UNKNOWN
sativa, Mehlotus oficinalis, Phaseolus vulgaris and
Trigonella foenum-graecum
Rhizobium tropici Phaseolus vulgaris L. beans and Leucaena sp. trees NO
Rhizobium tubonense Oxytropis glabra UNKNOWN
Rhizobium undicola Neptunia natans NO
Rhizobium vallis Phaseolus vulgaris, Mimosa pudica and Indigofera spicata UNKNOWN
Rhizobium vignae Vgna radiata NO
Rhizobium yanglingense Phaseolus vulgaris UNKNOWN
Shinella kummerowiae Kummerowia stipulacea UNKNOWN
Sinorhizobium/Ensifer abri Abrus precatorius UNKNOWN
Sinorhizobium/Ensifer Lotus arabicus UNKNOWN
adhaerens
Sinorhizobium/Ensifer Acacia spp. NO
americanum
Sinorhizobium/Ensifer Acacia senegal and Prosopis chilensis NO
arboris
Sinorhizobium/Ensifer fredii Glycine Max NO
Sinorhizobium/Ensifer Argyrolobium uniflorum, Medicago sativa UNKNOWN
garamanticus
Sinorhizobium/Ensifer Sesbania rostrata UNKNOWN
indiaense
Sinorhizobium/Ensifer Acacia senegal and Prosopis chilensis UNKNOWN
kostiensis
Sinorhizobium/Ensifer Kummerowia stipulacea UNKNOWN
kummerowiae
Sinorhizobium/Ensifer Medicago spp. NO
medicae
Sinorhizobium/Ensifer Medicago spp., e.g. Madicago truncatula NO
mehloti
Sinorhizobium/Ensifer Acacia angustissima UNKNOWN
mexicanus
Sinorhizobium/Ensifer Leucaena leucocephala UNKNOWN
morelense
Sinorhizobium/Ensifer Argyrolobium uniflorum, Lotus creticus UNKNOWN
numidicus
Sinorhizobium/Ensifer saheli Sesbania cannabina NO
Sinorhizobium/Ensifer Sesbania spp. UNKNOWN
sesbaniae
Sinorhizobium/Ensifer sojae Glycine max NO
Sinorhizobium/Ensifer Acacia laeta NO
terangae
In some embodiments, the nitrogen-fixing rhizobia natu-
rally capable of producing C35 hopanoids can comprise
Bradyrhizobia. Bradyrhizobia are Gram-negative bacilli
(rod shaped) with a single subpolar or polarflagellum. Bra-
dyrhizobia are a common soil dwelling microorganism that
can form symbiotic relationships with leguminous plant
species. Many members of this genus have the ability to fix
atmospheric nitrogen by forming either specific or general
symbioses. This means that one species of Bradyrhizobium
can only be able to nodulate one legume species, whereas
other Bradyrhizobium species can be able to nodulate sev-
eral legume species.
Exemplary Bradyrhizobia naturally capable of producing
C35 hopanoids and that are suitable to be used in biofertil-
izer, compositions, seeds, methods and systems herein
described include Bradyrhizobium diazoefliciens, Bra-
dyrhizobium elkanii, Bradyrhizobium embrapense, Bra-
dyrhizobium icense, Bradyrhizobium japonicum, Bra-
dyrhizobium jicamae, Bradyrhizobium lablabi,
Bradyrhizobium liaoningense, Bradyrhizobium
manausense, Bradyrhizobium neotropicale, Bradyrhizobium
oligotrophicum, Bradyrhizobium pachyrhizi, Bradyrhizo-
bium paxllaeri, Bradyrhizobium retamae, Bradyrhizobium
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stylosanthis, Bradyrhizobium tropiciagri, Bradyrhizobium
45 
valentinum, Bradyrhizobium viridifuturi, Bradyrhizobium
yuanmingense, Bradyrhizobium sp., Bradyrhizobium sp.
Aila-2, Bradyrhizobium sp. ARR65, Bradyrhizobium sp.
ATl, Bradyrhizobium sp. BR 10245, Bradyrhizobium sp.
50 BR 10303, Bradyrhizobium sp. BTAil, Bradyrhizobium sp.
CCBAU 15544, Bradyrhizobium sp. CCBAU 15635, Bra-
dyrhizobium sp. CCBAU 43298, Bradyrhizobium sp.
CCGE-LA001, Bradyrhizobium sp. CCH5-F6, Bradyrhizo-
bium sp. Cp5.3, Bradyrhizobium sp. DFCI-1, Bradyrhizo-
55 bium sp. DOAL Bradyrhizobium sp. DOA9, Bradyrhizo-
bium sp. Ec3.3, Bradyrhizobium sp. errll, Bradyrhizobium
sp. G22, Bradyrhizobium sp. Leaf396, Bradyrhizobium sp.
LMTR 3, Bradyrhizobium sp. LTSP849, Bradyrhizobium sp.
LTSP857, Bradyrhizobium sp. LTSP885, Bradyrhizobium
60 sp. LTSPM299, Bradyrhizobium sp. ORS 278, Bradyrhizo-
bium sp. ORS 285, Bradyrhizobium sp. ORS 375, Bra-
dyrhizobium sp. S23321, Bradyrhizobium sp. STM 3809,
Bradyrhizobium sp. STM 3843, Bradyrhizobium sp. th.b2,
Bradyrhizobium sp. Tv2a-2, Bradyrhizobium sp.
65 URHA0002, Bradyrhizobium sp. URHA0013, Bradyrhizo-
bium sp. URHD0069, Bradyrhizobium sp. WSM1253, Bra-
dyrhizobium sp. WSM1417, Bradyrhizobium sp. WSM1743,
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Bradyrhizobium sp. WSM2254, Bradyrhizobium sp.
WSM2793, Bradyrhizobium sp. WSM3983, Bradyrhizo-
bium sp. WSM4349, Bradyrhizobium sp. WSM471, and
Bradyrhizobium sp. YR681.
In particular, in some embodiments Bradyrhizobia that
are naturally capable of producing C35 hopanoids that can be
used in biofertilizer and related seeds compositions, meth-
ods and systems can include Bradyrhizobium BTAil, Bra-
dyrhizobium diazoeffciens USDA 110, Bradyrhizobium
japonicum USDA 6, Bradyrhizobium sp. ORS 278, and
Bradyrhizobium diazoeffciens.
In some of those embodiments, the nitrogen-fixing Bra-
dyrhizobium naturally capable of producing hopanoids that
can be used in biofertilizer and related seeds compositions,
methods and systems is Bradyrhizobium diazoeffciens. The
Bradyrhizobium diazoefficiens is a member of the Bra-
dyrhizobium genus, having the ability to form root nodules
on leguminous plants.
In particular, in embodiments herein described B. diazo-
effaciens can exhibit two different life-styles, free-living in
soil or symbiotic within legume root nodule cells [2, 20]. In
addition to its native soybean host, B. diazoefficiens can
engage in nitrogen-fixing symbioses with the stems and
roots of the tropical legume Aeschynomene afraspera [21].
In both of the these hosts, development of the symbiosis
progresses through a series of defined stages: (i) coloniza-
tion and invasion of host root tissue; (ii) internalization of
bacteria by plant cells to form an organelle-like structure
called the symbiosome, comprising endosymbiotic bacterial
cells termed "bacteroids" that are surrounded by a plant-
derived "peribacteroid" membrane (FIG. 3); and (iii) initia-
tion of nitrogen fixation by bacteroids, during which there is
a high rate of nutrient exchange across the symbiosome
membranes between plant-supplied carbon sources and
fixed atmospheric nitrogen produced by bacterial nitroge-
nase [2, 22].
In some embodiments, nitrogen fixing C35 producing
rhizobia to be used in biofertilizer, compositions, seeds
methods and systems herein described are rhizobia naturally
incapable of producing C35 hopanoids (herein also C35
hopanoid-deficient rhizobia), and genetically engineered to
include genes for production of C35 hopanoids thus provid-
ing genetically engineered rhizobia capable of producing
C35 hopanoids herein also indicated as genetically engi-
neered C35 rhizobia.
In some embodiments, the rhizobia naturally incapable of
producing C35 is a bacteria closely genetically related to (i.e.
within a same taxonomic order of) hopanoids-producing
legume symbionts capable of producing C35 hopanoids that
can be used in biofertilizers, compositions, methods and
systems herein described. For example, a rhizobium natu-
rally incapable of producing C35 hopanoids that can be
genetically modified in the sense of the disclosure comprise
Sinorhizobium meliloti, a symbiont of alfalfa (Medicago
spp.), which is closely genetically related to Bradyrhizobia
and to all other members of the Rhizobiales order of the
alpha proteobacteria having nitrogen-fixing capability in
symbioses with plants.
In embodiments herein described, nitrogen-fixing rhizo-
bia capable of producing C35 either naturally or following
genetic modification, can be used as biofertilizer for
legumes and/or soil. The term "biofertilizer" as used herein
refers to a substance containing living microorganisms,
which, when applied to seeds, plant surfaces, or soil, colo-
nizes the rhizosphere or the interior of the plant and/or
promotes growth by increasing the supply or availability of
primary nutrients to the host plant. Biofertilizers in the sense
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of the disclosure adds nutrients through the natural processes
of nitrogen fixation, solubilizing phosphorus, and stimulat-
ing plant growth through the synthesis of growth-promoting
substances.
5 Biofertilizers herein described comprise and in particular
essentially consist of nitrogen fixing rhizobia capable of
producing C35 hopanoids. In particular, in biofertilizers
essentially consisting of nitrogen fixing rhizobia capable of
producing C35 hopanoids herein described, at least 70%,
io preferably at least 80%, more preferably at least 85%, even
more preferably at least 90%, and more preferably at least
95%, of the nutrient adding activity of the biofertilizer is
performed by nitrogen fixing rhizobia capable of producing
C35 hopanoids. The nutrient adding activity of a bacteria
15 and/or the biofertilizer can be quantitatively detected by
detecting with techniques identifiable by a skilled person the
nitrogen fixed by the plant or soil, the nitrogen solubilized
in the plant or soil and/or a difference in plant growth,
following addition of the biofertilizer and/or of each rhizo-
2o bia strains. In general, nitrogen detection can be performed
by quantitatively detecting the percentage of the nitrogen
dry weight by spectrometry on a dry sample of soil and/or
the plants. Additional techniques comprise use of biosensors
that use a fluorescent label or other label that can be
25 incubated with a dried sample to report on the amount of
glutamine (the main form of fixed N2) or other forms of
fixed N2 as will be understood by a skilled person
The terms "detect' or "detection" as used herein indicates
the determination of the existence, presence or fact of a
30 compound, bacteria and/or related activity in a limited
portion of space, including but not limited to a sample, a
reaction mixture, and a substrate. The "detect' or "detec-
tion" as used herein can comprise determination of chemical
and/or biological properties of a bacteria, plant, soil and or
35 related compositions, including but not limited to ability to
fixing nitrogen, solubilize nitrogen promote growth and
additional properties identifiable by a skilled person upon
reading of the present disclosure. The detection can be
quantitative or qualitative. A detection is "quantitative"
40 when it refers, relates to, or involves the measurement of
quantity or amount of the compound, bacteria and/or related
activity (also referred as quantitation), which includes but is
not limited to any analysis designed to determine the
amounts or proportions of the compound, bacteria and/or
45 related activity. A detection is "qualitative" when it refers,
relates to, or involves identification of a quality or kind of
the target or s compound, bacteria and/or related activity
signal in terms of relative abundance to another compound,
bacteria and/or related activity, which is not quantified.
50 The terms "label" and "labeled molecule" as used herein
refer to a molecule capable of detection, including but not
limited to radioactive isotopes, fluorophores, chemilumines-
cent dyes, chromophores, enzymes, enzymes substrates,
enzyme cofactors, enzyme inhibitors, dyes, metal ions,
55 nanoparticles, metal sols, ligands (such as biotin, avidin,
streptavidin or haptens) and the like. The term "fluorophore"
refers to a substance or a portion thereof which is capable of
exhibiting fluorescence in a detectable image. As a conse-
quence, the wording "labeling signal' or signal as used
6o herein indicates the signal emitted from the label that allows
detection of the label, including but not limited to radioac-
tivity, fluorescence, chemiluminescence, production of a
compound in outcome of an enzymatic reaction and the like.
In embodiments herein described a biofertilizer for a
65 leguminous plant can be produced by providing a nitrogen
fixing rhizobium in a form suitable for administration to a
leguminous plant or seed or soil surrounding a leguminous
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plant or seed. In particular, the nitrogen-fixing rhizobium
can be provided in a biofertilizer in a culture in a viable form
and preferably in a culture with a percentage of live cells in
a whole population that can be at least 5%, preferably at least
25% and more preferably at least 50%
A skilled person will be able to identify different type of
rhizobia and related application including specific condition
for related viability. For example B. diazoefficiens differs
phylogenetically from Bradyrhizobium BTAil as for
example, Shc from these two strains falls in distinct phylo-
genetic clades [7]. Unlike Bradyrhizobium BTAil, B. diazo-
effaciens is unable to photosynthesize [23, 24]. Moreover, B.
diazoeffaciens infects plants via a Nod-factor dependent
pathway, whereas Bradyrhizobium BTAil uses alternate
symbiotic strategies [25]. The inability to delete shc in B.
diazoeffaciens suggests that hopanoids are essential in this
species, in contrast to Bradyrhizobium BTAil where shc
mutants are viable. Such difference between these two
species likely reflects differences in the niches the two
bacteria inhabit as a consequence of their metabolic differ-
ences, and what is required for survival therein.
In some embodiments, the nitrogen fixing rhizobia can be
provided in the biofertilizer in an isolated and/or purified
form wherein the bacteria are provided without a detectable
presence of other microorganism. A bacterial strain in iso-
lated form can be obtained by obtaining a clonal bacterial
preparation of the bacteria, for example by inoculating a
bacterial sample into a culture plate, and picking a single
bacterial colony grown on the plate as will be understood by
a skilled person. A purified bacterial strain can be obtained
for example by separating bacteria from a growth medium,
with methods identifiable by a skilled person such as inocu-
lating a bacterial culture broth with an isolated bacterial
colony, growing the culture, and subsequently separating the
bacteria from the medium (e.g. by centrifugation and dis-
carding the supernatant medium, while retaining the pelleted
bacteria). Additional techniques to isolate or purify bacteria
are identifiable by a skilled person upon reading of the
present disclosure.
In some embodiments, a biofertilizer for leguminous plant
can be provided from one or more candidate nitrogen fixing
rhizobia strains, by a method comprising: detecting among
the one or more candidate nitrogen fixing rhizobia strains, at
least one rhizobia strain capable of producing C35
hopanoids. The method further comprises providing the at
least one rhizobia strain capable of producing C35 hopanoids
in a form suitable for administration to a leguminous plant
or seed or soil surrounding a leguminous plant or seed.
In some embodiments, detecting rhizobia strains capable
of producing C35 hopanoids in natural samples can be
performed by culture-independent techniques, such as 16S
rDNA sequencing. Positive identification in this manner can
then be used to target particular samples for enrichment of
Rhizobia strains, followed by isolation using methods
described below.
In particular, detecting among the one or more candidate
nitrogen fixing rhizobia strains, at least one rhizobia strain
capable of producing C35 hopanoids can be performed by
detecting C35 hopanoids production by the one or more
candidate compounds For example, C35 hopanoids analysis
can be performed by routine extraction and analysis using
either high temperature GC-MS or ultra-performance LC-
MS as well as other approaches identifiable to a skilled
person in the art. Detailed protocol of hopanoid analysis can
be found for example in related publications such as
Welander et al., 2009 [11] or Neubauer et al., 2015 [26] as
well as in Example 6 of the present disclosure.
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In some embodiments detecting among the one or more
candidate nitrogen fixing rhizobia strains, detecting at least
one rhizobia strain capable of producing C35 hopanoids can
be performed by detecting genes for the synthesis of C35
5 hopanoids in the one or more candidate one rhizobia strain.
In some embodiments, detecting genes for synthesis of
C35 hopanoids in the one or more candidate rhizobia strains
can be performed by detecting sequences of one or more of
the shc, hpnH and hpnG, hpnO, as well as hpnP, and also
io hpnC, hpnD and hpnE, in the genome, transcriptome, or
proteome of the one or more candidate strains. Exemplary
techniques that can be used to detecting sequences of one
more genes (e.g. where the genome is known), comprises
computer-based tools for comparing gene sequences, tran-
15 script sequences, or protein sequences, such as those using
the Basic Local Alignment Search Tool (BLAST) or any
other similar methods known to those of ordinary skill in the
art.
In some embodiments, detecting genes for synthesis of
20 C35 hopanoids in the one or more candidate rhizobia strains
can be performed by detecting the genes and/or related
transcript in the one or more candidate rhizobia. Exemplary
techniques comprise wet bench approaches such as DNA
sequencing, PCR, Southern blotting, DNA microarrays, or
25 other methods of hybridization of DNA or RNA probes to
DNA, wherein probes are attached to a label capable of
emitting a signal such as radiolabeling, fluorescence, lumi-
nescence, mass spectroscopy or colorimetric methods.
Exemplary probes that can be used comprise primers from
3o known shc, hpnH and hpnG, hpnO, as well as hpnP, hpnC,
hpnD and/or hpnE, and/or related transcript as will be
understood by a skilled person.
In some embodiments, detecting genes for synthesis of
C35 hopanoids in the one or more candidate rhizobia strains
35 can be performed by detecting transcripts of shc, hpnH and
hpnG, hpnO, as well as hpnP, and/or also hpnC, hpnD and/or
hpnE. Exemplary techniques comprise RNA sequencing,
PCR, quantitative PCR, Northern blotting, in situ hybrid-
ization, RNA microarrays, or other methods of hybridization
40 of DNA or RNA probes to RNA.
In some embodiments, detecting genes for synthesis of
C35 hopanoids in the one or more candidate rhizobia strains
can be performed by detecting proteins encoded by shc,
hpnH and hpnG, hpnO, as well as hpnP, and/or also hpnC,
45 hpnD and/or hpnE detecting the proteins. Exemplary tech-
niques comprise proteomics, antibody-based methods
including immunohistochemistry, immunofluorescence,
western blotting, or any other method of protein detection.
In embodiments, herein described, the conditions and
50 parameters to use probes/primers to detect shc, hpnH and
hpnG, hpnO, as well as hpnP, hpnC, hpnD and/or hpnE, can
be varied to permit lower or higher threshold or stringency
of detection, to ensure hybridization within the least 55%
sequence identity at gene level in view of the specific
55 primers/probes selected. For example, use of oligonucle-
otides comprising one or more degenerated nucleotide bases
or or using an antibody that binds to more highly conserved
protein regions, can require modification of the detection
conditions as will be understood by a skilled person.
60 In some embodiments, detecting genes for synthesis of
C35 hopanoids in the one or more candidate rhizobia strains
can be performed by detecting C35 hopanoids in lipid
fractions or other cellular fractions isolated from cells using
methods mass spectrometry.
65 In an exemplary embodiment, the detection can be done,
for example, by isolating genomic DNA from a candidate
and performing PCR using primer sequences designed to
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amplify hpnH genes from known C35 hopanoid-producing
rhizobia, including the primers listed in Table 4. Alterna-
tively, RNA samples can be isolated from the candidate(s)
and these transcripts can be sequenced, and expression of the
hpnH gene can be detected by identification of this gene
using homology-based computational identification (e.g.
BLAST).
In some embodiments, providing the at least one rhizobia
strain capable of producing C35 hopanoids in a form suitable
for administration to a leguminous plant or seed or soil
surrounding a leguminous plant or seed, can be performed
by providing the at least one rhizobia strain in a culture in
a viable form and preferably in a culture containing a
percentage of live cells in a whole population that is at least
5%, preferably at least 25% and more preferably at least
50%. In some embodiment providing the at least one rhizo-
bia strain capable of producing C35 hopanoids in a form
suitable for administration to a leguminous plant or seed or
soil surrounding a leguminous plant or seed, in an isolated
or purified form wherein the bacteria are provided without a
detectable presence of other microorganism.
In some embodiments a biofertilizer for a leguminous
plant can be provided from a rhizobium naturally incapable
of producing C35 hopanoids, by a method comprising:
genetically engineering a nitrogen fixing rhizobia strain
incapable of producing C35 hopanoids to introduce C35
synthesis genes to provide a genetically engineered nitrogen
fixing rhizobia strains capable of producing C35 hopanoids,
and providing the genetically engineered nitrogen fixing
rhizobia strains in a form suitable for administration to a
leguminous plant or seed, and/or a soil surrounding legu-
minous plant or seed.
In some of those embodiments, genetically engineering a
nitrogen fixing rhizobia strain incapable of producing C35
hopanoids to introduce C35 synthesis genes can be per-
formed by providing at least one gene selected from shc,
hpnH and hpnG, hpnO, as well as hpnP, hpnC, hpnD and
hpnE and introducing the at least one gene in the rhizobium
incapable of producing C35 hopanoids for a time and under
conditions to allow expression of the at least one gene.
In some of those embodiments, genetically engineering a
nitrogen fixing rhizobia strain incapable of producing C35
hopanoids to introduce C35 synthesis genes can be per-
formed by obtaining C35 hopanoid synthesis genes from
rhizobium that naturally produces C35 hopanoid using poly-
merase chain reaction-based amplification and isolation of a
region of genomic DNA encoding hopanoid synthesis genes
and/or genomic regulatory elements, or cDNA encoding
hopanoid synthesis genes (see Examples 22-27). In some
embodiments, the introduction of C35 hopanoid synthesis
genes into C35 hopanoid-deficient rhizobia to produce
genetically engineered C35 rhizobia can be performed by
transduction using a recombinant viral vector containing a
C35 hopanoid synthesis gene expression construct.
Additional techniques and related vectors, methods and
systems to modify a nitrogen fixing rhizobia incapable of
producing C35 are identifiable by a skilled person.
In some embodiments, providing the genetically engi-
neered nitrogen fixing rhizobia strains in a form suitable for
administration to a leguminous plant or seed, and/or a soil
surrounding leguminous plant or seed can be performed by
providing the at least one genetically engineered rhizobia
strain in a culture in a viable form and preferably in a culture
a percentage of live cells in a whole population can be at
least 5%, preferably at least 25% and more preferably at
least 50%. In some embodiment providing the at least one
genetically engineered rhizobia strain capable of producing
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C35 hopanoids in a form suitable for administration to a
leguminous plant or seed or soil surrounding a leguminous
plant or seed, in an isolated or purified form wherein the
bacteria are provided without a detectable presence of other
5 microorganism.
In several embodiments, one or more biofertilizers of the
present disclosure are comprised in a biofertilizer composi-
tion together with one or more suitable vehicles, wherein the
term "vehicle" as used herein indicates any of various media
io acting usually as solvents, carriers, binders or diluents for
the biofertilizer that are comprised in the composition as an
active ingredient.
In some embodiments, a biofertilizer composition for a
leguminous plant comprises one or more biofertilizers
15 essentially consisting of one or more nitrogen-fixing rhizo-
bia capable of producing C35 hopanoids and an acceptable
vehicle. In some embodiments, the biofertilizer composition
can further comprise one or more C35 hopanoids. In the
biofertilizer composition the one or more biofertilizers and
20 the vehicle are formulated for administration to a legumi-
nous plant and/or for administration to a leguminous seed. In
some embodiments the biofertilizer composition is formu-
lated for administration to a soil as will be understood by a
skilled person.
25 In particular, in some embodiments in the biofertilizer
compositions the vehicle comprises one or more carriers.
Incorporation of carrier materials in the biofertilizer com-
position herein described can enable easy-handling, long-
term storage and high effectiveness of the nitrogen-fixing
30 capability of the nitrogen-fixing bacteria comprised in the
biofertilizer composition. In particular, the suitable carrier
material can allow gas exchance, also have high organic
matter content and high water holding capacity, as well as
provide a stable medium for the storage of the biofertilizer
35 while retaining high viability of the nitrogen-fixing bacteria
comprised therein as will be understood by a skilled person.
In particular, suitable carrier materials can enhance the
survival of the nitrogen-fixing rhizobia on the seed surface
against drying conditions until placed into soil, the survival
40 of the bacteria during the storage period, as well as the
survival of the bacteria in soil. After being introduced into
the soil, the carrier material provides nutrient and/or habit-
able micro-pore to the inoculant bacteria for them to com-
pete with native soil microorganisms.
45 Various types of carrier materials can be used for seed or
soil inoculation. For preparation of seed inoculant, the
carrier material can be milled to fine powder with particle
size of 10-40 µm. The properties of a suitable carrier
material for seed inoculation are (1) non-toxic to inoculant
5o bacterial strain, (2) good moisture absorption capacity, (3)
easy to process and free of lump-forming materials, (4) easy
to sterilize by autoclaving or gamma-irradiation, (5) avail-
able in adequate amounts, (6) inexpensive, (7) good adhe-
sion to seeds, and (8) good pH buffering capacity and (9)
55 non-toxic to plant. Further information about carrier mate-
rials can be found in "Handbook for Rhizobia" (Somasega-
ran and Hoben, Springer, 1994).
The carrier can be a material, such as peat, vermiculite,
lignite powder, clay, talc, rice bran, seed, rock phosphate
60 pellet, charcoal, soil, paddy straw compost, wheat bran or a
mixture of such materials. In common practice, for better
shelf-life of biofertilizer formulation, a carrier or a mixture
of such carrier materials are selected based on the viability
of the microorganisms mixed with them. In some particular
65 cases, to achieve a tight coating of inoculant on seed surface,
adhesive material, such as gum Arabic, methylethylcellu-
lose, sucrose solutions and vegetable oils, can be used as
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carrier. In some cases, supplementary nutrients and cell
protectants such as sucrose, maltose, trehalose, molasses,
glucose and glycerol can be used together with the carrier
material to ensure improved cell viability and extended
shelf-life.
In some embodiments, the biofertilizer composition com-
prises one or more nitrogen-fixing rhizobia capable of
producing C35 hopanoids and one or more C35 hopanoids. In
some embodiments the composition can be formulated for
administration to a leguminous plant, a leguminous seed
and/or soil surrounding the leguminous plant or leguminous
seed.
In some embodiments, a biofertilizer composition can be
formulated as an inoculant, wherein the term "inoculant" as
used herein indicates a biofertilizer composition containing
a bacterial culture capable of providing fixed nitrogen to
plants, either via direct association (symbiosis) or via
enrichment of the soil or medium in which the plant is
grown.
In particular, in some embodiments, the biofertilizers
formulation described herein can be prepared as carrier-
based inoculants containing C35 hopanoids, living C35-ho-
panoids-producing nitrogen-fixing bacteria and a carrier,
such as a C35-bacteria-carrier mixture, according to common
procedures as would be recognized by a person skilled in the
art of agriculture and fertilizer applications.
In particular, in some embodiments, a biofertilizer com-
position formulated as an inoculant can be prepared by first
harvesting log-phase cultures of diazotrophs in their appro-
priate free-living cultivation medium as described in litera-
tures. For a given plant host, a concentrated solution of
inoculation medium is prepared according to common pro-
cedures described in literatures, which typically contains the
necessary elements for the nitrogenase reaction, such as
molybdenum/vanadium, iron, sulfur-containing compounds.
A concentrated C35 hopanoid solution can be obtained by
total lipid extraction of a rhizobia culture using Bligh-Dyer
method [27] modified for large-scale extraction, followed by
purification using silica gel and HPLC as would be under-
stood by a skilled person in the art. Detailed description of
methods for obtaining purified hopanoids from hopanoid-
producing rhizobia can be found in related publications such
as C-H Wu et. al. [28] herein incorporated by reference in its
entirety.
In some embodiments, biofertilizer compositions herein
described can optionally comprise also C35 hopanoids and in
particular C35 hopanoids of Formula I. In particular, in
embodiments herein described, C35 hopanoids, and in par-
ticular C35 hopanoids of Formula I, can be comprised in
biofertilizer compositions together with C35-hopanoids-pro-
ducing nitrogen-fixing rhizobia naturally capable of produc-
ing hopanoids or with nitrogen fixing rhizobia naturally
incapable of producing hopanoids and genetically engi-
neered to produce C35 hopanoids of Formula I can be
combined at a weight ratio identifiable to a person of
ordinary skill in the art of agriculture, in particular, in the art
of fertilization.
In some embodiments, the biofertilizer or biofertilizer
composition herein described can be used to stimulate plant
growth with enhanced tolerance to the diverse stresses
encountered during the progression of plant-microbe sym-
bioses, including high temperature, oxic and hypoxic con-
dition, acidic, detergent, and oxidative stresses.
In particular, herein provided are methods of fertilizing
leguminous plants and/or soil with biofertilizer and/or
related biofertilizer compositions herein described.
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In some embodiments, the method comprises applying
one or more biofertilizer and/or biofertilizer compositions
herein described to a leguminous plant or soil surround a
leguminous plant for a time and under conditions to allow
5 symbiosis of the nitrogen-fixing rhizobia with the legumi-
nous plant.
In some embodiments, the biofertilizer and/or biofertilizer
compositions can be administered in combination with one
or more C35 hopanoids. In those embodiments, administer-
10 ing the biofertilizer and/or biofertilizer compositions and
administering one or more C35 hopanoids are further per-
formed for a time and under conditions allowing interaction
of the one or more C35 hopanoids with the nitrogen-fixing
15 rhizobia in the administered biofertilizer and/or biofertilizer
compositions.
In some embodiments, applying the biofertilizer or biofer-
tilizer composition alone or in combination with C35
hopanoids can be performed on the roots or to the soil in
20 which the roots are present. In particular, the applying can be
performed at any time in plant growth as will be understood
by a skilled person.
In some embodiments, application on legumes of C35
hopanoids, and C35 hopanoids-producing rhizobia herein
25 described and related biofertilizer composition, can be per-
formed under conditions allowing extensive host control of
bacteroid physiology and establishment of a specific host
microenvironment, defined by low oxygen, low pH, hyper-
osmosis and oxidative stress [1]. For example, in A. afrasp-
3o era application of C35 hopanoids, and rhizobia herein
described and related biofertilizer composition can be per-
formed in connection with the plant's ability to produce
nodule-specific, cysteine-rich antimicrobial peptides
(NCRs) that induce differentiation of the bacteroid into an
35 enlarged, elongated and polyploid state.
In some embodiments, application on legumes of biofer-
tilizers, biofertilizer composition alone or in combination
with C35 hopanoids, can be performed for microaerobic
growth and tolerance to diverse stresses of the rhizobia the
40 symbiotic microenvironment, such as oxic and hypoxic
condition, acidic (pH:56), detergent, oxidative stresses (such
as due to hydrogen peroxide), ambient (between 22° C. and
32° C.) and particularly higher temperatures (i.e. 37°
C.<T<32° C.) and/or to promote to outer membrane rigidity
45 (Examples 14-19 for B. diazoeffacients).
In some embodiments a method of fertilizing leguminous
plants can comprise coating and/or inoculating one or more
seeds of the leguminous plant with one or more biofertilizer
and/or biofertilizer compositions herein described. In some
50 embodiments, the seeds can be coated with bacteria and
desiccated for transport/storage. It is expected that coating or
inoculating with hopanoids will improve bacterial survival
of desiccation and long-term storage in a desiccated state. In
some embodiments the method further comprises coating
55 and/or inoculating one or more C35 hopanoids before the
coating and/or inoculating the one or more seeds of the
leguminous plant with one or more biofertilizer and/or
biofertilizer composition. In particular in those embodi-
ments the C35 hopanoids are typically applied prior to
6o applying the rhizobia to the seed.
In some embodiments applying the biofertilizer compo-
sition can be performed by coating and/or inoculating the
leguminous seeds with the biofertilizer formulation prior to
or at the time of planting. In some embodiments, applying
65 the biofertilizer formulation can be performed by dipping
the seedlings of the leguminous plants in a suspension
comprising the biofertilizer. Alternatively or in addition, the
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biofertilizer formulation can be directly applied to soil
where the seed is planted or to be planted.
In embodiments herein described, methods of fertilizing
leguminous plants are described. The methods comprise
administering the C35 hopanoids, and rhizobia herein
described and related biofertilizer composition to legumi-
nous plants through seedling dipping, and/or direct-soil
application, and/or seed treatment (also called seed inocu-
lation), or other fertilizer application approaches identifiable
by the skilled person.
In some embodiments, the methods of fertilizing legumi-
nous plants comprise preparing a suspension containing one
or more biofertilizer herein described and dipping the seed-
lings of the leguminous plants in the suspension for a certain
time under a certain condition to allow the symbiotic inter-
action between the rhizobia, C35 hopanoids and the legumi-
nous plants.
In particular, a biofertilizer/inoculant suspension compris-
ing C35 hopanoids and C35-hopanoids-producing nitrogen-
fixing bacteria is prepared in water. The roots of seedlings
are then dipped in the suspension and kept immersed for a
certain period of time, typically several minutes, before
being transplanted. Here, seedling refers to a young plant
sporophyte developing out of a plant embryo from a seed.
Seedling development starts with germination of the seed. A
typical young seedling consists of three main parts: the
radicle (embryonic root), the hypocotyl (embryonic shoot),
and the cotyledons (seed leaves). For example, for soybean,
each seedling can be treated with 1 ml of an OD600— 1.0
(-109 cells) suspension of bacteria in a nodulation medium
that includes trace elements required by the nitrogenase
cofactors to support nitrogen fixation.
In some embodiments, about —1 billion cells can be
suspended in a nodulation medium that contains C35
hopanoids at a concentration below its critical micelle
concentration (CMC).
The term "critical micelle concentration (CMC)" is used
herein to characterize the aqueous solubility of a lipid
compound such as C35 hopanoids. CMC indicates the con-
centration above which amphiphilic molecules aggregate to
form micelles. At low surfactant concentration the amphi-
philic molecules arrange on the surface of the liquid, but also
exist as free molecules in the solution, with the two groups
exchanging with one another. As more amphiphilic mol-
ecules are added, the surface becomes saturated, and the
concentration of free molecules in solutions approaches a
concentration specific to the molecule and environment, at
which point further addition of amphiphilic molecules will
lead to formation of micelles. This concentration point
above which micelles form is called the critical micelle
concentration.
Many factors have effects on the CMC of a lipid com-
pound as will be understood by a skilled person. For
example, the molecular structure of the lipid, temperature,
the presence of electrolyte in the solution and so on. Several
empirical correlations can be used for the estimation of
CMC values. For lipids with a straight and saturated single
carbon tail, the CMC can be calculated from (Klevens
1953):
Log CMC=A-Bn
where n is the number of carbon atoms in the hydrophobic
tail, and A and B are temperature dependent constants for a
given type of lipid. The values of A and B are identifiable for
a skilled person in the art. These constant values can also be
found in textbooks such as Kreshech 1975 [29]. It is also
possible to measure the CMC of a molecule with devices
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such as a contact angle system, a tensiometer, a Langmuir
trough, or with other equipment identifiable by a skilled
person.
In some embodiment, methods of fertilizing leguminous
5 plants herein described comprise applying one or more
biofertilizer and/or related biofertilizer composition herein
described alone or in combination with the C35 hopanoids
directly to the soil where the leguminous plants are grown.
In particular, the biofertilizer composition comprising a
io biofertilizer herein described, optionally in combination C35
hopanoids and can be directly applied to the soil before or
at the time of plantation or sowing.
For example, in some embodiments, the biofertilizer or
biofertilizer composition can be firstly mixed with finely
15 powdered farm yard manure (FYM), compost, or soil at a
specific ratio and then directly applied to the soil. The
formed mixture can be broad-cast at the time of plowing.
In some embodiments, methods of fertilizing leguminous
plants comprise applying the C35 hopanoids, C35 hopanoid-
20 producing rhizobia and related biofertilizer composition
herein described via soil inoculation by placing the biofer-
tilizer and related composition into the furrow under or
alongside the seeds.
In particular, the biofertilizer and related compositions
25 can further comprise a carrier material in granular form of a
size about 0.5-1.5 mm. Suitable carrier material includes
granular forms of peat, perlite, talcum powder, or materials
that can offer nutrient and/or habitable micro-pore to the
inoculants bacteria including carriers with micro-porous
30 structure such as charcoal or soil aggregates.
In some embodiments, the methods of fertilizing legumi-
nous plants comprise coating/inoculating the leguminous
seeds with the C35 hopanoids, C35 hopanoid-producing
rhizobia and related biofertilizer composition herein
35 described, also referred to as seed treatment methods.
In particular, to prepare for inoculation, the biofertilizer
can be firstly mixed with water to form a slurry mixture. The
seeds desired to be treated are then immersed in the mixture
for a certain period of time under certain conditions to form
40 seeds coated or inoculated with the inoculum.
Leguminous plant seeds can be treated with the biofer-
tilizer compositions comprising a carrier, C35 hopanoids and
C35-hopanoids-producing nitrogen-fixing bacteria inoculant
at a certain weight ratio identifiable to a skilled person in the
45 art of agriculture and inoculation. In particular, the skilled
person will recognize the relationship between seed size,
number of C35-hopanoids-producing nitrogen-fixing bacte-
ria, the amount of C35 hopanoids and weight of the inocu-
lant. Similar to the seedling dipping method described
5o above, about —1 billion cells can be suspended in a nodu-
lation medium that contains C35 hopanoids at a concentra-
tion below its CMC.
In some embodiments, the vechicle used in the biofertil-
izer for seed treatment is in the form of fine powder with
55 particle size of 10-40 µm. The carrier can be a material, such
as peat, vermiculite, lignite powder, clay, talc, rice bran,
seed, rock phosphate pellet, charcoal, soil, paddy straw
compost, wheat bran or a mixture of such materials. In
common practice, for better shelf-life of biofertilizer formu-
60 lation, a carrier or a mixture of such carrier materials are
selected based on the viability of the microorganisms mixed
with them. The carriers used in the biofertilizer for seed
inoculation are typically non-toxic to inoculant bacterial
strains and plant, with certain moisture absorption and pH
65 buffering capacity, easy to process and sterilize by autoclav-
ing or gamma-irradiation and cost-effective. In some par-
ticular cases, to achieve a tight coating of inoculant on seed
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surface, adhesive material, such as gum Arabic, methyleth-
ylcellulose, sucrose solutions and vegetable oils, can be used
as carrier. In some cases, supplementary nutrients and cell
protectants such as sucrose, maltose, trehalose, molasses,
glucose and glycerol can be used together with the carrier
material to ensure improved cell viability and extended
shelf-life.
In some embodiments, coated seeds comprising legumi-
nous plant seeds coated with the biofertilizer formulation or
inoculant are described. The coated seeds are prepared by
coating or inoculating the seeds with the biofertilizer/inocu-
lant according to the methods above described. The coated
seeds can be prepared by manufactures and then distributed
to farmers. Alternatively, the seeds can be coated or inocu-
lated by farmers prior to planting. In particular, the seeds are
leguminous seeds, including Vicia faba, Arachis Hypogaea,
Cicer arientum, Dolichos lablab, Lupinus albus, Pisum
arvense, Glycine max, Cajanus cajan, Lens esculenta, Vigna
radiate, Cyamopsis tetragonoloba, Vigna aconitifolius,
Vicia hirsute, Trigonella foenum-graecum, Onobrychis
sativa, Coronilla cretica, Ornithopus sativus, Desmodium
intortum, Indigofera hirsute, Medicago sativa, Trifolium
incarnatum, Lotus pedunculatus, Trifolium agrarium and
Lotonois bainesii. The biofertilizers formulation are carrier-
based inoculants containing C35 hopanoids, C35-hopanoids-
producing nitrogen-fixing bacteria and a carrier as described
above.
In some embodiments, C35 hopanoids have been shown to
promote protection against numerous stresses, in particular,
higher temperatures and acidic soil conditions. Conse-
quently, the biofertilizer formulation comprising C35-ho-
panoids and C35-hopanoids-producing bacteria as described
herein and the seeds inoculated with such biofertilizer can
achieve improved viability of the microorganism used in
such formulations prior to its release into the field as well as
to survive under certain soil conditions (Examples 16-18).
In some embodiments, the biofertilizer and/or inoculated
or coated seeds can be stored at ambient or higher tempera-
tures between 22° C. and 37° C. More preferably, the storage
condition includes a temperature of about 30° C. to about
35° C. In particular, in some embodiments, the biofertilizer
and/or inoculated or coated seeds herein described can be
stored at a temperature higher than 25° C., while still
retaining a high viability rate, compared to other biofertilizer
or inoculated/coated seeds comprising rhizobia incapable of
producing C35 hopanoids. In embodiments herein described,
the biofertilizer and/or inoculated or coated seeds can be
stored for long-term purpose in glycerol at —20° C. or below,
after flash-freezing, or desiccation with improved bacterial
survival rate and elongated storage time.
In some embodiments, the biofertilizer herein described
and the seed coated with such biofertilizer can be planted
under stress soil conditions such as high temperatures and
low pH to effectively enhance plant growth and soil life. The
stress soil condition includes a temperature of about 25° C.
to about 37° C. and a pH value of about 6 to 8.
In some embodiments, the biofertilizer herein described
comprises nitrogen-fixing rhizobia that can fix nitrogen
outside plants, such as photosynthetic rhizobia including
Bradyrhizobium BTAil, Cyanobacteria and Azotobacter
species. Rhizobia that can fix nitrogen outside plants com-
prise nif genes that are a set of genes encoding enzymes
involved in the fixation of atmospheric nitrogen into a form
of nitrogen available to living organisms. Such biofertilizer
can be applied to oxygen-poor soils to enrich the soil
nitrogen content. Exemplary rhizobia species that can be
comprised in these biofertilizer include Bradyrhizobium
30
BTAil, Bradyrhizobium ORS285, Bradyrhizobium ORS278
and other rhizobia that can fix nitrogen in free-living con-
ditions.
In some embodiments, the nitrogen-fixing rhizobia herein
5 described are wild type bacteria that can naturally produce
C35 hopanoids. In other embodiments, the nitrogen-fixing
bacteria herein described are nitrogen-fixing rhizobia that
are naturally incapable of producing C35 hopanoids (herein
also C35 hopanoid-deficient rhizobia) that are genetically
io modified to produce C35 hopanoids (herein also genetically
engineered C35 rhizobia). C35 hopanoid-deficient rhizobia
include rhizobia lacking of one or more C35 hopanoids
synthesis genes and capable of being mutated to include one
or more C35 hopanoids synthesis genes. Different from their
15 wild type counterparts that cannot naturally produce C35
hopanoids, genetically engineered C35 rhizobia are capable
of producing C35 hopanoids. The genetically engineered
C35 rhizobia are expected to be more stress tolerant com-
pared to their wild type counterparts.
20 Thus herein described are also one or more nitrogen-
fixing genetically engineered C35 rhizobia can be comprised
in the biofertilizer described herein alone or in combination
with C35 hopanoids.
In some embodiments, the genetically engineered C35
25 rhizobia comprise one or more bacteria closely genetically
related to (within the same taxonomic order of) Bradyrhizo-
bia, such as Sinorhizobium meliloti that are genetically
modified to produce C35 hopanoids. Additional exemplary
legume C35 bacteria mutants include mutants of, Rhizobium
30 leguminosarum, Mesorhizobium loti, Sinorhizobium meli-
loti, Azorhizobium caulinodans, and Ochrobactrum
anthropi.
General methods of preparing genetically engineered C35
rhizobia are identifiable to a person of ordinary skill in the
35 art upon reading of the present disclosure. In particular,
preparing C35 bacteria mutant can be achieved by introduc-
ing C35 hopanoids synthesis genes (e.g. C35 hopanoid gene
cluster shown in FIG. 2, panel B) required for C35 hopanoid
synthesis into a rhizobia incapable of producing C35
4o hopanoids, including the genes hpnP, shc, and hpnH, at
physiologically relevant levels to result in a beneficial effect
on plants afliliated with the bacteria, including legumes such
as A. afraspera or soybeans or others.
This genetic modification can be achieved using various
45 techniques identifiable by a skilled person including using
gene expression constructs that direct expression of genes
required for C35 hopanoid synthesis, including suitable pro-
moter, enhancer, and other elements required for expression
in bacteria that would be recognized to perform this function
5o by those of ordinary skill in the art. Methods for genetic
modification can include modification of the bacteria by
transfer of the genes using a recombinant plasmid, a recom-
binant non-viral vector, or a recombinant viral vector,
encoding such gene expression constructs and additional
55 methods identifiable by a skilled person.
In some embodiments, C35 hopanoid synthesis genes can
be obtained from "donor" rhizobium that naturally produces
C35 hopanoids, by using polymerase chain reaction (PCR)-
based amplification and isolation of a region of genomic
6o DNA encoding hopanoid synthesis genes and/or genomic
regulatory elements, or cDNA encoding hopanoid synthesis
genes (see Example 22). "Donor" genetic material used as a
template for obtaining these genes and/or regulatory ele-
ments can be in the form of isolated genomic DNA, cDNA,
65 or genetic material contained in previously-cloned plasmids.
Sequences of donor material can be obtained from available
gene databases and/or by sequencing the material using
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standard techniques. Using the DNA sequences in the donor
material as a guide, design of appropriate primers, PCR
reagents and methods can be achieved by a person of
ordinary skill in the art.
In some embodiments, after the C35 hopanoid synthesis 5
genes and/or other regulatory elements are obtained, incor-
poration of the genes and/or other regulatory elements into
a plasmid vector or other vector can be achieved using
standard molecular cloning techniques. For example, the C35
hopanoid synthesis genes can be excised from surrounding io
genetic material by restriction endonuclease digestion to
provide a C35 hopanoid synthesis gene "insert". In parallel,
restriction endonuclease digestion can be performed on a
plasmid vector or other vector into which the C35 hopanoid
genes are inserted. DNA ligation can then be performed to 15
result in a plasmid containing the C35 hopanoid synthesis
genes and/or regulatory sequences.
In some embodiments, the vector containing the C35
hopanoid synthesis genes can contain appropriate regulatory
elements to express the C35 hopanoid synthesis genes, 20
including but not limited to promoters, enhancers, 5' and 3'
untranslated regions, exons, introns, enzyme recognition
sites for appropriate processing of transcripts, and post-
transcriptional and post-translational genetic elements.
Exemplary regulatory elements that can be comprised in the 25
vector can comprise elements that are naturally associated
with the C35 hopanoid synthesis genes in genomic DNA of
the "donor" genetic material, and/or elements comprised of
"heterologous" elements that are not normally associated
with the natural C35 hopanoid synthesis genes, such as 30
promoters normally associated with other genes.
In some embodiments, vectors used to introduce C35
hopanoids synthesis genes can include in addition to ele-
ments for regulating expression of C35 hopanoid synthesis
genes, other genetic material comprising other regulatory 35
sequences, including origin of replication, genes for express-
ing antibiotic resistance, and restriction endonuclease sites.
In some embodiments, vectors used to introduce C35
hopanoids synthesis genes comprise a plasmid vector con-
taining an expression cassette for a single hopanoid synthe- 40
sis gene. In other embodiments, vectors used to introduce
C35 hopanoids synthesis genes comprise a plasmid vector
containing expression cassettes for more than one hopanoid
synthesis gene. In some embodiments, a recipient rhizobium
can be genetically modified with one or more plasmid 45
vectors containing one or more hopanoid synthesis gene
expression cassettes, as required to provide a full set of
hopanoid synthesis genes.
In some embodiments, vectors containing hopanoid syn-
thesis genes can be introduced into bacteria, including 50
rhizobia, by a process of transformation, whereby the bac-
terial cell wall is transiently opened allowing entry of the
plasmid DNA into the bacterium. Several methods of trans-
formation can be used, including electroporation, thermal
shock, freeze-thaw techniques (see Examples 25-27). 55
In some embodiments, transfer of vectors and in particu-
lar plasmid vectors containing C35 hopanoid synthesis genes
into rhizobia can be performed by a process of conjugation,
in which plasmid DNA is transferred from an E. coli
bacterial cell into a rhizobium by direct contact (see 60
Example 23).
In some embodiments, gene expression cassettes required
for genetically modifying a rhizobium to produce C35
hopanoids are maintained on an plasmid, rather than inte-
grating into bacterial host DNA. In other embodiments, gene 65
expression cassettes required for genetically modifying a
rhizobium to produce C35 hopanoids are integrated into host
32
rhizobial DNA. In some embodiments, integration into
rhizobial DNA is at a symbiotically-silent locus in the
genome. A person of ordinary skill in the art will be able to
identify appropriate plasmid vectors available that contain-
ing elements to either maintain a C35 hopanoid gene expres-
sion cassette in a plasmid, or that contain elements that
enable integration into a host bacterial genome, including
containing DNA sequences that enable homologous recom-
bination into host bacteria DNA, or non-homologous end-
joining of gene expression cassette DNA into host bacteria
DNA.
In some embodiments, introduction of C35 hopanoid syn-
thesis genes into C35 hopanoid-deficient rhizobia to produce
C35 rhizobia mutants can be performed by transduction
using a recombinant viral vector containing a C35 hopanoid
synthesis gene expression construct
In some embodiments, vectors containing hopanoid syn-
thesis genes can be introduced into bacteria, including
rhizobia, by a process of transformation, whereby the bac-
terial cell wall is transiently opened allowing entry of the
plasmid DNA into the bacterium. Several methods of trans-
formation can be used, including electroporation, thermal
shock, freeze-thaw techniques (see Examples 25-27).
In some embodiments, transfer of vectors and in particu-
lar plasmide vectors containing C35 hopanoid synthesis
genes into rhizobia can be performed by a process of
conjugation, in which plasmid DNA is transferred from an
E. coli bacterial cell into a rhizobium by direct contact (see
Example 23).
In some embodiments, introduction of C35 hopanoid syn-
thesis genes into C35 hopanoid-deficient rhizobia to produce
genetically engineered C35 rhizobia can be performed by
transduction using a recombinant viral vector containing a
C35 hopanoid synthesis gene expression construct
Additional techniques and related vectors methods and
systems to modify a nitrogen fixing rhizobia incapable of
producing C35 are identifiable by a skilled person.
Nitrogen fixing rhizobia capable of producing C35 natu-
rally or after genetic modifications as herein described can
be identified by screening methods performed on one or
more candidate rhizobia strains for their ability to produce of
C35 hopanoids.
In some embodiments, one or more candidate rhizobia
strains can be screened by a method of screening stress-
resistant rhizobia comprising providing the one or more
candidate rhizobia strains; and detecting in the one or more
candidate rhizobia strains, production of a C35 hopanoid
and/or C35 hopanoids synthesis genes to identify stress-
resistant rhizobia.
Detection of C35 hopanoid can be performed by directly
detecting the C35 hopanoid and/or molecules involved in the
related biosynthetic pathway including squalene, diploptene,
adenosyl hopane, ribosyl hopane, formyl hopane, other
hopanoid intermediates and C35 precursors as shown in
Welander 2009 and Welander 2012 and identifiable to a
skilled person in the art.
In particular, in some embodiments, a method of screen-
ing stress-resistant rhizobia strains can comprise providing a
plurality of rhizobia strains, culturing the cells of each
rhizobia strain, analyzing lipids extracted for presence of
C35 hopanoids, and selecting the rhizobia strain producing
C35 hopanoids as stress-resistant rhizobia.
For example, screening rhizobia for the ability to produce
C35 hopanoids can be performed by analysis of lipids
extracted from samples of rhizobia obtained from soil,
legume nodules, or other sources. In particular, the analysis
can be performed by culturing the rhizobia, extracting the
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lipid content from the cultured cells, and purifying the lipid
extract and performing analytical chemistry techniques to
detect the C35 hopanoids (including gas chromatography-
mass spectrometry and liquid chromatography-mass spec-
trometry) (see Example 29).
In some embodiments, detection of C35 hopanoid can be
performed in addition or in the alternative by detecting one
or more C35 hopanoids synthesis genes. Detection of C35
hopanoids synthesis genes can be performed by DNA
sequencing, PCR probes and/or other nucleotide amplifica-
tion techniques as will be understood by a skilled person.
For example, in some embodiments, a method of screen-
ing stress-resistant rhizobia strains as biofertilizer can com-
prise genetically screening rhizobia strains capable of pro-
ducing C35 hopanoids. In those embodiments, the method
can comprise providing a plurality of rhizobia strains, for
each rhizobia strain detecting C35 hopanoid synthesis genes
(e.g. by conducting a diagnostic polymerase chain reaction
or DNA sequencing methods) in the rhizobia strain, and
selecting the rhizobia strain with detected C35 hopanoid
synthesis genes.
In method for genetic screening of rhizobia, detected
presence of C35 hopanoid synthesis genes can be used as a
marker for the ability of particular rhizobia to produce C35
hopanoids (see Example 30). In some embodiments, detect-
ing Diagnostic PCR or DNA sequencing on genomic DNA
isolated from rhizobia obtained from soil, legume nodules,
or other sources can be performed to determine whether C35
hopanoid synthesis genes are present in a particular sample
rhizobial genome. Using available gene sequence informa-
tion, PCR primers can be designed to amplify genes in the
hopanoid synthesis gene cluster, whereby amplification of
genes necessary for C35 hopanoid synthesis indicates a
rhizobial species genetically capable of producing C35
hopanoids. Similarly, DNA sequencing may be used to
determine whether C35 hopanoid synthesis genes are present
in the genome of a sample rhizobium, and therefore whether
the rhizobium is genetically equipped to synthesize C35
hopanoids.
Additional techniques for detecting C35 hopanoids and/or
C35 hopanoids synthesis genes are identifiable by a skilled
person.
In some embodiments, biofertilizers, biofertilizer compo-
sitions, seed and methods herein described can comprise at
least one nitrogen fixing bacteria other than a rhizobia (e.g.
ar rhizobiales) which is symbiotic with legumes, is inca-
pable of producing C35 hopanoids (C35 deficient), and is
closely genetically related to (i.e. within a same taxonomic
order of) hopanoids-producing legume rhizobia symbiont
capable of producing C35 hopanoids. In those embodiments
the at least one nitrogen fixing bacteria other than a rhizobia
can be genetically engineered to include shc, hpnH and
hpnG, hpnO, as well as hpnP, hpnC, hpnD and/or hpnE and
provide a genetically engineered C35 bacteria that can be
used in fertilizers, biofertilizer compositions, seed and meth-
ods herein described.
The biofertilizer, biofertilizer composition, seeds, geneti-
cally engineered C35 rhizobia and C35 hopanoids herein
described can be provided as a part of systems to fertilize
leguminous plants or soil with suitable methods, including
any of the methods described herein. The systems can be
provided in the form of kits of parts. In a kit of parts, the
biofertilizer, biofertilizer composition, seeds and C35
hopanoids and other reagents to perform fertilization of the
leguminous plant or soil can be comprised in the kit inde-
pendently. The biofertilizer, biofertilizer composition, seeds
and C35 hopanoids can be included in one or more com-
34
positions, and nitrogen fixing rhizobia capable of producing
C35 hopanoids can be in a composition together with a
suitable vehicle.
In particular, the components of the kit can be provided,
5 with suitable instructions and other necessary reagents, in
order to perform the methods here described. The kit will
normally contain the compositions in separate containers.
Instructions, for example written or audio instructions, on
10 
paper or electronic support such as tapes or CD-ROMs, for
carrying out the assay, will usually be included in the kit.
The kit can also contain, depending on the particular method
used, other packaged reagents and materials such as buffers
and the like.
15 Further details concerning biofertilizers, and related seeds
compositions methods and system, cells and formulation of
the present disclosure will become more apparent hereinaf-
ter from the following detailed disclosure of examples by
way of illustration only with reference to an experimental
20 section.
EXAMPLES
The hopanoids, hopanoids-producing nitrogen-fixing bac-
25 teria, and related formulation and methods herein described
are further illustrated in the following examples, which are
provided by way of illustration and are not intended to be
limiting.
In particular, the following examples illustrate exemplary
30 hopanoids, hopanoids-producing nitrogen-fixing bacteria
forming symbiosis with exemplary leguminous plants and
related methods and systems. In particular, in the examples
described herein, B. diazoeliciens is used as a model strain
35 to study the roles of two hopanoid classes, 2Me-hopanoids
and C35 hopanoids, in symbiosis with leguminous plants
such as Aeschynomene afraspera and soybean.
A person skilled in the art will appreciate the applicability
and the necessary modifications to adapt the features
40 described in detail in the present section, to additional
hopanoids-producing nitrogen-fixing bacteria, such as other
related Bradyrhizobium bacteria as described in the above
disclosure capable of forming symbiosis with leguminous
plants, and related methods and systems according to
45 embodiments of the present disclosure.
Example 1: Hopanoids from B. diazoeffaciens
FIG. 1, panel A shows exemplary chemical structures of
50 isolated hopanoids from B. diazoeffaciens. While most
hopanoids are thought to occur free within membranes, the
C35 hopanoid, (2-Me) 34-carboxyl-bacteriohopane-32,33-
diol, was found to be covalently attached to LPS lipid A in
the outer leaflet of the outer membrane (OM), a well-
55 established player in a broad range of host-microbe inter-
actions, to form a compound called Hopanoid-Lipid A
(HoLA) [7, 30] (FIG. 1, panel B). As seen in the expanded
view of the OM, B. diazoeffaciens makes short (Cm)
hopanoids like diploptene and extended (C35) hopanoids
60 like bacteriohopanetetrol (BHT) and aminotriol. Penta- and
hexa-acylated Lipid A contain 5 and 6 fatty acyl chains,
respectively. Hepta-acylated Lipid A contains the C35
hopanoid, 34-carboxyl-bacteriohopane-32,33-diol, cova-
lently attached to hexa-acylated Lipid A. In addition to C31
65 and C35 hopanoids [5], B. diazoefficiens makes tetrahyma-
nol, a triterpenoid with a gammacerane skeleton [31] (FIGS.
1 and 2, panel A).
US 10,131,585 B2
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Example 2: Synthesis of Hopanoids from B.
diazoefficiens
C35 hopanoids are biosynthesized by a hopanoid biosyn-
thetic gene cluster in some bacteria. For example, in B.
diazoefficiens, C35 hopanoids can be synthesized by a
hopanoid biosynthetic gene cluster shown in FIG. 2, Panel
C. In particular, she (squalene hopene cyclase) catalyzes
36
squalene cyclization to hopene, the first reaction in the
hopanoid biosynthetic pathway; hpnH catalyzes addition of
adenosine to hopene, the first reaction in the synthesis of Cis
hopanoids; and hpnP catalyzes C-2 methylation. Detailed
description of the biosynthetic pathway and involved genes
can be found in Welander 2012 [12].
Table 2 lists the C35 hopanoid biosynthesis genes and their
sequences from R. palustris.
TABLE 2
DNA sequences of R. palustris hopanoid biosynthesis genes
Gene
Name DNA sequence
hpnC ATGACGTCTGCGAGCGAGCTTCGATCGGGCAAGACCCACCGGGACGAGAATTTC
CCGGTCGCGTCGTGGATCATCCATCCGCGGCATCGCGACCTGATTCTGGCGTTCT
ACAATTTCGTCCGGACCGCGGACGACATCGCCGATCACGAGATGCTCGATGGCG
ACACCAAGCTCGAATATCTCGATCTGCTCGAAGCCGAGCTGCTCGGCCGCGGCG
AGACCCAGCCCGAGGCGGTGCATCTGCGTCGGGCGCTGGCCGAACGCGGCATGC
CGCCGCGCCATGCGCTCGATCTGCTGACCGCGTTTCGGATGGACGTCACCAAGCT
GCGCTACGAGGATTGGGACGAGGTCATTCACTACTGCCGCTACTCGGCGATGCCG
GTTGGCCGCTTCATGCTCGACGTCCACGGCGAAAGCACCACGACCTGGCAGGCCT
CCGACGCGCTGTGCGCGGGGCTTCAGATCAACAATCACCTGCAGGACTGCGGCA
AGGACTATCGCACCCTCAATCGCGTGTATCTGCCACGCGACGTGCTCGATGCCGC
CGGCGCCAAGGTCGAAGACCTCGGCCTGCAGAAGTCGTCACCGGCGCTGCTGAA
ATGCCTGCAGGGTCTTGCGGTCCGCACCGCGTCGCTGCTCGGCGACGGCCGGCCG
CTCGCCGCCGAGATCAAGGATTATCGCCTCGGTCTCGAAGTCTCGGTGATCCAGG
CCTATGCCGATCGCATCGTGCGGATGCTGCAGACCCGCGATCCGCTCAGCGAGCG
CGTGCATCTGAAGCCGATCGAATTCGTGATCGCCAGCTTCGGCGCGATGAGTTCG
GAGATCGTCCGTCGTAGCTTCGGAAAGGGGCCGGTGTCGCATCCGGCGCCGCGC
GCATGA
hpnD ATGACCGTTCACGCCACGCCAGAGCCGGCCGCACATCAAGGTGTCGCGCTCGGC
AGTTCGTTCTACGCCGCGATGCGCATCCTGCCGCGTCCGCAGCGCGAGGCGATGT
TCCAGGTCTACAGCTTCTGCCGCTTCGTCGACGACATCGCCGATTCCGATCGGCC
GCGCGAGCAGCGGGTCGCCGAGCTGCAGCAATGGCGCGACGACATCGCCGCGCT
GTATCGCGGTGCGCCGCCGCCGCGGCTCGCCGACTATCAGGAGTCGCTGCGCACT
TTCGGGCTGAAGCGCGAGGACTTCGAGGCGATCATCGACGGCATGGAGATGGAT
GTCGACGCCGACATCCGCGCGCCCGATGAGGCCACGCTCGATCTGTACTGCGACC
GCGTCGCCAGCGCGGTGGGACGGCTGTCGGTGCGGATCTTCGGCCTTCCGGAAG
CCGACGGCATCGAGCTGTCGCATCATCTCGGACGCGCGCTGCAGCTCACCAACAT
CCTGCGCGACATCGACGAGGACACCGGCATCGGCCGGCTGTATCTGCCGAGCGA
GCTGCTGCACAAGGTCGGTATCACCGCAACCGATCCGCGCGTGGTCGCGGCGGA
TTCTGCGCTGCCGAGCGTCTGCGCGCCGCTGGTCGAGCGTGCGCTCGCGCATTTT
GCCGCCGCCGACAAGGTGATGAACCGTAATCCGCGCCGGGTGGTGAAAGCTCCC
CGTATCATGGGCAAGTACTACTACTCGATCTTGCAGCTTTTGATCGCGCGCGGTT
TCGCAGCGCCGCGCGCCCCGGTGAAGCTCGGCAAGGCTTCGAAGATCGCCATCC
TGCTGCAATACGCGATCGTGTGA
hpnE ATGTCGAAAACAGTTCACGTCATTGGTGCGGGAATCTCCGGGCTTGCGGCCGCGA
TCCGGCTCGCCCGCGCCGGCCTCACCGTCCATGTTCACGAAGCGATGCAGCAGGC
CGGTGGCCGCTGCCGCTCGTATTTCGACGCCCAGACCGGGCTTGTCATCGACAAC
GGCAATCACCTGCTGCTGTCGGGTAATCACGCCGCCTGCGACTACGCGCGGACG
ATCGGCACCGAGGCGGGCCTCGTCGGCCCGGAGCGCGCCGAGTTCGACTTCATC
GATCTGCCGGCTAATGCGCGCTGGCGGCTGAAGCTCGGCGGCGGCAAGCTGCCG
CTGTGGCTGTTTGATGCCAATAGCCGCGTGCCGGACACGTCGATCGGCGATTACC
TCGGCTTGATGCCGCTGCTGTGGGCGCCGACCACCAAACTGATCGGCGACACCAT
CAACTGCTCCGGCCCGCTGTACGACCGCTTGGTGGCGCCGCTGCTGCTCGCCGCG
CTCAACGTCGATCCGCCGGAAGGCTCGGCCGGGCTTGCCGGCGCGGTGGTTCGTG
AGACGCTGCTGGCCGGCGGCAAGGCCTGCCGGCCGCTGATCGCCCGCGATGGCC
TGTCGGCGGTGCTGGTCGAGCCGGCCGTGGCGCAGCTCGCCGCCCGCGGTCCAG
GAGTGCAGTTCGGCCACGAGCTGCGGGCGCTGACCCCGGCCGGCGACCGCGTCG
GCGCGCTGCAGTTCGGCGGTGAGGATGTCGTCACCCTCGGGCCGGATGATGCGG
TGGTGCTGGCGGTGCCGCCGCGCCCGGCCGCTTCGCTGCTGCCCGGGCTGAAGAC
GCCACAGGAATACCGCGCGATC
GTGAACGCGCACTTCAATTACGCGCCGCCGCCTGGCATGCCGGCCCTGACCGGG
GTGATCGGCGGGGTGGTGGAGTGGCTGTTCGCGTTCCCGAACCGGCTGTCCGTGA
CGATCAGCAACGGCGACCGGCTGGTGGACGCCCCGCGCGAGCAGCTTGCGGCCG
AAATTTGGGGCGAAATCTGTAAAATTGCGGGGATCTCGGCCAATCTGCCGCCGTG
GCAAATTGTCCGCGAGCGCCGCGCCACGTTCGCCGCTACACCGGCGCAGAACGC
CCTGCGCCCCGGGCCGGTCACCCAGTGGAGAAACCTATATCTCGCAGGCGATTG
GACTGATACGGGGTTACCGGCGACCATCGAGGGATCGGTCCGGTCCGGCAACCG
TGCCGCGGACCTGGTGCTGGCCGCTGGCCGCGCCTGA
SEQ
ID
NO
25
26
27
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TABLE 2-continued
DNA sequences of R. palustris hopanoid biosynthesis genes
SEQ
Gene ID
Name DNA sequence NO
hpnF ATGGATTCCGGCAGCTACACGACTGGTGTGGAGCGCAACGCGCTCGAAGCTTCG 28
ATCGATGCGGCGCGCAGCGCGCTGCTGAATTATCGTCGCGACGATGGCCATTGG
GTGTTCGAACTCGAGGCCGATTGCACCATTCCTGCCGAATACGTGCTGCTGCGGC
ATTACCTCGGCGAGCCGGTCGATGCCGAGCTCGAAGCCAAGATCGCGGTTTATCT
GCGCCGCATCCAGGGTGCCCATGGCGGCTGGCCGCTGGTGCACGACGGCGACTT
CGACATGAGCGCCAGCGTGAAGGGTTACTTCGCGCTGAAGATGATCGGCGACAG
CATCGATGCCCCGCATATGGTGCGGGCGCGCGAGGCGATCCGTTCGCGCGGCGG
CGCGATCCACTCCAACGTCTTCACCCGGTTTCTGCTCACGTTGTACGGCGTTACG
ACCTGGCGCGCGGTTCCGGTACTGCCGGTCGAGATCATGCTGCTGCCGAGCTGGT
CGCCGTTCACACTGACCAAGATCTCGTATTGGGCGCGTACCACGATGGTGCCGCT
GCTCGTGCTGTGCGCGCTGAAGCCGCAGGCCAAGAATCCGAAGGGCGTCGGCAT
CGACGAACTATTCCTTCAGGACCCGAAGACGATCGGGATGCCGGTCAAGGCGCC
GCATCAGAACTGGGCGCTGTTCAAGCTGTTCGGATCGATCGACGCGGTGCTGCGC
GTGATCGAGCCTGTGATGCCCAAAGGCATCCGCAAGCGCGCGATCGACAAGGCG
CTCGCCTTCATCGAGGAGCGGCTCAACGGCGAGGACGGCATGGGCGCGATCTTC
CCGCCGATGGCCAACGCCGTGATGATGTACGAGGCGCTCGGCTATCCCGAGGAC
TATCCGCCGCGCGCCAGCCAGCGCCGCGGCATTGATCTCTTGCTGGTCGATCGCG
GCGACGAAGCCTACTGCCAGCCCTGCGTGTCGCCGGTGTGGGACACCGCGCTCG
CCAGCCATGCGGTGCTCGAGGCGGACGGTCACGAGGGCGCCAAGTCGGTGCGGC
CGGCGCTCGACTGGCTGCTCCCGCGCCAGGTGCTCGACGTCAAGGGCGACTGGG
CCGTCAAGGCCCCGAACGTCCGCCCCGGCGGCTGGGCGTTCCAGTACAACAACG
CCCACTATCCGGATCTCGACGATACCGCGGTGGTGGTGATGGCGCTCGACCGCGC
CCGCAAGGACCAGCCGAATCCCGCCTACGATGCCGCGATTGCCCGCGCCCGCGA
GTGGATCGAGGGGATGCAGAGCGACGATGGCGGCTGGGGTGCCTTCGACATCAA
CAACACTGAGTATTATTTGAACAACATCCCGTTCTCGGACCATGGCGCGATGCTC
GATCCGCCGACCGAGGACGTCACCGCGCGCTGCGTCTCGATGCTGGCTCAGCTCG
GTGAGACCATGGACAGCAGCCCGGCGCTGGCCCGCGCCGTCGGCTATCTGCGCG
ACACCCAGCTCGCCGAGGGCTCCTGGTACGGCCGCTGGGGCATGAATTACATCTA
CGGCACCTGGTCGGTGCTGTGCGCCCTCAACGCCGCCGGCGTTCCCCATGCCGAT
CCGATGATCCGCAAGGCGGTCGCCTGGCTGGAGTCGGTGCAGAATCGCGACGGC
GGCTGGGGCGAGGACGCGGTCAGCTACCGACTGGATTACCGCGGCTACGAAAGT
GCACCTTCGACCGCCTCTCAGACGGCATGGGCTTTGCTTGCTCTGATGGCTGCGG
GTGAGGTCGATCATCCCGCCGTGGCACGGGGCATCGAGTACCTGAAAAGCACAC
AGACCGAAAAAGGACTGTGGGACGAGCAGCGTTACACGGCGACGGGCTTCCCGC
GGGTGTTTTATCTGCGGTATCATGGCTATTCGAAGTTCTTCCCACTCTGGGCGCTC
GCCCGGTATCGGAACTTGCAGGCCACGAACAGCAAGGTGGTAGGGGTCGGAATG
TGA
hpnG GTGATTCTGGGGGCAGTGGACGACCAGGCCGCGGCGCTTCGCCAAGATCCGCGG 29
CCGGTACTGATTGTGACGGGCCTGATTCAGGAAGCACGTATCGCGGCGGGGCCG
GGCCTCACCGTTATCTGCAGCAGCAGTGACCCCAAGCAATTGCGCGCGATCATGG
CCGACTTCGACGCATCGTCGATCCGGGGCGTGATCAGCTTCGGCGTCGCCGGGGG
GCTGGATCCCTCTCTCGAGGCAGGTGACATCGTCATCGCCACCGAGGTTGTGGCG
GGTGAACGCCGCTGGACGTCGGAAGTTGCACTGACCGACGAATTATTGCGAAGC
GCCGGGCTCGGCCGTCAGCGCGTCGTGCGCGGCGGTCTGGTCGGCGCCGAGCAG
GTGATCGCAGCGCGCTCCGCCAAGGCGGCGCTGCGCTCGGAGACCGGTGCGGCT
GCGGTCGATATGGAAAGCCACATCGCCGCCGATTTCGCCGCCGCCGCCAAGCTG
CCGTTCGCGGCGCTCCGGGTGATCAGCGATCCGGCGAATCGCAGCCTGCCGCAG
ATCGTGTCGAGCGCGATCAAGCCGAACGGCGATATCGACCTGCGCAAGGTGCTG
CGCGGCATCGCCCGTCACCCGACCTCGATCCGCTCGCTGGTGTCGACCGGCATCG
ACTTCAACCGCGCGCTGCGCTCCCTGCGCGGCTGTCGGAACTTTGTGCAGGACGC
CGTGCTCGGCCGCGGCGGTCTCGTCGCCGAGATCTGA
hpnH ATGGCTATTCCGTTTCACAAGGAACTGGTGATCGGCGGTTATCTGCTGAAGCAGA 30
AGCTGCTCGGGCGGAAGCGTTATCCGCTGGTACTGATGCTGGAGCCGCTGTTCCG
CTGTAACCTCGCCTGCGCCGGCTGCGGCAAGATCGACTATCCCGACGCGATCCTG
AACCGCCGGATGACCGCACAAGAGTGCTGGGACGCCGCCGAGGAATGCGGCGCG
CCGATGGTTGCGATCCCGGGCGGCGAACCGCTGATCCACAAGGAGATCGGCGAG
ATCGTGCGCGGCCTGGTGGCGCGCAAGAAGTTCGTGTCGCTGTGCACCAACGCG
CTGCTGCTCGAGAAGAAGCTGCATCTGTTCGAGCCGTCGCCCTACCTGTTCTTCTC
GGTGCATCTCGACGGCCTGAAGGAGCACCACGACAAGGCGGTGTCGCAGCAGGG
CGTGTTCGACCGCGCAGTCGCGGCGATCAAGGCCGCCAAGGCCAAGGGCTTCAC
CGTCAACGTCAACTGCACGGTGTTCGACGGCTACGCCGCCGAAGACATCGCCAA
GTTCATGGACTTCACCGAGGAACTCGGCGTCGGCGTCTCGATCTCGCCGGGCTAC
GCCTATGAGCGCGCTCCGGACCAGGAGCACTTCCTCAACCGCACCAAGACCAAG
AACCTGTTCCGCGAGGTGTTCGCGCGCGGCAAGGGCAAGAAGTGGAGCTTCATG
CACTCCAGCATGTTCCTCGACTTCCTGGCCGGCAATCAGGAGTTCGAGTGCACGC
CGTGGGGTATGCCGGCGCGCAACATTTTCGGCTGGCAGAAGCCCTGCTACCTGCT
CGGCGAAGGCTACGCCAAGACTTTCCAGGAGCTGATGGAAACCACCGATTGGGA
TTCCTACGGCACCGGCAAGTACGAGAAGTGCGCCGACTGCATGGCGCATTGCGG
CTACGAACCGACCGCGGCGATGGCCTCTCTCAACAATCCGCTGAAGGCCGCCTG
GGTGGCGCTCCGCGGCATCAAGACCTCGGGCCCGATGGCGCCGGAGATCGACAT
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TABLE 2-continued
DNA sequences of R. palustris hopanoid biosynthesis genes
SEQ
Gene ID
Name DNA sequence NO
GTCGAAGCAGCGCCCGGCGCAGTACGTGTTCTCCGAGCAGGTCCAGAAGACGCT
GACGCAGATCCGCCAGGACGAGGCCGCCGAGGCCAAGGACAAGCGGCAGGCGG
AAAGGTCGACGGCGGCCTGA
hpnN GTGCTGAAAAGTGCCATCGTCTCCATTGTCAGAGCCAGCACCCGTTTTGCGGCTT 31
TTACTGTGCTGATCGGCGTATTTCTCGCAGTTGCAGCAGGTTTCTATACTTACCAA
CATTTCGGGATCAACACAGACATCAATCATTTGATCTCGTCTGATCTCGACTGGC
GCAAACGTGATATCGCGTTCGAGAAGGCATTCGACCAGGAACGGCTGATCCTGG
CCGTCGTCGAGGCCCCGACGCCGGAATTCGCCAATGCCGCGGCGGCCAAGCTCA
CGGCCGAATTGTCCAAGAATAACATCAACTTCGACTCGGTGAAGCGGCTCGGCG
GCGGGCCGTTTTTCGACCGCAGCGGGCTGCTGTTCCTGCCCAAGGACGAGGTCGC
CAAGGCCACCGGCCAGTTCCAGCAGGCGGTTCCCCTGATCGAGATCATGGCCGG
CGATCCGTCGATCCGCGGCCTGACGGCGGCACTCGAGACCGGTCTGGTCGGGTTG
AAACGCGGGGAACTGACCCTCGACGCCACCGCGAAACCTTTCAATACAGTCGCC
GCGACCGTCGAGGACGTGCTCGGCAAGCAGCAGGCGTTCTTCTCCTGGCGCGGC
CTGGTCAATCCGGAACCGCTGACCGATGGCGACAAGCGCGCCTTCATCGAGGTC
AAGCCGATCCTCGACTTCAAGGCGCTCGAACCCGGCAAGGCGGCGACCGACGCG
ATCCGTCAGGCGGCAGTCGATCTCAAGATCGAGCAGGATTTCGGCGCCCGGGTG
CGGCTGACCGGCCCGGTGCCGATCGCCAACGAGGAATTCGCTACCGTTAAGGAC
GGCGCCGTGGTCAACGGCATCGGGACCGTCGTGGTGGTGCTGCTGATCCTCTGGA
TGGCGCTGCATTCCTCCAAGATCATCTTCGCGGTGGCGGCCAATCTGGTGATCGG
CCTGTCGATCACCACCGCGGTCGGCCTGATGCTGGTGGATTCGCTCAACCTGCTG
TCGATCGCGTTCGCGGTGCTGTTCGTCGGCCTCGGCGTCGATTTCGGCATCCAATT
CAGCGTCCGCTATCGATCGGAACGCCACAAGACCGGGGACCTCGAGAAGGCCCT
GGTCCAGGCCGCCGAATACTCCGCGGTGCCGCTGTCACTGGCGGCGATGTCGACC
ACGGCCGGCTTCCTGTCGTTCCTGCCGACGTCCTACAAAGGCATTTCCGAACTCG
GCGAGATCGCCGGTGCCGGCATGGCGATCGCGTTCTTCACCAGCATCACCGTGCT
GCCGGCGCTGCTGAAGCTGCTGAACCCGGCGGGTGAGAAGGAACCGCTTGGCTA
CGCCTTCCTGGCGCCGGTCGATCACTTCCTGGAGAAGCACCGCATCGCCATCATC
GTCGGCACGATCGGTGTCGCGCTGGCCGGCCTGCCACTGCTGTACTTCATGCATT
TCGACTTCAACCCGATCAATCTGCGCAGCCCGAAGGTCGAGTCGATCGCGACGTT
CCTTGACCTGCGCAAGGATCCGAATACCGGTGCCAACGCCGTCAACGTGATGGC
GCCGAACGAGCAGGCGGCTCGTGAGATCGAAGCCAAGCTCGCCAAGCTGCCGCA
GGTATCGCGCACCATCTCGCTCGACACTTTCGTGCCGCCGGACCAGCCGGAGAAG
CTGAAGCTGATCCAGGCCGGCGCCAAGGTGCTGGAGCCCGCGCTCAATCCCGAG
CAGATCGATCCGCCGCCGTCCGATCAGGACAATATCGCGTCGCTGAAGAGCTCG
GCCGAAGCGCTGCGCCGCGCCGCCGGCGAGGCCACTGGACCCGGCGCCGACGCC
TCGCGCCGGCTCGCTACCGCGCTGACCAAGCTTGCGGGCGCCGATCAGGCGATG
CGCGAGAAGGCCCAGGACGTGTTCGTGCGGCCGCTGCTGCTCGACTTCGAACTGC
TGCGCAACATGCTGAAAGCGCAGCCGGTGACGCTCGACAACCTGCCGGCCGACA
TCGTGTCGTCGTGGAAGACCAAGGACGGTCAGATCCGCGTCGAGGTGCTGCCGA
GCGGCGACCCCAACGACAACGATACGCTGCGCAAGTTCGCCGCCGCCGTGCTGC
AGGCCGAGCCGTTGGCGACCGGCGGTCCGGTGTCGATCCTGAAGTCGGGCGATA
CCATCGTGGCCTCGTTCATCCAGGCCGGGCTGTGGGCGTTATTGTCGATCTCGAT
CCTGCTGTGGATCACGCTGCGCCGGATTTCCGACGTGGCGCTGACCCTGGTGCCG
CTGCTGGTGGCCGGTGCGGTGACGCTGGAGATCTGCGTGCTGATCGATCTGCCGC
TGAACTTCGCCAACATCGTCGCCTTGCCGCTGCTGCTCGGCGTCGGCGTCGCGTT
CAAGATCTATTACGTGACCGCCTGGCGCTCCGGCCGCACCAACCTGCTGCAGTCG
GCGCTGACCCGGGCGATTTTCTTCAGCGCCCTGACCACCGCCACCGCATTCGGCA
GCCTGTGGCTGTCGAGCCATCCGGGAACGGCCAGCATGGGCAAGCTGCTGGCGC
TGTCGTTGCTCACCACGCTCGGTGCCGTGCTGCTGTTCCAGCCGGCCCTGATGGG
CAAGCCGCGCCACATCGACGAGTCCGGCGACACCGATCTGTGA
hpnO ATGTATCAGCCGAATTTAGACCTTGCCGAGATGTTTGCGGCGCGCGAAGCGAACC 32
GCAGTTCGATGCACGCCCGGCATCTCAACGAGCAGCTCGTCCGCGTCCTCAAAAC
CATCGGCTACGACGTCGGCTTCCAGAAGGGCACCGGTCAGTACCTCTACGACCGC
GACGGCGCCCGCTATCTCGACCTGCTCAGCGGCTTTGGCGTCTTCGCGCTCGGCC
GCAACCATCCGGTGGTGCGCAAGGCGTTGCAGAGCGTGCTCGATGCCGACCTGC
CCAATCTGGTGCAGCTCGACGTCTCGACGCTCGCCGGTATCCTGGCTGAGCGGCT
GCTCGAGCAGGTGCCGTATCTCGACAAGGTGTTCTTCGCCAATTCCGGCGCCGAG
AGCGTCGAGGCCGCGATCAAGTTCGCGCGCGGTGCAACGGGACGCAACGGTATC
GTCAATTGCGACCACAGCTACCATGGCCTGACCTACGGCGCGCTGTCGCTGACCG
ACGACCAGAATTTCCAGGGTGGCTTTGGGCCGCTGCTGCCGGGTGTCACCACCAT
CCCGTTCAACGATCTCGAAGCGCTGGAGAAGGTGCTGTCGACCCGCGAGGTCGC
CGCCTTCATCGTCGAGCCGATCCAGGGCAAGGGCGTCAACATGCCCACCGACGA
GTTCCTGCCGGGCGCCGCCGCGCTGTGCAAACGCTACGGCACGTTGTTCGTCGCC
GACGAAATCCAGACCGGCATGGGCCGCACCGGCCGCTTCCTCGCGGTCGAGCAC
TGGAATGTCGAACCCGACATGGTGCTGCTGTCGAAGGCGCTGTCGGGCGGCCAC
GTACCGGTCGGCGCGGTGCTGACCCGCAAGTCGATCTTCGACAAGATCTTCAACC
GCATGGATCGCGCCGTGGTGCACGGCTCGACCTTCGCCAAGAACGATCTGGCGA
TGGCTGCCGGCATTGCGACGCTGGAAGTCCTCAAAGCCGAGAAGCTGGTCGAGG
CCGCCGCCAAGCGCGGCGCCGAATTGCGGCTGGCGCTCACGCGCATGGTCCCCG
GCTACGAACTGCTCAAGGAAGTGCGCGGCAAGGGGCTGATGATCGGCGTCGAAT
TCGGCCCGCCGCAATCGCTGCGGCTGAAGGCGTCGTGGACGATGCTGGAGACCG
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TABLE 2-continued
DNA sequences of R. palustris hopanoid biosynthesis genes
SEQ
Gene ID
Name DNA sequence NO
CCAACAAGGGCCTGTTCGTCCAGCTGATCACCGTGCCGCTGTTCAAGGATCACAA
GATCCTGACGCAGGTCGCGGGCCATGGGCTGCACACCATCAAGCTGCTGCCGCC
GCTGACCATCACCGAAGACGACTGCGCCTGGATCGAACGCGCCTTCGACGACAC
CATCGCTGCCAGCCACAAGGTGCCGGGCGCGATCTGGTCGCTCGGCAAGACCCT
GGTCGACAACGCGGTGCGTAAGTCGGCGTAA
Example 3: Bacterial Strains and Growth
Conditions
For microaerobic growth of Bradyrhizobium diazoeffi-
ciens in peptone-salts-yeast extract (PSY), the medium was
made anaerobic by boiling under a stream of nitrogen for 10
minutes, dispensing 25 ml cooled medium in 500 ml anaero-
bic bottles in a nitrogen chamber, exchanging gas phase of
stoppered media bottles with nitrogen for an hour, followed
by autoclaving. The sterilized medium was inoculated with
aerobic PSY-grown log-phase cultures at 10-2 dilution and
the gas phase exchanged with 12-14 psi 99.5/0.5% nitrogen/
oxygen gas mix for 3-5 minutes every 8-16 hours (h) [32].
In all media, B. diazoefficiens strains were incubated at 30'
C. with shaking at 250 rpm for aerobic cultures and 60 rpm
for microaerobic cultures, unless indicated otherwise. Anti-
biotics were used for selection at these concentrations (µg/
ml): spectinomycin, 100; kanamycin (Km), 100; tetracycline
(Tc), 50.
Example 4: Sequence Analysis
The Integrated Microbial Genome (IMG) system (https://
img.jgi.doe.gov/cgi-bin/w/main.cgi) was used to access
DNA and protein sequences, identify orthologs and assess
genomic context of genes [33].
EN
Example 5: Mutant Construction
15
Fusion PCR products of —1 Kb upstream and downstream
regions of genes of interest were cloned into pKl8mobsacB
to obtain deletion plasmids that were mobilized into WT and
selected using Km resistance (Table 3). Subsequently, the
20 plasmid integrants were resolved by growth in non-selective
medium and segregants were obtained by 5% sucrose selec-
tion. Potential mutants were screened by PCR and verified
by sequencing. Deletion of she (hpnF) and the hpnCDEFG
25 (FIG. 213) operon using pKl8mobsacB- and pSUP202pol4-
based plasmids (Table 3) were attempted. For the latter, a 1.2
Kb Km resistance cassette from pBSL86 was sub-cloned
between —1 Kb upstream and downstream regions of the
genes in pSUP2O2pol4. Following selection of deletion
30 plasmids with Km resistance, potential Km resistant and Tc
sensitive mutants were screened by PCR. It was unable to
isolate an she mutant with either methods in PSY at 30' C.
or room temperature (23-25' C.) with and without 100 µM
35 cholesterol or diplopterol as supplements. Counterselection
of she deletion plasmid segregants at lower sucrose concen-
trations (14%) were also carried out, but the mutant was
still not obtained. Tables 3 and 4 list the strains, plasmids and
primers used in constructing the mutants.
TABLE 3
Strains and plasmids
Source
Strain or plasmid Genotype, description and construction' or USb
Strains
E. coli DH1013 F— endAl recAl galE15 ga1K16 nupG rpsL AlacX74 (D801acZAM15 [34]
araD139 A(ara,leu)7697 mcrA A(mrr-hsdRMS-mcrl3Q T—; DKN89
E. coli 517-1 thi pro hdsR hdsM' recA; chromosomal insertion of RP4-2 (Tc::Mu [35]
Km::Tn7); DKNI
DKN1391 B. japonicum IIOspc4, Sp', WT [36]
DKN1386 B. japonicum 110spc4 AhpnP; deletion of blr2995 in DKN1391 This study
using pGK247
DKN1529 B. japonicum 110spc4 AhpnH; deletion of blr3006 in DKN1391 This study
using pGK255
Plasmids
pKl8mobsacB Km' mobilizable pUC18 derivative, mob, sacB (DKN1387) [37]
pSUP202pol4 Tc' pSUP202 part of the polylinker subcloned into pBluescript II [38]
KS (+) using EcoRI and Pstl sites (DKN1390)
pBSL86 Ap', Km' (DKN1388) [39]
pGK259 she deletion vector; HindIIUPstI-digested blr3004 (she) upstream This study
and downstream fusion PCR product amplified using primers
shcupfor,shcuprevfusion-new,shcdnforfusion-new and shcdnrev
was ligated to HindIII/PstI-digested pKl8mobsacB (DKN1492)
pGK248 NotI/XbaI-digested she upstream PCR product amplified using This study
primers pSUPshcupfor and pSUPshcuprev was ligated to
NotI/Xbal-digested pSUP202pol4 (DKN1421)
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TABLE 3-continued
Strains and plasmids
Source
Strain or plasmid Genotype, description and construction' or USb
pGK262 XbaI/PstI-digested she downstream PCR product amplified using This study
primers pSUPshcdnfor-new and pSUPshcdmev was ligated to
XbaI/PstI-digested pGK248
pGK263 she deletion vector; 1.2 Kb Km' cassette from XbaI-digested This study
pBSL86 sub-cloned into XbaI-digested pGK262 (DKN1430)
pGK268 hpnCDEFG deletion vector; blr3001 (hpnC) upstream and blr3005 This study
(hpnG) downstream PCR products amplified using primers
hpnCupforw/pKl8fusion, hpnCuorevw/hpnGfusion and
hpnGdnforw/hpnCfusion, hpnGdnrevw/pKl8fusion were Gibson
cloned into XbaUPstl-cut pKl8mobsacB (DKN1604)
pGK269 Notl/XbaI-digested hpnC upstream PCR product amplified using This study
primers hpnCupfor and hpnCuprev was ligated to NotI/Xbal-
digested pSUP202pol4 (DKN1605)
pGK270 XbaI/PstI-digested hpnG downstream PCR product amplified using This study
primers hpnGdnfor and hpnGdmev was ligated to XbaI/PstI-
digested pGK269 (DKN1606)
pGK276 hpnCDEFG deletion vector; 1.2 Kb Km' cassette from XbaI- This study
digested pBSL86 sub-cloned into XbaI-digested pGK270
(DKN1609)
pGK247 hpnP deletion vector; BamHUPstI-digested hpnP upstream and This study
downstream fusion PCR product amplified using primers
hpnPupfor, hpnPuprevfusion, hpnPdnforfusion and hpnPdnrev was
ligated to BamHUPstI-digested pKl8mobsacB (DKN1395)
pGK255 hpnH deletion vector; HindIIUPstI-digested hpnH upstream and This study
downstream fusion PCR product amplified using primers
hpnHupfor, hpnHuprevfusion, hpnHdnforfusion and hpnHdnrev
was ligated to HindIIUPstI-digested pKl8mobsacB (DKN1482)
'Km, Kanamycin; Sp, Spectinomycin
bunderlined sequence
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TABLE 4
Primers
SEQ ID
Primers Sequences Source NO
Shcupfor TATCTAGAAAGCTTGCAGTTTCCCTTCGTCGATA HindIII 1
shcuprevfusion- ACCATGATACCGTAGATAGAATACACGGGGCATCTGGCT 2
new CGATTACTCCGATAGTTAATT
shcdnforfusion- AATTAACTATCGGAGTAATCGAGCCAGATGCCCCGTGTAT 3
new TCTATCTACGGTATCATGGT
Shcdnrev TATCTAGACTGCAGAGCAGGTCCAGAAGAAGCTC PstI 4
pSUPshcupfor TATATATAGCGGCCGCGCAGTTTCCCTTCGTCGATA NotI 5
pSUPshcuprev TATATATATCTAGACATCTGGCTCGATTACTCCGATAGTT XbaI 6
AATT
pSUPshcdnfor- TATATATATCTAGACCCCGTGTATTCTATCTACGGTATCAT XbaI 7
new GG
pSUPshcdnrev TATATATACTGCAGAGCAGGTCCAGAAGAAGCTC PstI 8
hpnCupforw/pK18 TTCGAGCTCGGTACCCGGGGATCCTCTAGAGTGGAACCGT 9
fusion CGGACAGC
MI
45
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TABLE 4-continued
Primers Sequences Source
SEQ ID
NO
hpnCuprevw/hpnG TTGTCAGATCGAGACGCTCACTGGTTTACAATCGTTTGGA 10
fusion CAGGAAGAGC
hpnGdnforw/hpnG GCTCTTCCTGTCCAAACGATTGTAAACCAGTGAGCGTCTC 11
fusion GATCTGACAA
hpnGdnrevw/pK1S ACGGCCAGTGCCAAGCTTGCATGCCTGCAGGCTGATCCAC 12
fusion AAGGAGATCG
hpnCup for TATATATAGCGGCCGCGTGGAACCGTCGGACAGC NotI 13
hpnCuprev TATATATATCTAGACTGGTTTACAATCGTTTGGACAGGAA XbaI 14
GAGC
hpnGdnfor TATATATATCTAGATGAGCGTCTCGATCTGACAA XbaI 15
hpnGdnrev TATATATACTGCAGGCTGATCCACAAGGAGATCG PstI 16
hpnPupfor TATCTAGACTGCAGAACACCATCGGGCTGAAG PstI 17
hpnPuprevfusion GGAAGCCTCGCGCAGCCGGATCGAATAGTTCATAGCGTA 18
ATGCTGTCGCCGGAATTTCTC
hpnPdnforfusion GAGAAATTCCGGCGACAGCATTACGCTATGAACTATTCGA 19
TCCGGCTGCGCGAGGCTTCC
hpnPdnrev TATCTAGAGGATCCTTTTCGAGCATGCCTTATCC BamHI 20
hpnHupfor TATCTAGAAAGCTTAACTTTGAAGCGGATTGGTG HindIII 21
hpnHuprevfusion TTTTTGTTCGTGGTGCTGTTTCTCGCCTTACATTACACGTT 22
TCTTTCTGGGCTTGAAATT
hpnHdnforfusion AATTTCAAGCCCAGAAAGAAACGTGTAATGTAAGGCGAG 23
AAACAGCACCACGAACAAAAA
hpnHdnrev TATCTAGACTGCAGCCTGATTGCAACACAGAACG PstI 24
Example 6: Hopanoid Analysis For liquid chromatography/mass spectrometry (LC-MS),
40 100 µl 1 mg/ml TLE was evaporated under nitrogen, dis-
Triplicate cultures of B. diazoeffaciens strains were grown solved in isopropanol-acetonitrile-water (2:1:1) or DCM-
till saturation in aerobic (100 ml PSY in 500 ml flasks) and McOH (9:1) and then analyzed [26]. Hopanoid peaks were
microaerobic (25 ml PSY in 500 ml Wheaton bottles) identified by comparison of retention times and mass spectra
growth media. They were centrifuged at 5000xg for 20 min
to those of Rhodopseudomonas palustris TIE-1 (Tables 5
at 4° C. and frozen at -80° C. until extraction. Cell pellets 45
were suspended in 2 ml water and transferred to Teflon and 6) [26, 41].
centrifuge tubes (VWR, Bridgeport, N.7.), followed by
addition of 5 ml methanol (MeOH) and 2.5 ml dichlo- TABLE 5
romethane (DCM) and sonicated for 15 min at room tem-
perature (VWR B2500A-DTH; 42-kHz radio frequency Compounds identified by high temperature GAMS
power, 85 W). Samples were centrifuged at 7000xg for 10 50 Rt
min at 22° C. and the supernatants transferred to new tubes. Compound (min) Diagnostic ions (m/z)
Cell pellets obtained from aerobically-grown cultures were
sonicated again, centrifuged, and the supernatants combined Pregnane-acetate (I) 15.93 358, 298, 283, 255, 145, 105, 79
with the first extraction. The samples were separated intop p
2-Methylhop-17(21)-ene 17.37 424, 381, 245, 205, 161, 135
Hop-17(21)-ene (11) 17.51 410, 367, 231, 191, 161, 135
two phases by adding 7.5-13 ml DCM and centrifuged at 55 2-Methylhop-x-ene 19.30 424, 409, 281, 205, 189,95
6000xg for 10 rain at 22° C. The organic phase was Hop-x-ene (111) 19.49 410, 395, 243, 203, 191, 189,95
transferred to a new vial and evaporated in a chemical hood 2-Methylhop-22(29)-ene 20.27 424, 313, 205, 189, 95
overnight. The total lipid extract TLE was resuspended inp ( ) p
Hop-22(29)-ene 20.47 410, 299, 191, 189, 95
(Diploptene, IV)
DCM at a concentration of I mg/rill. 100 µl of this extract 2-Methylhop-21-ene 20.33 424, 381, 355, 245, 205, 189, 121
was combined with 1µl of an internal standard (500 ng/µl 60 Hop-21-ene (V) 20.52 410, 367, 341, 231, 191, 189, 121
pregnane-acetate [40]) and evaporated at 60° C. The TLE 2-Methylhopan-22-o1 23.84 442, 409, 205, 189, 149, 95
was derivatized to acetate esters by incubation in 100 ld 1:1 Hopan-22-o1 (Diplopterol, 24.05 428, 395, 191, 189, 149, 95
acetic anhydride/pyridine for 30 min at 60° C. and then VI)
analyzed by gas chromatography/mass spectrometry (GC- 2-Methyltetrahymanol 24.84 484, 424, 249, 205, 189,8320-Methyltetrahymanol 24.84 424, 409, 249, 205, 189
MS). Peak areas of hopanoid species were integrated and 65 Tetrahymanol (vii) 25.09 470, 410, 249, 191, 189,69
compared to those from pregnane-acetate standards to obtain BHP-508 (VIII) 34.78 508, 493, 369, 287, 213, 191, 111
the yields from TLE [41]
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TABLE 5-continued
Compounds identified by high temperature GC-MS
Rt
Compound (min) Diagnostic ions (m/z)
2-Methylbacteriohopanetetrol 38.11 728, 669, 493, 383, 205, 95
Bacteriohopanetetrol 38.44 714, 655, 493, 369, 191, 95
TABLE 6
Compounds identified by ultra Derformance LC-MS
Compound Rt (min) m/z Ion
Aminobacteriohopanetriol 4.34 546.487 [M + H]'
(aminotriol, a)
2- 4.76 560.504 [M + H]'
Methylamino bacteriohopanetri of
(e)
Bacteriohopanetetrol (BHT) 5.66 529.462 [M — H20 + H]'
Bacteriohopanetetrol (b) 5.66 569.454 [M — Na]'
Adenosylhopane (d) 5.94 662.501 [M + H]'
2-Methylbacteriohopanetetrol 6.22 543.478 [M — H20 + H]'
2-Methylbacteriohopanetetrol (e) 6.20 583.470 [M — Na]'
Example 7: Lipid a Analysis
Bacterial cells were extracted using the phenol/water
method [42] and after extensive dialyses, the extracted
phases were subjected to enzymatic digestion with DNases,
RNases and proteases in order to remove nucleic acids and
protein contaminants and recovered by ultracentrifugation
(100 000xg, 4° C., 24 h). Water phases were analysed
through 13.5% SDS-PAGE; the lipopolysaccharide (LPS)
fraction was exclusively found in water phase as suggested
by the presence of the typical ladder in its migration pattern
in the gel. The LPS material was further purified by a second
extraction with phenol/chloroform (CHC13)/petroleum
methods to get rid of glucan contaminants, and LPS frac-
tions were further purified by size filtration chromatography
(Sephacryl S-400 HR in 50 mM ammonium carbonate
(NH4CO3) from GE Healthcare).
LPS sugar content was determined by GLC-MS analysis
of acetylated O-methyl derivatives. Methanolic hydrochlo-
ric acid (HCl) was added to dried LPS and incubated at 85°
C. for 16 h, the sample was subsequently acetylated with
pyridine and Ac201 85° C., 20 min and analysed by GLC-
MS [43]. Linkage analysis was carried out by methylation
analysis. The sample was hydrolyzed with 4 M trifluoro-
acetic acid (100° C., 4 h), carbonyl-reduced with sodium
borodeuteride (NaBD4), carboxy-methylated, carboxyl-re-
duced, acetylated and analysed by GLC-MS [44]. Total fatty
acid content was obtained by acid hydrolysis. LPS was first
treated with 4M HCl (4 h, 100'C.) and then with 5M sodium
hydroxide (NaOH, 30 min, 100° C.). Fatty acids were then
extracted in CHC131 methylated with diazomethane and
analysed by GLC-MS. The ester bound fatty acids were
selectively released by base-catalysed hydrolysis with 0.5M
NaOH/MeOH (1:1 v/v, 85° C., 2 h), then the product was
acidified, extracted in CHC13, methylated with diazometh-
ane and analysed by GLC-MS [45].
In order to obtain lipid A, LPS was dissolved in acetate
buffer (pH 4.4), and was hydrolyzed for 5 h at 100° C. Then,
adequate amounts of CHC13 and McOH were added to the
hydrolysate to obtain CHC13/MeOH/hydrolysate 2:2:1.8
(v/v/v), and the mixture was vigorously shaken, then cen-
U.";
trifuged [46]. The lipid A-containing CHC13 phases were
collected and washed twice with the water phase from a
freshly prepared two-phase Bligh-Dyer mixture (CHC13/
McOH/water, 2:2:1.8 (v/v/v)].
5 For MALDI TOE MS, a 4800 Proteomic Analyzer (AB-
Sciex), MALDI TOF/TOF instrument equipped with a
Nd:YAG laser at a wavelength of 355 mn with <500-ps pulse
and 200-Hz firing rate was employed. External calibration
was performed using an ABSciex calibration mixture. All
10 measurements were performed in positive polarity. Approxi-
mately, 1500 laser shots were accumulated for each spec-
trum in the MS experiments. Samples were dissolved in
CHC13/MeOH (50:50, v/v) at a concentration of 1 mg/ml.
Matrix solution was prepared by dissolving trihydroxyac-
15 etophenone (TRAP) in McOH/0.1% trifluoroacetic acid/
acetonitrile (7:2:1, by volume) at a concentration of 75
mg/ml. 1µl of the sample/matrix solution (1:1, v/v) was
deposited onto the well plate and allowed to dry at room
temperature.
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Example 8: Membrane Rigidity
For whole cell membrane rigidity measurements, as
described in [8], PSY-grown aerobic cultures of B. diazoef-
25 ficiens strains were washed once with 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) buffer (50 mM
HEPES, 50 mM sodium chloride (NaCI), pH 7.0) and then
resuspended in the same to an OD600-0.2 with 7.36 µM of
the fluorophore diphenyl hexatriene (DPH). Prior to mea-
30 surement of fluorescence polarization, samples were incu-
bated in a 25° C. or 40° C. water bath in dark for 30 min.
Three biological replicates were measured, each containing
8 technical replicates.
35 Example 9: CRYO-TEM (Transmission Electron
Microscopy
PSY-grown aerobic cultures at an OD600 of 1 were con-
centrated 5 times and frozen in a Vitrobot MkIV (FEI,
40 Hillsboro, Oreg.) as described previously [47, 48]. In brief,
2 µl of a 10 mn colloidal gold (Sigma Aldrich, St. Louis,
Mo.) in 5% Bovine serum albumin (BSA) was added to 8µl
of culture. 3µl of this suspension was placed onto a glow
discharged carbon-coated R 2/2 Quantifoil copper-finder
45 grid in the Vitrobot maintained at 22.5° C. with 95%
humidity. This was followed by a 3 s blot with a pressure of
6 atm, a drain time of 1 sec, and plunge freezing in a mixture
of liquid ethane (63%) and propane (37%). The frozen grids
were then stored in liquid nitrogen until further use. Grids
50 were imaged in Tecnai TEM 120 KeV (FEI, Hillsboro,
Oreg.) at —178° C. using a Gatan 626 cryoholder and Gatan
2x2K CCD. Images were acquired with Digital Micrograph
at 15,000x magnification [49, 50].
55 Example 10: Growth Curves and Stress Assays
To monitor growth in different media, triplicate cultures
were inoculated at 10-2 dilution using aerobic PSY-grown
log-phase (OD600-0.5-0.7) WT or mutant strains. Growth
60 was measured at OD600 using a Spectronic 20D+ (Thermo
Scientific) or a Beckman Coulter spectrophotometer for
microaerobic medium. Unless otherwise indicated, the incu-
bation temperature was 30° C. Growth curves were per-
formed in triplicates at least twice independently.
65 Sensitivity to high temperature (37° C.) and low or high
pH was measured by monitoring growth in PSY at OD600
using Spectronic 20D+. Acidic (pH-6) and alkaline (pH 8)
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media were prepared by buffering PSY with 100 mM MES
(4-Morpholineethanesulfonic acid) and 100 mM bicine 
(N,N-Bis(2-hydroxyethyl)glycine) or BIS-TRIS Propane,
respectively. It was unable to collect a growth curve at pH-8
because this was outside the WT growth range. Growth
curves were performed in triplicates at least twice indepen-
dently.
Growth in the presence of osmotic and membrane stresses
was measured using gradient plates. To prepare these, 25 ml
of 50 mM 3-(N-morpholino)propanesulfonic acid (MOPS)-
buffered PSY agar (pH-7) with 50 mM NaCl, 500 mM
inositol, 0.4% bile salts (BS, Himedia, Mumbai, India) or 1
mM ethylenediaminetetraacetic acid (EDTA) was poured in
a slightly tilted square grid plate (Fisher, Pa.). The solidified
plate was topped with 25 ml PSY-MOPS agar. Control plates
contained 50 ml PSY-MOPS agar. 5µl of aerobic PSY-
grown log-phase cultures at 10-4 dilution were spotted on
the plates. To assess stationary-phase stress, saturated
instead of log-phase cultures were used for plating. The
plates were incubated at 30° C. for 5-7 days. Spotting assays
were performed in duplicates at least two independent times.
Disk diffusion assays were used to quantify growth under
oxidative, acidic and detergent stresses. For this, 4 day-old
cultures of B. diazoeffaciens strains grown in yeast extract-
mannitol (YM) medium were washed and adjusted to an
OD60. of 1.2 ml bacterial suspensions were then mixed with
100 ml of 42° C. pre-warmed YM soft agar (0.8% agar) and
5 ml portions of this mixture were poured on solid YM.
Filter disks were placed at the center of the plates, and 5µl
of 5.5 M H202, 2 M HCl or SDS (10% w/v), were deposited
on the disks. The diameters of growth inhibition areas were
measured after incubation at 30° C. for 5 days.
Example 11: MIC Determination
The MIC of polymyxin B was determined by the E-test
method using disk diffusion assay as described above. Strips
containing a gradient of polymyxin B ranging from 0.064-
1024 µg/mL (Biomerieux, Marcy-l'etoile, France) were
placed in the center of plates, which were incubated at 30°
C. for 7 days before recording the results. The experiment
was done in triplicates.
The effect of the NCR335 peptide on cell viability was
determined by spot assays. YM-grown exponential phase
cultures were washed three times in 10 mM potassium
phosphate buffer pH 7.0, diluted to an OD... of 0.01, and
treated with 6µM NCR335 for 24 h at 30° C. Samples were
serially diluted in YM medium, and 5µl aliquots of each
dilution were spotted in duplicate on YM agar. CFU/ml were
determined after 7 days at 30° C. The experiment was
performed in triplicates.
Example 12: Plant Cultivation and Symbiotic
Analysis
A. afraspera seeds were surface sterilized by immersion
in sulfuric acid for 45 minutes with shaking, followed by
thorough washing in sterile distilled water and incubation in
the same overnight. The seeds were germinated by trans-
ferring to 0.8% agar plates for 2 days at 37° C. in dark.
Subsequently, plantlets were rooted in buffered nodulation
medium (BNM)-filled test tubes, which were covered with
aluminum foil for hydroponic culturing [51]. Plants were
grown in a 28° C. growth chamber with a 16 h light and 8
h dark cycle and 70% humidity. Seven days after transfer,
each seedling was inoculated with a 1 ml cell suspension
50
from a 5 day-old bacterial culture washed in BNM and
adjusted to reach an OD... of 1.
Soybean (Glycine max Williams 82) seeds were cleaned
with 100% ethanol for 30 seconds and sterilized with 1%
5 bleach for 5 min. After several washes with sterile distilled
water, seeds were germinated on tap-water agar plates at 28°
C. for 3 days. Seedlings were then transferred to magenta
boxes filled with BNM, inoculated and grown hydroponi-
cally as described above for Aeschynomene plants. Plants
10 were watered with BNM medium.
Infection assays were carried out three independent times
with 7 and 10 plants for soybean and A. afraspera, respec-
tively. At 21 d.p.i., plants were analyzed for the number of
nodules and nitrogenase activity as previously described
15 [52].
Example 13: Cytological Analyses and Microscopy
Cytological analyses were done on 5-10 nodules origi-
20 nating from 3 different plants for each condition; micro-
scopic observations were performed for each of the 3 plant
experiments, except for the TEM observations which were
only done once. Semi thin nodule sections (30-40 µm) were
prepared using a vibratome (VT1000S; Leica, Nanterre,
25 France). Immediately after slicing, the sections were incu-
bated for 20 min in live/dead staining solution (5 µM SYTO
9 and 30 µM propidium iodide (PI) in 50 mM Tris pH 7.0
buffer; Live/Dead BacLight, Invitrogen). Sections were then
removed and incubated an additional 15 min in 10 mM
30 phosphate saline buffer (PBS) containing calcofluor white
M2R (Sigma, Munich) to a final concentration of 0.01%
(w/v) to stain the plant cell wall [53]. After washing with
PBS, the sections were mounted on microscope slides in
PBS containing glycerol at a final concentration of 50%
35 (v/v). Analyses were carried out using a confocal laser-
scanning microscope (Carl Zeiss LSM 700; Jena, Germany).
Calcofluor was excited at 405 nm with emission signal
collection at 405 to 470 mu. For SYTO 9 and PI, an
excitation wavelength of 488 nm and 555 nm was used with
40 emission signal collection at 490 to 522 nm and 555 to 700
mu, respectively. Images were obtained using the ZEN 2008
software (Zeiss).
For TEM of the nodules, the samples were fixed in a 4%
glutaraldehyde, 0.1 M cacodylate buffer (pH 7.2), postfixed
45 in 1% osmium tetroxyde, dehydrated using a series of
acetone washes, and embedded in TAAB 812 epon resin.
Ultrathin sections (60 nm) were mounted on collodion
carbon-coated copper grids, contrasted using uranyl acetate
and lead citrate, and examined at 80 kV with a TEM (Jeol
50 100CX II).
Example 14: Elimination of Shc in B. diazoeffaciens
To eliminate hopanoid production in B. diazoefficiens, and
55 to test whether a requirement for hopanoids in efficient
symbiosis is conserved between B. diazoeffaciens and Bra-
dyrhizobium BTAil, deletion of the gene encoding the
enzyme catalyzing the first step in hopanoid biosynthesis,
squalene hopene cyclase (Shc) (FIG. 213) was carried out. A
6o Ashc mutant was isolated using either the pKl8mobsacB-
based markerless gene deletion method (-400 colonies
screened) or the gene replacement strategy with
pSUP202pol4 (1200 colonies screened) [54]. No we were
NOT able to isolate this mutant. We don't have an she
65 deletion for B. diazoefficiens.
This suggests that Shc may be essential either because
hopanoids are required for growth and survival of B. diazo-
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effaciens or because squalene, the substrate of Shc [11],
accumulates to toxic levels within Ashc. To rule out the latter
possibility, deletion of the entire operon encoding squalene-
synthesizing enzymes (hpnCDE), she (hpnF) and hpnG
(catalyzes second step in the synthesis of C35 hopanoids)
[12] was carried out. The AhpnCDEFG mutant (-150 colo-
nies screened) (FIG. 213) was unable to obtain. These results
suggest that hopanoid synthesis is essential for the survival
of B. diazoefficiens under the conditions used to select the
mutants.
Example 15: B. diazoefficiens AhpnP and AhpnH
Mutants
To eliminate synthesis of 2Me- or C35 hopanoids specifi-
cally, genes predicted to encode the C-2 methylase, hpnP
[55] or the first enzyme catalyzing the extension of C31
hopanoids, hpnH [12] (FIG. 213) were deleted.
As illustrated in FIG. 2C, no methylated hopanoids were
detected in AhpnP TLE using gas chromatography-mass
spectrometry (GC-MS) and liquid chromatography-mass
spectrometry (LC-MS) (Tables S1 and S2) [26, 41]. AhpnH
does not make any detectable C35 hopanoids, including
aminotriol (a, c), BHP-508 (VIII, degradation product of
aminotriol), bacteriohopanetetrol (b, e) and adenosylhopane
(d). In addition, AhpnH accumulates a 6-fold excess of the
HpnH substrate [12], diploptene (IV, WT 18±2 µg/mg
TLE, AhpnP 29±6 µg/mg TLE, AhpnH 111±3 µg/mg
TLE).
The presence of HoLA in the mutants using MALDI-MS
(FIG. 4) was also analyzed. WT and AhpnP lipid A are
composed of a mixture of penta- to hepta-acylated species,
whereas AhpnH lipidA is mainly hexa-acylated (FIG. 113). In
WT and AhpnP hepta-acylated species, a C35 hopanediolic
acid is ester-linked to hexa-acylated lipid A, and traces of a
second hopanoid substitution are also detected; conversely,
AhpnH is missing any lipid A-bound hopanoids. Not only do
the results confirm the proposed roles of HpnP and HpnH,
they also show that synthesis of C35 hopanoids is required
for HoLA production.
Example 16: Hopanoids Contribute to Outer
Membrane Rigidity
A fluorescence polarization method was employed by
incubating the dye diphenyl hexatriene (DPH) with whole
cells to determine whether 2Me- and C35 hopanoids affect
the rigidity of B. diazoefficiens membranes at 25' C. and 40'
C. (FIG. 5). Because previous studies of whole cells of
different R. palustris hopanoid mutants indicated that the
majority of DPH gets incorporated in the OM, whole cell
polarization values was interpreted to reflect the rigidity of
the OM [8, 26].
Membranes of all strains were less rigid at higher tem-
perature. The AhpnP membrane was as rigid as the WT
membrane at both temperatures, whereas the AhpnH mem-
brane was less rigid. Thus, C35 hopanoids are important for
maintaining membrane rigidity in B. diazoeffaciens in vivo,
in contrast to R. palustris, where the AhpnH membrane
showed similar rigidity to the WT, despite the capacity of
C35 hopanoids to enhance rigidity in vitro [8]. This indicates
that the fraction of C35 hopanoids or HoLA in the OM may
be greater in B. diazoefficiens than R. palustris. Despite the
lack of C35 hopanoids, the AhpnH membrane is morpho-
logically indistinguishable from the WT membrane, as seen
in whole cell cryo-transmission electron microscopy (TEM)
micrographs (FIG. 6).
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Example 17: Aerobic Growth of B. diazoeffaciens
WT, AhpnP and AhpnH Mutants
To address the question whether a less rigid membrane
5 affect the fitness of AhpnH at different temperatures, aerobic
growth of AhpnH at 30' C. and 37' C. were compared with
WT and AhpnP (FIGS. 7A and B). AhpnP grows like WT at
both temperatures, whereas AhpnH grows slower at 30' C.
and is unable to grow at 37' C.
10 These results suggest that C35 hopanoids are important for
growth at ambient temperature (30' C.) and essential for
growth at higher temperature (37' C.). As shown in our
whole cell membrane fluidity measurements, the higher the
15 temperature, the less rigid the membrane. This might be the
reason why C35 hopanoids are absolutely required to main-
tain membrane rigidity at 37' C., but are dispensable at 30'
C. It is important to note that the phenotypic defect of
AhpnH could be either due to the absence of C35 hopanoids
20 or the lack of downstream products, such as HoLA, and even
accumulation of the HpnH substrate diploptene, or a com-
bination of these factors.
Example 18: Stress Tolerance Tests of B.
25 
diazoef,ciens AhpnP and AhpnH Mutants
Hopanoids have been shown to contribute to stress toler-
ance in diverse organisms [7, 9-11]. It is speculated that such
protection would also be seen in B. diazoefficiens. To test
30 this hypothesis, AhpnP and AhpnH were challenged with a
variety of stressors that are relevant during the initiation and
progression of symbiosis, such as hypoxia, acidic pH, high
osmolarity, reactive oxygen species and peptide antibiotics
[l, 56].
35 Under hypoxic conditions with 0.5% oxygen, AhpnP is
unable to attain growth yields as high as WT and AhpnH
fails to grow (FIG. 7C). This indicates that in the free-living
state 2Me-hopanoids contribute to microaerobic growth and
C35 hopanoids are essential.
40 Using GC-MS, the abundance of these hopanoid types in
the WT (Table 7) was determined. The amount of 2Me-
hopanoids dramatically increased from 33±2% TLE under
oxic conditions to 77±2% TLE under hypoxic conditions.
This is consistent with hopanoid methylation being impor-
45 tant to sustain WT-levels of microaerobic growth. The only
C35 hopanoid detectable by GC-MS, BHP-508, increased in
abundance from 3±1% TLE for cells grown aerobically to
21±1% TLE when grown microaerobically, in agreement
with a microaerobic growth defect for AhpnH.
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TABLE 7
Hopanoid and tetrahymanol quantification by GC-MS using pregnane-
acetate as standard
55 Growth % Total hopanoids'
condition Strain C30 Tetrahymanol C35 % 2Meb
Aerobic WT 69 ± 1 28 ± 1 3 ± 1 33 ± 2
(PSY) AhpnP 72 ± 6 23 ± 4 5 ± 2 0
AhpnH 94 ± 0 6 ± 0 0 11 ± 0.2
60 Microaerobic WT 34 ± 2 46 ± 4 21 ± 1 77 ± 2
AhpnP 61 ± 1 34 ± 0.3 6 ± 1 0
AhpnH NG` NG NG NG
'Total hopanoids = methylated and unmethylated versions of Cap hopanoids (compounds
II, III, N V, VI) + tetrahymanol (VII) and C35 hopanoids (VIII) (refer to table 5 for
compound names).
65 b , 2Me = ratio of methylated to total hopanoids
`NG, no growth
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Under acidic conditions (pH-6), AhpnH is unable to grow
(FIG. 7D). AhpnH is also more prone to stationary phase
stress, osmotic stressors (NaCl and inositol) and membrane
destabilizers (bile salts and ethylenediaminetetraacetic acid,
EDTA [12]) than WT, as evidenced by a reduction in AhpnH 5
growth on stressor gradient plates (FIG. 7E).
Additionally, disc diffusion assays showed that AhpnH is
more sensitive to oxidative (hydrogen peroxide (H202)),
detergent (SDS) and acidic (hydrochloric acid (HCl))
stresses than WT (FIG. 7F). 10
Because B. diazoefficiens is exposed to NCRs in A.
afraspera, the sensitivity of AhpnH to two antimicrobial
peptides, polymyxin B [57] and NCR335 from the legume
Medicago truncatula [58] was also tested. AhpnH displayed
a 10-fold lower MIC (48 µg/ml) for polymyxin B than WT 15
(512 µg/ml). In addition, AhpnH was found to be 100-fold
more susceptible than WT to NCR335 (FIG. 7G). AhpnP
withstood all of the aforementioned stressors as well as the
WT, with the exception of acidic stress, where it grew slower
than WT. 20
Example 19: C35 Hopanoids are Required to
Establish an Efficient Symbiosis with A. Afraspera
and with Soybean
25
Because hopanoids are required for microaerobic growth
and stress tolerance in the free-living state, it is hypothesized
that they would aid survival within the plant microenviron-
ment. To test this, the symbiotic phenotypes of AhpnP and
AhpnH on two host plants, soybean and A. afraspera were 30
analyzed.
FIG. 8 shows the symbiotic phenotypes of AhpnP and
AhpnH on soybean. On soybean, at 21 days post inoculation
(d.p.i.), both mutants induced fewer nodules and displayed
reduced nitrogenase activity as estimated by the acetylene 35
reduction assay (ARA) relative to WT (FIG. 8, panels A-C).
The ARA data shown in FIG. 8, panel B has a unit of µcool.
h-i. g-'  per plant as a result of normalization per gram. As
further described with respect to FIG. 11, panels (b) and (d),
the N2-fixation deficit of AhpnH is due to the reduction in 40
nodule mass and the normalization of ARA rates by nodule
dry weight eliminates the N2-fixation rate difference
between wild type and AhpnH (see FIG. 11, panel d, upper
graph vs. FIG. 11, panel b, lower-right graph). Therefore,
one would expect that if the ARA data of FIG. 8, panel B is 45
not normalized per gram, the differences between the WT
and AhpnH mutant would be expected to be more statisti-
cally significant. Thus, under the conditions of these assays,
hpnH mutation appears to have a symbiotic effect on the host
plants when B. diazoefficiens infects soybean. 50
FIG. 9 shows the symbiotic phenotypes of AhpnP and
AhpnH on A. afraspera. Plants inoculated with AhpnH
displayed typical nitrogen starvation symptoms, including
foliage chlorosis, reduced plant growth and half the ARA
activity of WT- and AhpnP-infected plants (FIG. 9, panels A, 55
B). Reduced nitrogen fixation was not due to a decrease in
the number of nodules, which was comparable in WT- and
AhpnH-infected plants at 9, 14 and 21 d.p.i., suggesting that
the hpnH mutation does not affect nodule organogenesis
(FIG. 9, panels C and 10). However, cytological analyses 60
revealed that AhpnH nodules displayed several disorders in
comparison to WT and AhpnP nodules (FIG. 9, panels D-Z').
At the cellular level, AhpnH nodules were smaller (FIG.
9, panels D-F) and had pink or, in —30% of cases, even white
central tissue in contrast to WT and AhpnP nodules, which 65
were dark pink due to the accumulation of the 02-carrier,
leghemoglobin (FIG. 9, panels G-I). The central symbiotic
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tissue of AhpnH nodules was often disorganized and par-
tially infected (FIG. 9, panels L, M, R), as opposed to the
fully occupied tissue of WT and AhpnP nodules (FIG. 9,
panels 7, K, P, T). In some AhpnH nodules, the presence of
necrotic regions—characterized by the accumulation of
autofiuorescent brown compounds—could be seen (FIG. 9,
panels M, N). These are likely polyphenol compounds
whose production is associated with plant defense responses
[59]. Within AhpnH nodules, iodine staining also revealed
accumulation of starch granules in the non-infected cells
surrounding the symbiotic tissue, whereas such granules
were rarely observed in WT and AhpnP nodules (FIG. 90).
Starch accumulation is indicative of an imbalance between
the photosynthates furnished by the plant and the ability of
the bacteria to metabolize them, a typical feature of non-
fixing or underperforming strains [60, 61].
To determine whether AhpnH symbiotic defects stem
from a problem in the bacterial differentiation process or are
due to a damaged membrane, nodule sections were exam-
ined by confocal microscopy using live-dead staining [62]
and TEM to analyze the ultrastructure of bacteroids. Con-
focal microscopy revealed that all strains, including AhpnH,
differentiated properly into elongated bacteroids, which
were, for the majority, viable, as indicated by the green
Syto9 staining (FIG. 9, panels P-U). However, TEM analysis
showed that the cell envelope of some AhpnH bacteroids
was not well delineated and in a few cases, even broken
(FIG. 9, panels Y-Z'). Similar damage was seen in the
peribacteroid membrane that surrounds bacteroids. Deposits
of cellular material, possibly resulting from the release of
plant or bacterial cytoplasm, were also observed in the
peribacteroid space, suggesting a beginning of senescence or
perhaps necrosis of symbiotic bacterial cells (FIG. 9, panels
Z, Z'). Such defects were not observed in the WT (FIG. 9,
panels V-X) or AhpnP nodules.
Taken together, the data indicate that under these condi-
tions C35 hopanoids, but not 2Me-hopanoids, play an impor-
tant role in facilitating the fitness of B. diazoefficiens in
symbiosis with A. afraspera and soybean.
Two reasons the plant host mounts an immune response
against AhpnH may be that the altered mutant surface layer,
as seen in TEM images, is unable to suppress this response
[63] and/or the host induces nodule senescence pre-maturely
on detecting an under-productive symbiont [64]. Consistent
with this, nitrogenase activity is reduced in AhpnH relative
to WT, a likely consequence of poor cell viability. Similarly,
the build-up of plant carbon as starch in AhpnH nodules
might indicate slow metabolism and/or perturbation of
membrane transport processes that facilitate bacteroid car-
bon acquisition.
Example 20: Assessment of Effects of AhpnH in B.
diazoefficiens on A. afraspera Nodules
To assess survival rates of WT B. diazoefficiens and
AhpnH mutants of B. diazoefficiens within A. afraspera root
nodules, live cross-sections of WT and AhpnH within A.
afraspera root nodules were stained with SYTO9 (a live
cell-permeable DNA dye) and propidium iodide (a live
cell-impermeable DNA dye that reports on the fraction of
dead cells). Imaging these sections with confocal micros-
copy revealed that the density and proportion of live bac-
terial cells is indistinguishable between WT and AhpnH
nodules as shown in FIG. 11, panel c. Instead, the main
difference observed was a reduction in size in AhpnH
nodules, reducing the number of infected plant cells.
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To confirm the observed reduction in size, nodules were
harvested from WT- and AhpnH-inoculated plants at 24 dpi
and their dry weight determined. In particular, to calculate
nodule dry weight, all nodules from each plant were har-
vested by hand, transferred into a pre-weighted Eppendorf
tube and dried for 48 hours in a drying oven at 50° C. before
weighting.
As shown in FIG. 11, panel (d), lower graph, consistent
with the microscopy data, the nodule dry mass per plant was
—50% less for AhpnH-inoculated plants. Since the normal-
ization of acetylene reduction rates by nodule dry weight
eliminates the N2-fixation rate difference between wild type
and AhpnH (see FIG. 11, panel d, upper graph), the results
suggest that the N2-fixation deficit of AhpnH is due to the
reduction in nodule mass. The N2-fixation rate per bacterium
is likely similar between the two strains. Thus, the primary
symbiotic defect in the AhpnH mutant observed at 24 dpi
appears to be an inhibition of proper root nodule develop-
ment.
To further test how a nodule volume reduction at 24 dpi
arises, Acetylene reduction assays were performed every 4
days between 8 dpi and 40 dpi. As shown in FIG. 12, panel
a, a total of 36 plants were inoculated for each strain. At each
time point, 4 inoculated plants for each strain (and 1
un-inoculated control plant) were chosen randomly for ARA
measurements. The experiment was repeated once.
The results shown in FIG. 12, panel b indicate that by 40
dpi, the per-nodule N2-fixation rates, number of nodules per
plant, and nodule dry weight per plant are indistinguishable
between the strains. These data demonstrate that a develop-
mental arrest in AhpnH nodules is not sufficient to explain
their low N2-fixation rates.
Example 21: Computational Modeling of Root
Nodule Development in B. diazoefficiens WT and
hpnH Mutant
Plants were inoculated as previously described. After 5-7
dpi, 5 plants each for WT and hpnH were removed from
their plant culture tubes and transferred to a plastic imaging
dish containing pre-warmed, sterile plant medium. Images
of plant roots were taken using a Keyence digital micro-
scope and manually aligned. After imaging each plant was
returned to its original culture tube and returned to the plant
cultivation chamber. Plant roots were imaged every 2-4 days
for 40 days; only nodules that were visible within 14 dpi
were tracked, due to the increasing likelihood of cross-
contamination over time.
For each nodule, the radius was measured and the nodule
volumes were estimated by approximating nodules as
spheres. FIG. 13, panel a plots raw nodule volumes over
time (dpi). Multiple models were tested to identify the
function that best fit the nodule growth curves. FIG. 13,
panel d plots nodule volumes fit to quadratic, exponential or
sigmoidal curves and panel e shows additional parameter
fitting for the sigmoidal fit.
The following parameters were extracted from each fitted
sigmoidal curve: dV/dt, maximum nodule growth rates;
Vmi,,, the time at which a nodule was visible to the naked
eye; Vm,,, maximum nodule volumes; and to, the time of
bacterial internalization (an approximation of the nodule
initiation time, e.g. when volumes surpassed 0.1 rum).
FIG. 14 shows the results from computational modeling
of root nodule development in both B. diazoefficiens WT and
the hpnH mutant. In particular, panel a illustrates a sche-
matic overview of determinate root nodule development.
Parameters describing this process include: to, the time of
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bacterial internalization, and Vo, the volume of the first
infected cell; tm,,,, the time at which a nodule is visible by
eye, and Vm,,,, the smallest nodule volume visible by eye;
tm,,, the time at which nodule growth has leveled off, and
5 Vm,,, the volume of the nodule when nodule growth stops;
dV/dt, the rate of increase in nodule volume between tm,
and tm_. Panel b shows sample wild-type nodule growth
time course. Nodule radii are measured directly and the
nodule volume is determined by approximation of nodules
to 
as spheres. Panel c plots the distribution of newly-emerged
nodules over time (in dpi) for wild-type and hpnH nodules
from 40 plants each.
For each nodule, a sigmoidal curve, such as the sigmoidal
15 curve shown in FIG. 13, panel f, was generated, from which
dV/dt, to, and V_ were extracted. FIG. 14 Panels d,e,f plot
the distributions of dV/dt, predicted to, and V_ for about 75
wild-type nodules and about 50 hpnH nodules.
The results shown in FIG. 14, panels d-f suggest that both
20 reduced nodule growth rates and more variable nodule
initiation times occur for AhpnH nodules, and preliminary
computational simulations suggest they contribute equally
to nodule size defects.
25 Example 22: Polymerase Chain Reaction-Based
Cloning of Hopanoid Synthesis Genes
In the following paragraphs, an exemplary procedure is
provided that is expected to provide effective genetic modi-
30 fication of rhizobia incapable of producing C35 hopanoids
(C35 hopanoid-deficient rhizobia) is described.
In some cases, genetic modification of C35 hopanoid-
deficient rhizobia can be performed by polymerase chain
reaction-based cloning of C35 hopanoid synthesis genes,
35 based on some common approaches described in related
literatures such as the method in Welander et al. (2012) [12]
which is incorporated herein by reference in its entirety.
Briefly, C35 hopanoid synthesis genes including one or
more of shc, hpnH, hpnG, hpnO, hpnP, hpnC, hpnD and
4o hpnE shown in FIG. 2, panel B are cloned into a rhizobium
expression plasmid vector. A suitable plasmid vector such as
those described in Welander et al (2009) [11], Ledermann et
al (2015) Mol. Plant Microbe Interact. 28:959, or Vincze and
Bowra (2006) [65] are used. For example, a plasmid with
45 broad host range such as pPZP211 was engineered contain-
ing a spectinomycin resistance gene, an origin of replication
recognized by the recipient rhizobium and E. coli, and
compatible cloning sites comprising unique restriction endo-
nuclease recognition sites. The cloning site where a C35
5o hopanoid synthesis gene is inserted is downstream of a
promoter recognized by the recipient rhizobium, to ensure
expression of the C35 hopanoid synthesis gene in the recipi-
ent rhizobium. Primers used to amplify a C35 hopanoid
synthesis gene comprise forward and reverse sequences
55 complementary with 5' and 3' ends of a C35 hopanoid
synthesis gene sequence, flanked by sequences for compat-
ible unique restriction endonuclease recognition sites that
are present in the insertion site in the plasmid.
The C35 hopanoid producing rhizobium Bradyrhizobium
6o diazoefficiens can be used as donor species, from which the
hopanoid biosynthesis genes are obtained. Genomic DNA
from Bradyrhizobium diazoefficiens is isolated using a
DNeasy Blood and Tissue Kit (Qiagen). Primers are
designed based on the DNA sequences for genes in the
65 hopanoid synthesis gene cluster required to amplify genes
required for C35 hopanoid biosynthesis, for example hpnH
(Genbank locus tag AAV28 RS 11540) as shown in Table 2,
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with the addition of appropriate restriction endonuclease
recognition sites at the 5' and 3' ends flanking the gene
Hopanoid for example, the C35 hopanoid synthesis gene
hpnH is amplified using PCR and the resulting amplicon is
analyzed by agarose gel electrophoresis. An amplicon band
of the expected size is excised from the gel and purified
using the Wizard SV Gel and PCR Clean-Up System (Pro-
mega). The purified hpnH amplicon is then cloned into the
expression plasmid vector, for example pPZP211 containing
an antibiotic resistance gene, for example spectinomycin to
permit selection of positive clones, as follows. The plasmid
and hpnH amplicon insert are digested with restriction
enzymes to create compatible DNA ends for the inserting the
hpnH amplicon into the pPZP211 cloning site. For ligation
of the insert into the plasmid, the plasmid is mixed with the
hpnH insert, ligation buffer and T4 DNA ligase, and incu-
bated at room temperature for 30 minutes. One aliquot of E.
coli S17-1 competent cells is transformed by electroporation
with the ligation mixture, and streaked onto Luria-Bertani
(LB) agar plates containing antibiotic, for example spec-
tinomycin. 12-16 hours later, colonies are picked and used
to inoculate LB broth cultures containing spectinomycin.
After cultures are grown, 1 mL of bacterial culture is used
for preparing glycerol stocks, which is stored at —80° C. and
used for starting subsequent cultures. The remainder of the
transformed E. coli S17-1 culture is used for plasmid puri-
fication using a QIAprep Spin Miniprep Kit (Qiagen). Integ-
rity of cloned plasmids is assessed using analytical restric-
tion endonuclease digestion and gel electrophoresis.
Following identification of positive clones by analytical
restriction digest analysis, clones are also analyzed by DNA
sequencing, using primers designed to bind to sequences
flanking the inserted amplicon in the plasmid.
Example 23: Transfer of a Plasmid Vector
Comprising a hpnH Expression Plasmid into a
Recipient Rhizobium that Naturally Expresses all
Genes Required for C35 Hopanoid Synthesis
Except hpnH, by Conjugation with E. coli S17-1
Derivatives
In one example, transfer of a plasmid vector expressing
hpnH into a recipient rhizobium expressing all genes
required for C35 hopanoid synthesis except hpnH, is
expected to be performed by conjugation with E. coli S-17
cells that are transformed with a plasmid vector containing
the hopanoid synthesis genes, as follows.
Late log cultures ofE. coli 517-1 (DKNI) strain (5-10 ml)
and a rhizobium recipient strain (10-20 ml) are harvested by
centrifugation (10 min, 5000 rpm). The supernatant is dis-
carded and cells are washed with 10-20 ml sterile 0.9%
NaCl. The OD... of this solution is measured and cells are
again centrifuged. Cells are resuspended in a volume to yield
an OD... of approximately 4. 250 µl of E. coli donor cells
are mixed with 750 µl of a rhizobium recipient strain. The
cell mixture is centrifuged (1 min, 13000 rpm, RT) and the
supernatant reduced to —50 µl in which the cells are resus-
pended. The resuspended cells are transferred as a drop onto
a plate containing suitable growth medium, which is dried
for approx. 15 min under a laminar flow bench. The plate is
incubated for at least two days at 30° C. The cells paste is
collected from the plate with a loop, resuspended in 2 ml
0.9% NaCl and appropriate aliquots (e.g. 50, 100, 200 µl) are
streaked on selective agar plates containing suitable growth
medium and appropriate selection antibiotic. E. coli S17-1
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donor cells are counter-selected with 20 µg/ml chloram-
phenicol which does not interfere with growth of the recipi-
ent rhizobial cells.
Colonies and grown for 48 h in the presence of appro-
5 priate selection antibiotic. Plasmid DNA is isolated from the
recipient rhizobium transformants using a Qiagen plasmid
preparation kit, following the manufacturer's directions.
Plasmids are analyzed using restriction endonuclease diges-
io 
tions and gel electrophoresis and DNA sequencing.
Example 24: Preparation of
Transformation-Competent S. meliloti Cells
As an alternative to conjugation method in Example 23,i5 
transfer of plasmids containing hopanoid synthesis genes
into recipient S. meliloti cells is expected to be performable
using transformation methods. Prior to transformation, S.
meliloti cells is expected to be treated to become transfor-
20 mation-competent, based on the protocol of Vincze and
Bowra (2006) [65] as follows. PSY medium is inoculated
with S. meliloti and grown at 28° C. with vigorous shaking
until it reaches the stationary growth phase.
Two milliliters from the stationary-phase cultures is used
25 to inoculate 50 ml of PSY medium and incubated with
shaking for 6 h at 28° C. Cells are harvested by centrifu-
gation at 12,000 g for 10 min at 4° C., and the pellet is
resuspended in 2 ml of ice-cold 20 mM CaCl2 solution. The
resulting cell suspension is placed into ice-cold 1.5-m1
30 microcentrifuge tubes in aliquots of 100 ul before being
snap-frozen in liquid Nz. The prepared competent cells are
stored at —80° C.
Example 25. Transformation of Competent
35 Recipient S. meliloti Cells with Plasmid Vectors
Comprising Hopanoid Synthesis Genes Using an
Electroporation Method
In one example, S. meliloti are expected to be transform-
4o able with plasmid vectors containing hopanoid synthesis
genes using an electroporation method, based on the method
of Garg et al (1999) [66].
In particular, recipient S. meliloti cells can be grown for
72 h at 30° C. with vigorous shaking to mid-logarithmic
45 phase (absorbance at 600 nm of 0.4 to 0.6). Cells are
prepared for electroporation by a modification of the pro-
cedure of Dower et al (1988) [67]. Cells can be chilled for
15 to 30 min on ice and then harvested by centrifugation at
9,000 rpm for 10 min at 4° C. The cell pellet is washed four
50 times with cold sterile deionized water and finally washed
with 10% glycerol. The cells can be resuspended in 10%
glycerol to have an approximate concentration of 1010 to
10~ i colony-forming units/ml (CFU/ml) and kept on ice. The
cell suspension can be distributed in aliquots of 90 µl and
55 mixed thoroughly with plasmid vector containing hopanoid
synthesis genes (2 µg) by vortexing at high speed for 10 s
and then kept on ice for 30 min. The cell-DNA mixture can
be loaded in a chilled electroporation cuvette with a 0.1-cm
gap (BTX Inc., San Diego, Calif.) and is subjected to a
60 single pulse of high voltage. For pulse generation, an
electrocell manipulator, model 600 (BTX Inc.), may be used
that is capable of generating a field strength of up to 25
kV/cm with a 0.1-cm-gap cuvette. After the pulse is deliv-
ered, the cuvettes are kept on ice for 10 min. The electropo-
65 rated cells are suspended in PSY broth and incubated for 24
h at 30° C. The cell suspension is diluted and plated on
selective medium containing the appropriate antibiotic.
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Colonies from the electrotransformed S. meliloti can be
selected and grown for 48 h in the presence of appropriate
selection antibiotic. Plasmid DNA is isolated from the S.
meliloti transformants using a Qiagen plasmid preparation
kit, following the manufacturer's directions. Plasmids are
analyzed using restriction endonuclease digestions and gel
electrophoresis and DNA sequencing.
Example 26: Transformation of Competent
Recipient S. meliloti Cells with Plasmid Vectors
Comprising Hopanoid Synthesis Genes Using a
Freeze-Thaw Method
In one example, transformation of competent S. meliloti
cells with plasmid vectors containing hopanoid synthesis
genes is expected to be performable following a "freeze-
thaw" method based on that of Vincze and Bowra (2006)
[65]. Approximately 1 ug of a vector plasmid containing
cloned hopanoid synthesis genes, can be made up to a
volume of 5 ul with sterile distilled water. This can be then
added to a 100 ul aliquot of competent cells immediately
after they are removed from —80° C. Subsequently, the
mixture is kept at 37° C. for 5 min without shaking. For the
recovery phase, 1 ml of the appropriate medium is added to
the transformed cells before they are transferred to 10-m1
tubes and incubated at 28° C. for 2 h with shaking. To
determine the actual transformation efficiency, the cell sus-
pension is diluted and plated on nonselective agar medium
to count the cells. Cells without added DNA and the appro-
priately diluted transformation mixture are plated on selec-
tive medium to calculate the number of spontaneous resis-
tant colonies and transformation efficiency, respectively.
Similar to the results of Vincze and Bowra (2006), it is
expected that a 6-h growth period for competent-cell prepa-
ration will be sufficient to produce transformants of fast-
growing species of Sinorhizobium. The S. meliloti transfor-
mants are checked for the presence of the introduced
plasmid comprising cloned hopanoid synthesis genes. Colo-
nies from the transformed S. meliloti are selected and grown
for 48 h in the presence of appropriate selection antibiotic.
Plasmid DNA is isolated from the S. meliloti transformants
using a Qiagen plasmid preparation kit, following the manu-
facturer's directions. Plasmids are analyzed using restriction
endonuclease digestions and gel electrophoresis and DNA
sequencing
Example 27: Transformation of Competent
Recipient S. meliloti Cells with Plasmid Vectors
Comprising Hopanoid Synthesis Genes Using a
Thermal Shock Method
In one embodiment, transformation of S. meliloti with
plasmid vectors containing hopanoid synthesis genes is
expected to be performable by a "thermal shock" method,
based on a protocol by Courtois et al. (1988) [68], as
follows.
The recipient S. meliloti is grown up in the appropriate
medium in a rotary bath shaker (60 revolutions per min) at
30° C. to a density of 10$ CFU/ml, and it maintained static
at 30° C. After 3 h of incubation, the cells are harvested by
centrifugation at 3,OOOxg for 10 min and suspended in the
appropriate medium to give a cell density of 109 CFU/ml.
A0.2-ml portion of this suspension can be added to 0.1 ml
of vector plasmid containing hopanoid synthesis genes dis-
solved in 0.15 M NaCl (pH 7). The mixture is chilled rapidly
at 0° C. After 15 min at 0° C., it is transferred for 5 min at
37° C. then at 0° C. After 40 min, the mixture is incubated
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for 30 min in a 30° C. water bath. Then, to allow phenotypic
expression of the drug markers, the cells are diluted in
appropriate medium and streaked on selective agar plates
containing appropriate medium and antibiotic. After 4 days
5 of incubation at 30° C., S. meliloti transformant colonies are
analyzed for the presence of the plasmid vector.
Colonies from the different electrotransformed S. meliloti
can be selected and grown for 48 h in the presence of
appropriate selection antibiotic. Plasmid DNA is isolated
to from the S. meliloti transformants using a Qiagen plasmid
preparation kit, following the manufacturer's directions.
Plasmids are analyzed using restriction endonuclease diges-
tions and gel electrophoresis and DNA sequencing
15 Example 28: Assessment of the Ability of S.
meliloti Harboring Plasmid Vectors Containing
Hopanoid Synthesis Genes to Form Nodules
In one embodiment, assessment of the ability of geneti-
20 cally modified S. meliloti harboring plasmid vectors con-
taining hopanoid synthesis genes to form nodules is
expected to be based on the method of Vincze and Bowra
(2016) [65].
It is expected that the presence of the plasmid vector will
25 not prevent the transformed S. meliloti from forming effec-
tive nodules on legumes. To confirm the stability of the
plasmid in the S. meliloti during nodulation, bacteria and
bacteroids are isolated from nodules 4 weeks after inocula-
tion and are characterized, as follows. The bacteria are
30 isolated on nonselective medium from the surface-sterilized
nodules. The colonies are tested for antibiotic resistance on
selective plates, and the restriction endonuclease digest
pattern of the purified plasmid was analyzed by gel electro-
phoresis. It is expected that no loss of antibiotic resistance
35 is observed, and the S. meliloti isolated from the nodules
harbors the plasmid vector containing the hopanoid sysnthe-
sis genes.
Example 29: Analysis of C35 Hopanoid Production
40 in Rhizobia
In some cases, screening of rhizobia for the production of
C35 hopanoids is expected to be performed using analysis of
lipids extracted from cultured rhizobia for the presence of
45 C35 hopanoids, based on some common approaches
described in related literatures such as the method in
Welander et al. (2012) [12], which is incorporated herein by
reference in its entirety.
Briefly, rhizobial cells can be grown in YPS medium
50 under aerobic conditions at 30° C. to stationary phase (3
days). Cells are harvested by centrifugation at 4° C. and
lipids are extracted by sonication the cells for 15 minutes at
room temperature in 10 ml of 10:5:4 (v:v:v) methanol
(MeOH): dichloromethane (DCM):water. Samples are cen-
55 trifuged for 10 minutes at 3000xg and the supernatant is
transferred to a new tube. Cell pellets are sonicated again in
10 ml of McOH:DCM:water (10:5:4, v/v/v), centrifuged,
and the supernatant combined with the first extraction.
The samples can be separated into two phases by adding
6o 20 ml 1:1 (v/v) DCM:water, centrifuged for 10 minutes at
3000xg, and the organic phase is transferred to a new vial.
To the remaining aqueous phase, 10 ml of DCM:water (1:1,
v/v) is added again, centrifuged, and the organic phase was
combined with the previous extract. The organic solvents are
65 evaporated under N2 and the total lipid extract (TLE) is
redissolved in 2 ml DCM. The TLE is divided into two 1 ml
aliquots. One aliquot is separated by chromatography on a
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silica gel column. Six fractions are eluted: F1: hexane; F2:
hexane:DCM (4:1, v/v); F3: DCM; F4: DCM:ethyl acetate
(EtOAC) (4:1, v/v); F5: EtOAc; F6: McOH. Separation of
the TLE facilitated the detection of diplopterol in fraction 4.
Fractions 4, 5, 6 and the remaining TLEs are incubated in 5
100 µl of acetic anhydride: pyri dine (1:1, v/v) for 1 hour at
70° C. to derivatize alcohols into acetate esters. The hydro-
carbon fractions (F1 and F2), the acetylated fractions (F4,
F5, and F6), and the acetylated TLEs are analyzed by high
temperature gas chromatography-mass spectrometry (GC- 10
MS) as previously described (Welander et al., 2009) [11].
The acetylated TLEs can be also analyzed by liquid
chromatography-mass spectrometry (LC-MS). A Poroshell
120 EC-C18 column (2.1 x150 mm, 2.7 µm; Agilent Tech-
nologies), set at 30° C., is eluted isocratically first with 15
McOH/water (95:5, v:v) for 2 min at a flow rate of 0.15
ml/min, then using a linear gradient up to 20% (v) of
isopropyl alcohol (IPA) over 18 min at a flow rate of 0.19
ml/min, and isocratic for 10 min. The linear gradient is then
set to 30% (v) of IPA at 0.19 ml/min over 10 min, and 20
maintained for 5 min. The column is subsequently eluted
using a linear gradient up to 80% IPA (v) over 1 min at a flow
rate of 0.15 ml/min and isocratic for 14 min. Finally the
column was eluted with McOH/water (95:5, v:v) at 0.15
ml/min for 5 min. The APCI parameters were as follows: gas 25
temperature 325° C., vaporizer temperature 350° C., drying
gas (N2) flow 6 1/min, nebulizer (N2) flow 30 1/min, capil-
lary voltage 1200 V, corona needle 4µA, fragmentor 150 V.
Data are recorded by scanning from m/z 100 to 1600.
Identification of the hopanoids is done using their exact 30
mass and by comparison of the retention time and the mass
spectra with published data (Talbot et al., 2007; Talbot et al.,
2003b) [69, 70].
Example 30: Genetic Screen of Stress-Resistant 35
Rhizobia as a Biofertilizer
Screening of rhizobia for the production of C35 hopanoids
is expected to be performed by using a method of perform-
ing a diagnostic screen for the presence of C35 hopanoid 40
synthesis. Oligonucleotide primers are designed to amplify
sequences of genes for C35 hopanoid synthesis, based on the
DNA sequences of of the genes.
Briefly, genomic DNA can be isolated from rhizobia and
diagnostic PCR is performed using primers to amplify C35 45
hopanoid synthesis genes. The resulting amplicons are ana-
lyzed by gel electrophoresis to confirm expected DNA band
molecular weight. In addition, DNA sequencing is per-
formed on genomic DNA samples to confirm the presence of
hopanoid synthesis genes. 50
The diagnostic PCR and DNA sequencing can determine
whether C35 hopanoid synthesis genes are present in the
genome of a rhizobium sample, and therefore whether the
rhizobium is capable of synthesizing C35 hopanoids, and
thus to be used as biofertilizer with enhanced stress-resis- 55
tance properties.
The examples set forth above are provided to give those
of ordinary skill in the art a complete disclosure and descrip-
tion of how to make and use the embodiments of the
compositions, microorganisms, systems and methods of the 60
disclosure, and are not intended to limit the scope of what
the inventors regard as their disclosure. Those skilled in the
art will recognize how to adapt the features of the exempli-
fied hopanoids, hopanoids-producing nitrogen-fixing bacte-
ria, leguminous plants and related formulation and uses to 65
others according to various embodiments and scope of the
claims.
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The examples set forth above are provided to give those
of ordinary skill in the art a complete disclosure and descrip-
tion of how to make and use the embodiments of the
compositions, microorganisms, systems and methods of the
disclosure, and are not intended to limit the scope of what
the inventors regard as their disclosure. Those skilled in the
art will recognize how to adapt the features of the exempli-
fied hopanoids, hopanoids-producing nitrogen-fixing bacte-
ria, leguminous plants and related formulation and uses to
others according to various embodiments and scope of the
claims.
All patents and publications mentioned in the specifica-
tion are indicative of the levels of skill of those skilled in the
art to which the disclosure pertains.
The entire disclosure of each document cited (including
patents, patent applications, journal articles, abstracts, labo-
ratory manuals, books, or other disclosures) in the Back-
ground, Summary, Detailed Description, and Examples is
hereby incorporated herein by reference. All references cited
in this disclosure are incorporated by reference to the same
extent as if each reference had been incorporated by refer-
ence in its entirety individually. However, if any inconsis-
tency arises between a cited reference and the present
disclosure, the present disclosure takes precedence. Further,
the computer readable form of the sequence listing of the
ASCII text file P1953-US-Seq-List-ST25 is incorporated
herein by reference in its entirety.
The terms and expressions which have been employed
herein are used as terms of description and not of limitation,
and there is no intention in the use of such terms and
expressions of excluding any equivalents of the features
shown and described or portions thereof, but it is recognized
that various modifications are possible within the scope of
the disclosure claimed. Thus, it should be understood that
although the disclosure has been specifically disclosed by
embodiments, exemplary embodiments and optional fea-
tures, modification and variation of the concepts herein
disclosed can be resorted to by those skilled in the art, and
that such modifications and variations are considered to be
within the scope of this disclosure as defined by the
appended claims.
It is also to be understood that the terminology used herein
is for the purpose of describing particular embodiments only,
and is not intended to be limiting. As used in this specifi-
cation and the appended claims, the singular forms "a,"
"an," and "the" include plural referents unless the content
clearly dictates otherwise. The term "plurality" includes two
or more referents unless the content clearly dictates other-
wise. Unless defined otherwise, all technical and scientific
terms used herein have the same meaning as commonly
understood by one of ordinary skill in the art to which the
disclosure pertains.
When a Markush group or other grouping is used herein,
all individual members of the group and all combinations
and possible subcombinations of the group are intended to
be individually included in the disclosure. Every combina-
tion of components or materials described or exemplified
herein can be used to practice the disclosure, unless other-
wise stated. One of ordinary skill in the art will appreciate
that methods, device elements, and materials other than
those specifically exemplified may be employed in the
practice of the disclosure without resort to undue experi-
mentation. All art-known functional equivalents, of any such
methods, device elements, and materials are intended to be
included in this disclosure. Whenever a range is given in the
specification, for example, a temperature range, a frequency
range, a time range, or a composition range, all intermediate
US 10,131,585 B2
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ranges and all subranges, as well as, all individual values
included in the ranges given are intended to be included in
the disclosure. Any one or more individual members of a
range or group disclosed herein may be excluded from a
claim of this disclosure. The disclosure illustratively
described herein suitably may be practiced in the absence of
any element or elements, limitation or limitations which is
not specifically disclosed herein.
A number of embodiments of the disclosure have been
described. The specific embodiments provided herein are
examples of useful embodiments of the invention and it will
be apparent to one skilled in the art that the disclosure can
be carried out using a large number of variations of the
devices, device components, methods steps set forth in the
present description. As will be obvious to one of skill in the
art, methods and devices useful for the present methods may
include a large number of optional composition and pro-
cessing elements and steps.
In particular, it will be understood that various modifica-
tions may be made without departing from the spirit and
scope of the present disclosure. Accordingly, other embodi-
ments are within the scope of the following claims.
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SEQUENCE LISTING
<160> NUMBER OF SEQ ID NOS: 32
<210> SEQ ID NO 1
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 1
tatctagaaa gcttgcagtt tcccttcgtc gata 34
<210> SEQ ID NO 2
<211> LENGTH: 60
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 2
accatgatac cgtagataga atacacgggg catctggctc gattactccg atagttaatt 60
<210> SEQ ID NO 3
<211> LENGTH: 60
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 3
aattaactat cggagtaatc gagccagatg ccccgtgtat tctatctacg gtatcatggt 60
<210> SEQ ID NO 4
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 4
tatctagact gcagagcagg tccagaagaa gctc 34
<210> SEQ ID NO 5
<211> LENGTH: 36
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 5
tatatatagc ggccgcgcag tttcccttcg tcgata 36
<210> SEQ ID NO 6
<211> LENGTH: 44
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 6
tatatatatc tagacatctg gctcgattac tccgatagtt aatt 44
<210> SEQ ID NO 7
<211> LENGTH: 43
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
68
69
US 10,131,585 B2
-continued
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 7
tatatatatc tagaccccgt gtattctatc tacggtatca tgg 43
<210> SEQ ID NO 8
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 8
tatatatact gcagagcagg tccagaagaa gctc 34
<210> SEQ ID NO 9
<211> LENGTH: 48
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 9
ttcgagctcg gtacccgggg atcctctaga gtggaaccgt cggacagc 48
<210> SEQ ID NO 10
<211> LENGTH: 50
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 10
ttgtcagatc gagacgctca ctggtttaca atcgtttgga caggaagagc 50
<210> SEQ ID NO 11
<211> LENGTH: 50
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 11
gctcttcctg tccaaacgat tgtaaaccag tgagcgtctc gatctgacaa 50
<210> SEQ ID NO 12
<211> LENGTH: 50
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 12
acggccagtg ccaagcttgc atgcctgcag gctgatccac aaggagatcg 50
<210> SEQ ID NO 13
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 13
tatatatagc ggccgcgtgg aaccgtcgga cagc 34
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-continued
<210> SEQ ID NO 14
<211> LENGTH: 44
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 14
tatatatatc tagactggtt tacaatcgtt tggacaggaa gagc 44
<210> SEQ ID NO 15
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 15
tatatatatc tagatgagcg tctcgatctg acaa 34
<210> SEQ ID NO 16
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 16
tatatatact gcaggctgat ccacaaggag atcg 34
<210> SEQ ID NO 17
<211> LENGTH: 32
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 17
tatctagact gcagaacacc atcgggctga ag 32
<210> SEQ ID NO 18
<211> LENGTH: 60
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 18
ggaagcctcg cgcagccgga tcgaatagtt catagcgtaa tgctgtcgcc ggaatttctc 60
<210> SEQ ID NO 19
<211> LENGTH: 60
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 19
gagaaattcc ggcgacagca ttacgctatg aactattcga tccggctgcg cgaggcttcc 60
<210> SEQ ID NO 20
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
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-continued
<400> SEQUENCE: 20
tatctagagg atccttttcg agcatgcctt atcc 34
<210> SEQ ID NO 21
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 21
tatctagaaa gcttaacttt gaagcggatt ggtg 34
<210> SEQ ID NO 22
<211> LENGTH: 60
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 22
tttttgttcg tggtgctgtt tctcgcctta cattacacgt ttctttctgg gcttgaaatt 60
<210> SEQ ID NO 23
<211> LENGTH: 60
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 23
aatttcaagc ccagaaagaa acgtgtaatg taaggcgaga aacagcacca cgaacaaaaa 60
<210> SEQ ID NO 24
<211> LENGTH: 34
<212> TYPE: DNA
<213> ORGANISM: Artificial Sequence
<220> FEATURE:
<223> OTHER INFORMATION: Synthetic polynucleotide
<400> SEQUENCE: 24
tatctagact gcagcctgat tgcaacacag aacg 34
<210> SEQ ID NO 25
<211> LENGTH: 879
<212> TYPE: DNA
<213> ORGANISM: Rhodopseudomonas palustris
<400> SEQUENCE: 25
atgacgtctg cgagcgagct tcgatcgggc aagacccacc gggacgagaa tttcccggtc 60
gcgtcgtgga tcatccatcc gcggcatcgc gacctgattc tggcgttcta caatttcgtc 120
cggaccgcgg acgacatcgc cgatcacgag atgctcgatg gcgacaccaa gctcgaatat 180
ctcgatctgc tcgaagccga gctgctcggc cgcggcgaga cccagcccga ggcggtgcat 240
ctgcgtcggg cgctggccga acgcggcatg ccgccgcgcc atgcgctcga tctgctgacc 300
gcgtttcgga tggacgtcac caagctgcgc tacgaggatt gggacgaggt cattcactac 360
tgccgctact cggcgatgcc ggttggccgc ttcatgctcg acgtccacgg cgaaagcacc 420
acgacctggc aggcctccga cgcgctgtgc gcggggcttc agatcaacaa tcacctgcag 480
gactgcggca aggactatcg caccctcaat cgcgtgtatc tgccacgcga cgtgctcgat 540
gccgccggcg ccaaggtcga agacctcggc ctgcagaagt cgtcaccggc gctgctgaaa 600
74
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tgcctgcagg gtcttgcggt ccgcaccgcg tcgctgctcg gcgacggccg gccgctcgcc 660
gccgagatca aggattatcg cctcggtctc gaagtctcgg tgatccaggc ctatgccgat 720
cgcatcgtgc ggatgctgca gacccgcgat ccgctcagcg agcgcgtgca tctgaagccg 780
atcgaattcg tgatcgccag cttcggcgcg atgagttcgg agatcgtccg tcgtagcttc 840
ggaaaggggc cggtgtcgca tccggcgccg cgcgcatga 879
<210> SEQ ID NO 26
<211> LENGTH: 840
<212> TYPE: DNA
<213> ORGANISM: Rhodopseudomonas palustris
<400> SEQUENCE: 26
atgaccgttc acgccacgcc agagccggcc gcacatcaag gtgtcgcgct cggcagttcg 60
ttctacgccg cgatgcgcat cctgccgcgt ccgcagcgcg aggcgatgtt ccaggtctac 120
agcttctgcc gcttcgtcga cgacatcgcc gattccgatc ggccgcgcga gcagcgggtc 180
gccgagctgc agcaatggcg cgacgacatc gccgcgctgt atcgcggtgc gccgccgccg 240
cggctcgccg actatcagga gtcgctgcgc actttcgggc tgaagcgcga ggacttcgag 300
gcgatcatcg acggcatgga gatggatgtc gacgccgaca tccgcgcgcc cgatgaggcc 360
acgctcgatc tgtactgcga ccgcgtcgcc agcgcggtgg gacggctgtc ggtgcggatc 420
ttcggccttc cggaagccga cggcatcgag ctgtcgcatc atctcggacg cgcgctgcag 480
ctcaccaaca tcctgcgcga catcgacgag gacaccggca tcggccggct gtatctgccg 540
agcgagctgc tgcacaaggt cggtatcacc gcaaccgatc cgcgcgtggt cgcggcggat 600
tctgcgctgc cgagcgtctg cgcgccgctg gtcgagcgtg cgctcgcgca ttttgccgcc 660
gccgacaagg tgatgaaccg taatccgcgc cgggtggtga aagctccccg tatcatgggc 720
aagtactact actcgatctt gcagcttttg atcgcgcgcg gtttcgcagc gccgcgcgcc 780
ccggtgaagc tcggcaaggc ttcgaagatc gccatcctgc tgcaatacgc gatcgtgtga 840
<210> SEQ ID NO 27
<211> LENGTH: 1257
<212> TYPE: DNA
<213> ORGANISM: Rhodopseudomonas palustris
<400> SEQUENCE: 27
atgtcgaaaa cagttcacgt cattggtgcg ggaatctccg ggcttgcggc cgcgatccgg 60
ctcgcccgcg ccggcctcac cgtccatgtt cacgaagcga tgcagcaggc cggtggccgc 120
tgccgctcgt atttcgacgc ccagaccggg cttgtcatcg acaacggcaa tcacctgctg 180
ctgtcgggta atcacgccgc ctgcgactac gcgcggacga tcggcaccga ggcgggcctc 240
gtcggcccgg agcgcgccga gttcgacttc atcgatctgc cggctaatgc gcgctggcgg 300
ctgaagctcg gcggcggcaa gctgccgctg tggctgtttg atgccaatag ccgcgtgccg 360
gacacgtcga tcggcgatta cctcggcttg atgccgctgc tgtgggcgcc gaccaccaaa 420
ctgatcggcg acaccatcaa ctgctccggc ccgctgtacg accgcttggt ggcgccgctg 480
ctgctcgccg cgctcaacgt cgatccgccg gaaggctcgg ccgggcttgc cggcgcggtg 540
gttcgtgaga cgctgctggc cggcggcaag gcctgccggc cgctgatcgc ccgcgatggc 600
ctgtcggcgg tgctggtcga gccggccgtg gcgcagctcg ccgcccgcgg tccaggagtg 660
cagttcggcc acgagctgcg ggcgctgacc ccggccggcg accgcgtcgg cgcgctgcag 720
ttcggcggtg aggatgtcgt caccctcggg ccggatgatg cggtggtgct ggcggtgccg 780
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ccgcgcccgg ccgcttcgct gctgcccggg ctgaagacgc cacaggaata ccgcgcgatc 840
gtgaacgcgc acttcaatta cgcgccgccg cctggcatgc cggccctgac cggggtgatc 900
ggcggggtgg tggagtggct gttcgcgttc ccgaaccggc tgtccgtgac gatcagcaac 960
ggcgaccggc tggtggacgc cccgcgcgag cagcttgcgg ccgaaatttg gggcgaaatc 1020
tgtaaaattg cggggatctc ggccaatctg ccgccgtggc aaattgtccg cgagcgccgc 1080
gccacgttcg ccgctacacc ggcgcagaac gccctgcgcc ccgggccggt cacccagtgg 1140
agaaacctat atctcgcagg cgattggact gatacggggt taccggcgac catcgaggga 1200
tcggtccggt ccggcaaccg tgccgcggac ctggtgctgg ccgctggccg cgcctga 1257
<210> SEQ ID NO 28
<211> LENGTH: 1962
<212> TYPE: DNA
<213> ORGANISM: Rhodopseudomonas palustris
<400> SEQUENCE: 28
atggattccg gcagctacac gactggtgtg gagcgcaacg cgctcgaagc ttcgatcgat 60
gcggcgcgca gcgcgctgct gaattatcgt cgcgacgatg gccattgggt gttcgaactc 120
gaggccgatt gcaccattcc tgccgaatac gtgctgctgc ggcattacct cggcgagccg 180
gtcgatgccg agctcgaagc caagatcgcg gtttatctgc gccgcatcca gggtgcccat 240
ggcggctggc cgctggtgca cgacggcgac ttcgacatga gcgccagcgt gaagggttac 300
ttcgcgctga agatgatcgg cgacagcatc gatgccccgc atatggtgcg ggcgcgcgag 360
gcgatccgtt cgcgcggcgg cgcgatccac tccaacgtct tcacccggtt tctgctcacg 420
ttgtacggcg ttacgacctg gcgcgcggtt ccggtactgc cggtcgagat catgctgctg 480
ccgagctggt cgccgttcac actgaccaag atctcgtatt gggcgcgtac cacgatggtg 540
ccgctgctcg tgctgtgcgc gctgaagccg caggccaaga atccgaaggg cgtcggcatc 600
gacgaactat tccttcagga cccgaagacg atcgggatgc cggtcaaggc gccgcatcag 660
aactgggcgc tgttcaagct gttcggatcg atcgacgcgg tgctgcgcgt gatcgagcct 720
gtgatgccca aaggcatccg caagcgcgcg atcgacaagg cgctcgcctt catcgaggag 780
cggctcaacg gcgaggacgg catgggcgcg atcttcccgc cgatggccaa cgccgtgatg 840
atgtacgagg cgctcggcta tcccgaggac tatccgccgc gcgccagcca gcgccgcggc 900
attgatctct tgctggtcga tcgcggcgac gaagcctact gccagccctg cgtgtcgccg 960
gtgtgggaca ccgcgctcgc cagccatgcg gtgctcgagg cggacggtca cgagggcgcc 1020
aagtcggtgc ggccggcgct cgactggctg ctcccgcgcc aggtgctcga cgtcaagggc 1080
gactgggccg tcaaggcccc gaacgtccgc cccggcggct gggcgttcca gtacaacaac 1140
gcccactatc cggatctcga cgataccgcg gtggtggtga tggcgctcga ccgcgcccgc 1200
aaggaccagc cgaatcccgc ctacgatgcc gcgattgccc gcgcccgcga gtggatcgag 1260
gggatgcaga gcgacgatgg cggctggggt gccttcgaca tcaacaacac tgagtattat 1320
ttgaacaaca tcccgttctc ggaccatggc gcgatgctcg atccgccgac cgaggacgtc 1380
accgcgcgct gcgtctcgat gctggctcag ctcggtgaga ccatggacag cagcccggcg 1440
ctggcccgcg ccgtcggcta tctgcgcgac acccagctcg ccgagggctc ctggtacggc 1500
cgctggggca tgaattacat ctacggcacc tggtcggtgc tgtgcgccct caacgccgcc 1560
ggcgttcccc atgccgatcc gatgatccgc aaggcggtcg cctggctgga gtcggtgcag 1620
aatcgcgacg gcggctgggg cgaggacgcg gtcagctacc gactggatta ccgcggctac 1680
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gaaagtgcac cttcgaccgc ctctcagacg gcatgggctt tgcttgctct gatggctgcg 1740
ggtgaggtcg atcatcccgc cgtggcacgg ggcatcgagt acctgaaaag cacacagacc 1800
gaaaaaggac tgtgggacga gcagcgttac acggcgacgg gcttcccgcg ggtgttttat 1860
ctgcggtatc atggctattc gaagttcttc ccactctggg cgctcgcccg gtatcggaac 1920
ttgcaggcca cgaacagcaa ggtggtaggg gtcggaatgt ga 1962
<210> SEQ ID NO 29
<211> LENGTH: 744
<212> TYPE: DNA
<213> ORGANISM: Rhodopseudomonas palustris
<400> SEQUENCE: 29
gtgattctgg gggcagtgga cgaccaggcc gcggcgcttc gccaagatcc gcggccggta 60
ctgattgtga cgggcctgat tcaggaagca cgtatcgcgg cggggccggg cctcaccgtt 120
atctgcagca gcagtgaccc caagcaattg cgcgcgatca tggccgactt cgacgcatcg 180
tcgatccggg gcgtgatcag cttcggcgtc gccggggggc tggatccctc tctcgaggca 240
ggtgacatcg tcatcgccac cgaggttgtg gcgggtgaac gccgctggac gtcggaagtt 300
gcactgaccg acgaattatt gcgaagcgcc gggctcggcc gtcagcgcgt cgtgcgcggc 360
ggtctggtcg gcgccgagca ggtgatcgca gcgcgctccg ccaaggcggc gctgcgctcg 420
gagaccggtg cggctgcggt cgatatggaa agccacatcg ccgccgattt cgccgccgcc 480
gccaagctgc cgttcgcggc gctccgggtg atcagcgatc cggcgaatcg cagcctgccg 540
cagatcgtgt cgagcgcgat caagccgaac ggcgatatcg acctgcgcaa ggtgctgcgc 600
ggcatcgccc gtcacccgac ctcgatccgc tcgctggtgt cgaccggcat cgacttcaac 660
cgcgcgctgc gctccctgcg cggctgtcgg aactttgtgc aggacgccgt gctcggccgc 720
ggcggtctcg tcgccgagat ctga 744
<210> SEQ ID NO 30
<211> LENGTH: 1161
<212> TYPE: DNA
<213> ORGANISM: Rhodopseudomonas palustris
<400> SEQUENCE: 30
atggctattc cgtttcacaa ggaactggtg atcggcggtt atctgctgaa gcagaagctg 60
ctcgggcgga agcgttatcc gctggtactg atgctggagc cgctgttccg ctgtaacctc 120
gcctgcgccg gctgcggcaa gatcgactat cccgacgcga tcctgaaccg ccggatgacc 180
gcacaagagt gctgggacgc cgccgaggaa tgcggcgcgc cgatggttgc gatcccgggc 240
ggcgaaccgc tgatccacaa ggagatcggc gagatcgtgc gcggcctggt ggcgcgcaag 300
aagttcgtgt cgctgtgcac caacgcgctg ctgctcgaga agaagctgca tctgttcgag 360
ccgtcgccct acctgttctt ctcggtgcat ctcgacggcc tgaaggagca ccacgacaag 420
gcggtgtcgc agcagggcgt gttcgaccgc gcagtcgcgg cgatcaaggc cgccaaggcc 480
aagggcttca ccgtcaacgt caactgcacg gtgttcgacg gctacgccgc cgaagacatc 540
gccaagttca tggacttcac cgaggaactc ggcgtcggcg tctcgatctc gccgggctac 600
gcctatgagc gcgctccgga ccaggagcac ttcctcaacc gcaccaagac caagaacctg 660
ttccgcgagg tgttcgcgcg cggcaagggc aagaagtgga gcttcatgca ctccagcatg 720
ttcctcgact tcctggccgg caatcaggag ttcgagtgca cgccgtgggg tatgccggcg 780
cgcaacattt tcggctggca gaagccctgc tacctgctcg gcgaaggcta cgccaagact 840
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ttccaggagc tgatggaaac caccgattgg gattcctacg gcaccggcaa gtacgagaag 900
tgcgccgact gcatggcgca ttgcggctac gaaccgaccg cggcgatggc ctctctcaac 960
aatccgctga aggccgcctg ggtggcgctc cgcggcatca agacctcggg cccgatggcg 1020
ccggagatcg acatgtcgaa gcagcgcccg gcgcagtacg tgttctccga gcaggtccag 1080
aagacgctga cgcagatccg ccaggacgag gccgccgagg ccaaggacaa gcggcaggcg 1140
gaaaggtcga cggcggcctg a 1161
<210> SEQ ID NO 31
<211> LENGTH: 2607
<212> TYPE: DNA
<213> ORGANISM: Rhodopseudomonas palustris
<400> SEQUENCE: 31
gtgctgaaaa gtgccatcgt ctccattgtc agagccagca cccgttttgc ggcttttact 60
gtgctgatcg gcgtatttct cgcagttgca gcaggtttct atacttacca acatttcggg 120
atcaacacag acatcaatca tttgatctcg tctgatctcg actggcgcaa acgtgatatc 180
gcgttcgaga aggcattcga ccaggaacgg ctgatcctgg ccgtcgtcga ggccccgacg 240
ccggaattcg ccaatgccgc ggcggccaag ctcacggccg aattgtccaa gaataacatc 300
aacttcgact cggtgaagcg gctcggcggc gggccgtttt tcgaccgcag cgggctgctg 360
ttcctgccca aggacgaggt cgccaaggcc accggccagt tccagcaggc ggttcccctg 420
atcgagatca tggccggcga tccgtcgatc cgcggcctga cggcggcact cgagaccggt 480
ctggtcgggt tgaaacgcgg ggaactgacc ctcgacgcca ccgcgaaacc tttcaataca 540
gtcgccgcga ccgtcgagga cgtgctcggc aagcagcagg cgttcttctc ctggcgcggc 600
ctggtcaatc cggaaccgct gaccgatggc gacaagcgcg ccttcatcga ggtcaagccg 660
atcctcgact tcaaggcgct cgaacccggc aaggcggcga ccgacgcgat ccgtcaggcg 720
gcagtcgatc tcaagatcga gcaggatttc ggcgcccggg tgcggctgac cggcccggtg 780
ccgatcgcca acgaggaatt cgctaccgtt aaggacggcg ccgtggtcaa cggcatcggg 840
accgtcgtgg tggtgctgct gatcctctgg atggcgctgc attcctccaa gatcatcttc 900
gcggtggcgg ccaatctggt gatcggcctg tcgatcacca ccgcggtcgg cctgatgctg 960
gtggattcgc tcaacctgct gtcgatcgcg ttcgcggtgc tgttcgtcgg cctcggcgtc 1020
gatttcggca tccaattcag cgtccgctat cgatcggaac gccacaagac cggggacctc 1080
gagaaggccc tggtccaggc cgccgaatac tccgcggtgc cgctgtcact ggcggcgatg 1140
tcgaccacgg ccggcttcct gtcgttcctg ccgacgtcct acaaaggcat ttccgaactc 1200
ggcgagatcg ccggtgccgg catggcgatc gcgttcttca ccagcatcac cgtgctgccg 1260
gcgctgctga agctgctgaa cccggcgggt gagaaggaac cgcttggcta cgccttcctg 1320
gcgccggtcg atcacttcct ggagaagcac cgcatcgcca tcatcgtcgg cacgatcggt 1380
gtcgcgctgg ccggcctgcc actgctgtac ttcatgcatt tcgacttcaa cccgatcaat 1440
ctgcgcagcc cgaaggtcga gtcgatcgcg acgttccttg acctgcgcaa ggatccgaat 1500
accggtgcca acgccgtcaa cgtgatggcg ccgaacgagc aggcggctcg tgagatcgaa 1560
gccaagctcg ccaagctgcc gcaggtatcg cgcaccatct cgctcgacac tttcgtgccg 1620
ccggaccagc cggagaagct gaagctgatc caggccggcg ccaaggtgct ggagcccgcg 1680
ctcaatcccg agcagatcga tccgccgccg tccgatcagg acaatatcgc gtcgctgaag 1740
agctcggccg aagcgctgcg ccgcgccgcc ggcgaggcca ctggacccgg cgccgacgcc 1800
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tcgcgccggc tcgctaccgc gctgaccaag cttgcgggcg ccgatcaggc gatgcgcgag 1860
aaggcccagg acgtgttcgt gcggccgctg ctgctcgact tcgaactgct gcgcaacatg 1920
ctgaaagcgc agccggtgac gctcgacaac ctgccggccg acatcgtgtc gtcgtggaag 1980
accaaggacg gtcagatccg cgtcgaggtg ctgccgagcg gcgaccccaa cgacaacgat 2040
acgctgcgca agttcgccgc cgccgtgctg caggccgagc cgttggcgac cggcggtccg 2100
gtgtcgatcc tgaagtcggg cgataccatc gtggcctcgt tcatccaggc cgggctgtgg 2160
gcgttattgt cgatctcgat cctgctgtgg atcacgctgc gccggatttc cgacgtggcg 2220
ctgaccctgg tgccgctgct ggtggccggt gcggtgacgc tggagatctg cgtgctgatc 2280
gatctgccgc tgaacttcgc caacatcgtc gccttgccgc tgctgctcgg cgtcggcgtc 2340
gcgttcaaga tctattacgt gaccgcctgg cgctccggcc gcaccaacct gctgcagtcg 2400
gcgctgaccc gggcgatttt cttcagcgcc ctgaccaccg ccaccgcatt cggcagcctg 2460
tggctgtcga gccatccggg aacggccagc atgggcaagc tgctggcgct gtcgttgctc 2520
accacgctcg gtgccgtgct gctgttccag ccggccctga tgggcaagcc gcgccacatc 2580
gacgagtccg gcgacaccga tctgtga 2607
<210> SEQ ID NO 32
<211> LENGTH: 1392
<212> TYPE: DNA
<213> ORGANISM: Rhodopseudomonas palustris
<400> SEQUENCE: 32
atgtatcagc cgaatttaga ccttgccgag atgtttgcgg cgcgcgaagc gaaccgcagt 60
tcgatgcacg cccggcatct caacgagcag ctcgtccgcg tcctcaaaac catcggctac 120
gacgtcggct tccagaaggg caccggtcag tacctctacg accgcgacgg cgcccgctat 180
ctcgacctgc tcagcggctt tggcgtcttc gcgctcggcc gcaaccatcc ggtggtgcgc 240
aaggcgttgc agagcgtgct cgatgccgac ctgcccaatc tggtgcagct cgacgtctcg 300
acgctcgccg gtatcctggc tgagcggctg ctcgagcagg tgccgtatct cgacaaggtg 360
ttcttcgcca attccggcgc cgagagcgtc gaggccgcga tcaagttcgc gcgcggtgca 420
acgggacgca acggtatcgt caattgcgac cacagctacc atggcctgac ctacggcgcg 480
ctgtcgctga ccgacgacca gaatttccag ggtggctttg ggccgctgct gccgggtgtc 540
accaccatcc cgttcaacga tctcgaagcg ctggagaagg tgctgtcgac ccgcgaggtc 600
gccgccttca tcgtcgagcc gatccagggc aagggcgtca acatgcccac cgacgagttc 660
ctgccgggcg ccgccgcgct gtgcaaacgc tacggcacgt tgttcgtcgc cgacgaaatc 720
cagaccggca tgggccgcac cggccgcttc ctcgcggtcg agcactggaa tgtcgaaccc 780
gacatggtgc tgctgtcgaa ggcgctgtcg ggcggccacg taccggtcgg cgcggtgctg 840
acccgcaagt cgatcttcga caagatcttc aaccgcatgg atcgcgccgt ggtgcacggc 900
tcgaccttcg ccaagaacga tctggcgatg gctgccggca ttgcgacgct ggaagtcctc 960
aaagccgaga agctggtcga ggccgccgcc aagcgcggcg ccgaattgcg gctggcgctc 1020
acgcgcatgg tccccggcta cgaactgctc aaggaagtgc gcggcaaggg gctgatgatc 1080
ggcgtcgaat tcggcccgcc gcaatcgctg cggctgaagg cgtcgtggac gatgctggag 1140
accgccaaca agggcctgtt cgtccagctg atcaccgtgc cgctgttcaa ggatcacaag 1200
atcctgacgc aggtcgcggg ccatgggctg cacaccatca agctgctgcc gccgctgacc 1260
atcaccgaag acgactgcgc ctggatcgaa cgcgccttcg acgacaccat cgctgccagc 1320
US 10,131,585 B2
85 86
-continued
cacaaggtgc cgggcgcgat ctggtcgctc ggcaagaccc tggtcgacaa cgcggtgcgt 1380
aagtcggcgt as 1392
The invention claimed is:
1. A biofertilizer for a leguminous plant essentially con-
sisting of one or more nitrogen-fixing rhizobia naturally
incapable of producing C35 hopanoids and genetically engi-
neered to include a set of genes of a nitrogen-fixing rhizobia
naturally capable of producing C35 hopanoids, enabling
production of C35 hopanoids by the one or more nitrogen-
fixing rhizobia naturally incapable of producing C35
hopanoids, in a form suitable for administration to one or
more leguminous plant or seed, and/or for administration to
a soil surrounding the one or more leguminous plant or seed,
wherein the set of genes comprises she gene encoding a
squalene-hopene cyclase, hpnH gene encoding a B12
binding radical SAM, and gene hpnG encoding for a
nucleosidase.
2. The biofertilizer of claim 1, the biofertilizer is in
combination with suitable carrier allowing increased stabil-
ity, viability and/or effectiveness of gas exchange of the one
or more nitrogen-fixing rhizobia.
3. The biofertilizer of claim 1, wherein the one or more
nitrogen-fixing rhizobia naturally incapable of producing
C35 hopanoids comprise at least one selected from the group
consisting of Rhizobium eth, Rhizobium leguminosarum,
Mesorhizobium loti, Sinorhizobium meliloti, Azorhizobium
caulinodans, and Ochrobactrum anthropi.
4. A method to provide biofertilizer for a leguminous plant
of claim 1, the method comprising
genetically engineering a nitrogen-fixing rhizobia strain
incapable of producing C35 hopanoids to introduce C35
synthesis genes of a nitrogen-fixing rhizobia naturally
capable of producing C35 hopanoids comprising
squalene-hopene cyclase she gene, B12 binding radical
SAM hpnH gene, and nucleosidase hpnG gene, thus
providing a genetically engineered nitrogen-fixing
rhizobia strain capable of producing C35 hopanoids;
and
providing the genetically engineered nitrogen-fixing
rhizobia strains in a form suitable for administration to
a leguminous plant or seed, and/or a soil surrounding
leguminous plant or seed thus providing the biofertil-
izer for the leguminous plant.
5. A biofertilizer composition for a leguminous plant, the
one or more biofertilizers essentially consisting of one or
more genetically engineered nitrogen-fixing rhizobia
to capable of producing C35 hopanoids of claim 1 together
with an acceptable vehicle.
6. The biofertilizer of claim 5, wherein the acceptable
vehicle is a carrier allowing increased stability, viability
15 and/or effectiveness of the nitrogen-fixing bacteria gas
exchange of the one or more nitrogen-fixing rhizobia.
7. The biofertilizer composition of claim 5, wherein the
one or more nitrogen-fixing bacteria further comprise at
least one Bradyrhizobium.
20 8. The biofertilizer composition of claim 5, wherein the
one or more nitrogen-fixing bacteria naturally incapable of
producing C35 hopanoids comprise at least one selected from
the group consisting of Rhizobium eth, Rhizobium legumi-
25 nosarum, Mesorhizobium loti, Sinorhizobium meliloti,
Azorhizobium caulinodans, and Ochrobactrum anthropic.
9. The biofertilizer composition of claim 5, wherein the
vehicle is a carrier selected from the group consisting of
peat, vermiculite, lignite powder, clay, talc, rice bran, seed,
3o rock phosphate pellet, charcoal, soil, paddy straw compost,
wheat bran, gum Arabic, methylethylcellulose, sucrose solu-
tions, vegetable oils and a mixture thereof.
10. The biofertilizer composition of claim 5, further
comprising one or more C35 hopanoids.
35 11. The biofertilizer composition of claim 10, wherein the
one or more C35 hopanoids comprise the one or more C35
hopanoids having a formula of (I)
H
24
wherein
55 C22, C31, C33 and C34 have independently R or S
chirality;
R, R11, R12 and R13 are independently selected from H, D,
methyl, or ethyl groups;
60 R1, R3, R4, and R5 are selected from H, D, methyl,
hydroxymethyl, aminomethyl, hydroxyl, or amino
groups, wherein at least three of the R1, R3, R4, and R5
groups each contains hydroxymethyl, aminomethyl,
65 
hydroxyl, or amino groups;
R2 is selected from OH, NH2, hydroxymethyl, aminom-
biofertilizer composition comprising ethyl, formula (11)
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Formula (II)
R21
O R22
l0 m2
R23
R25
R24
in which n a wavy line on the ring carbon indicates a R
or S chirality of the ring carbon,
m, and m2 are independently 0 or 1;
R21, R22, R23, R24 and R25 are selected from OH, NH21
hydroxymethyl, or aminomethyl groups wherein R211
R22, R23, R24 and R25 contain at least one NHz or
aminimethyl groups and one of R24 and R25 is
hydroxymethyl, or aminomethyl groups.
12. The biofertilizer composition of claim 10, wherein the
one or more C35 hopanoids comprise at least one C35
hopanoid selected from the group consisting of bacterio-
hopanetetrol (BHT) and aminobacteriohopanetriol,
2-methyl bacteriohopanetriol, aminobacteriohopanetriol,
bacteriohopanetetrol, 2Me-aminobacteriohopanetriol,
adenosylhopane, and 2Me-bacteriohopanetetrol.
13. A seed of a leguminous plant coated and/or inoculated
with the biofertilizer of claim 1.
14. The coated seed of claim 13, wherein the leguminous
plant is soybean (Glycine max).
15. A method of fertilizing a leguminous plant, the
method comprises
applying one or more biofertilizer of claim 1 to a legu-
minous plant or soil surrounding a leguminous plant for
a time and under conditions to allow symbiosis of the
nitrogen-fixing rhizobia with the leguminous plant,
wherein the one or more biofertilizer is in a form suitable
for administration to the leguminous plant, and/or for
administration to a soil surrounding the leguminous
plant.
16. The method of claim 15, wherein applying the one or
more biofertilizer is performed in combination with one or
more C35 hopanoids, and wherein the applying is performed
for a time and under conditions allowing interaction of the
one or more C35 hopanoids with the nitrogen-fixing rhizobia
in the administered biofertilizer and/or biofertilizer compo-
sitions.
17. A method of fertilizing a leguminous plant, the
method comprising
coating and/or inoculating one or more seeds of the
leguminous plant with one or more biofertilizer of
claim 1, in a form suitable for administration to the one
or more seeds of the leguminous plant.
18. The method of claim 17, the method further compris-
ing
coating and/or inoculating one or more C35 hopanoids
before the coating and/or inoculating the one or more
seeds of the leguminous plant with the one or more
biofertilizer.
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19. A system to fertilize leguminous plants, the system
comprising one or more biofertilizer essentially consisting
of one or more nitrogen-fixing rhizobia naturally incapable
of producing C35 hopanoids and genetically engineered to
5 include a set of genes of a nitrogen-fixing rhizobia naturally
capable of producing C35 hopanoids, enabling production of
C35 hopanoids by the one or more nitrogen fixing rhizobia
naturally incapable of producing C35 hopanoids, and/or
biofertilizer compositions comprising said one or more
10 
biofertilizer and one or more C35 hopanoids for simultane-
ous, sequential or combined use in fertilizing a leguminous
plant
wherein the set of genes comprises she gene encoding a
squalene-hopene cyclase, hpnH gene encoding a B12
binding radical SAM, and gene hpnG encoding for a
15 nucleosidase.
20. A system to fertilize a leguminous plant, the system
comprising one or more leguminous seed coated with one or
more biofertilizer essentially consisting of one or more
nitrogen-fixing rhizobia naturally incapable of producing
20 C35 hopanoids and genetically engineered to include a set of
genes of a nitrogen-fixing rhizobia naturally capable of
producing C35 hopanoids, enabling production of C35
hopanoids by the one or more nitrogen-fixing rhizobia
and/or biofertilizer composition comprising said one or
25 more biofertilizer and one or more C35 hopanoids for simul-
taneous, sequential or combined use in fertilizing a legumi-
nous plant
wherein the set of genes comprises squalene-hopene
cyclase she gene, B 12 binding radical SAM hpnH gene,
30 and nucleosidase hpnG gene.
21. The system of claim 19, wherein the one or more
nitrogen-fixing rhizobia comprise at least one selected from
the group consisting of Rhizobium eth, Rhizobium lequmi-
nosarum, Mesorhizobium loti, Sinorhizobium meliloti,
35 Azorhizobium caulinodans, and Ochrobactrum anthropi.
22. The biofertilizer of claim 10, wherein the acceptable
vehicle is a carrier allowing increased stability, viability
and/or effectiveness of the gas exchange of the one or more
nitrogen-fixing rhizobia.
40 23. The biofertilizer composition of claim 10, further
comprising one or more bacteria selected from the group
consisting of Bradyrhizobium BTAil, Bradyrhizobium
japonicum, Bradyrhizobium diazoefficiens, Bradyrhizobium
ORS278, and Methylobacterium nodulans.
45 24. The biofertilizer composition of claim 10, wherein the
one or more nitrogen-fixing bacteria comprise Rhizobium
eth, Rhizobium leguminosarum, Mesorhizobium loti,
Sinorhizobium meliloti, Azorhizobium caulinodans, and
Ochrobactrum anthropi.
50 25. The biofertilizer composition of claim 10, wherein the
vehicle is a carrier selected from the group consisting of
peat, vermiculite, lignite powder, clay, talc, rice bran, seed,
rock phosphate pellet, charcoal, soil, paddy straw compost,
wheat bran, gum Arabic, methylethylcellulose, sucrose solu-
55 tions, vegetable oils and a mixture thereof.
26. The biofertilizer composition of claim 10, wherein the
C35 hopanoids are covalently linked to lipid A to form
HoLA.
